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Abstract 
 
 
Decidualization denotes the differentiation of endometrial stromal cells (EnSCs) 
into specialized decidual cells that control embryo implantation. This process can 
be recapitulated in culture upon treatment of primary EnSCs with cyclic AMP 
analogue and progesterone. In this work, I subjected undifferentiated and 
decidualizing human EnSCs to Assay for Transposase Accessible Chromatin 
with sequencing (ATAC-seq) to map the underlying chromatin changes. 
 
ATAC-seq is a newly developed technique that utilizes the highly active 
transposase Tn5 to interrogate accessibility of the genome and map open 
chromatin regions. These putative cis-regulatory DNA regions can be further 
explored for “footprints” of transcription factor (TF) binding. In this study, I 
optimized ATAC-seq and used this technique first to investigate the regulatory 
mechanisms underlying decidualization of the human endometrial cells. A total of 
185,084 open DNA loci were mapped accurately in EnSCs. Altered chromatin 
accessibility within 10 kb of transcription start sites upon was strongly associated 
with differential gene expression in decidualizing EnSCs. Analysis of 1,533 
opening as well as closing chromatin regions revealed overrepresentation of DNA 
binding motifs for known decidual TFs and identified putative new regulators, 
including RAR related orphan receptor A (RORA), aryl hydrocarbon receptor 
nuclear translocator like (ARNTL) and Meis homeobox 1 (MEIS1). Conversely, 
downregulation of runt related transcription factor 1 and 2 (RUNX1/RUNX2), 
SRY-box 12 (SOX12), transcription factor 3 (TCF3), and ETS Proto-Oncogene 1 
(ETS1) upon decidualization corresponded to loss of corresponding high-affinity 
binding sites differentiating EnSCs.  
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Because of its dynamic nature, cyclic human endometrium is a rich source of 
adult stem cells that could be exploited for clinical purposes. However, clinical 
use of eMSCs is hampered by differentiation and loss of proliferative capacity of 
cells in prolonged cultures. As part of my Monash-Warwick alliance studentship, 
I joined the laboratory of Professor Gargett in Melbourne, Australia, and applied 
integrated ATAC-seq and RNA-seq analyses to study the impact of TGF-β 
receptor inhibition on endometrial mesenchymal stem cells (eMSCs) maintained 
in prolonged culture. I demonstrated that culturing of eMSCs in the presence A83-
01, a small molecule inhibitor the of TGF-β receptor, maintains the proliferative 
capacity and attenuates the loss of stemness features of eMSCs in extended 
cultures. Furthermore, integrated ATAC-seq and RNA-seq revealed that A83-01 
modifies the chromatin accessibility of 5,967 loci and alters the expression 1,463 
genes. Mining and cross-referencing of these data sets revealed that A83-01 not 
only maintains selected stemness-associated genes but also that it represses 
multiple genes involved in extracellular matrix (ECM) deposition and metabolism. 
Furthermore, my analysis indicated that induction nuclear receptor subfamily 4 
group A member 1 (NR4A1, also known as NUR77) may be an important TF that 
mediate the repression of ECM genes in response to A83-01 treatment.  
 
In summary, by integrating advanced genome-wide expression and DNA 
accessibility profiling techniques, my work has advanced our understanding of 
the dynamic changes in the cis-regulatory DNA landscape underpinning 
decidualization of EnSCs and in the maintenance of a stem-like phenotype of  
eMSCs in prolonged cultures. Analyses of these two large data sets revealed  
  
18 
 
novel transcriptional regulators in cycling endometrium and putative new targets 
that could be exploited to accelerate clinical translation of autologous eMSC 
therapies for a variety of reproductive disorders. Furthermore, the data sets 
generated during the course of my investigations constitute an important 
resource to interrogate fundamental molecular questions pertaining to human 
endometrial cell biology.  
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1.1 Human endometrium 
 
The endometrium is the mucosa that lines the uterine cavity. It is composed of 
two major compartments: the basalis, a basal layer lying on the myometrium, 
contains the bases of the endometrial glands immerged in a rich stroma, and the 
functionalis, a functional layer containing the glands extending from surface 
epithelium and a loose stroma (Figure 1.1) (Gargett et al., 2012; Padykula, 1991).  
 
It consists of surface and glandular epithelial cells and a rich stroma. The latter 
comprises a heterogeneous population of cells, such as stem/progenitor cells, 
including mesenchymal stem cells (MSCs) and transit amplifying (TA) cells, 
mature fibroblasts and decidual cells (Table 1.1) (Gargett, 2007; Gellersen et al., 
2007; Gellersen & Brosens, 2014; Masuda et al., 2012; Schwab & Gargett, 2007). 
Both epithelial and stromal cellular compartments are exquisitely responsive to 
ovarian hormone signalling. During the proliferative phase of the menstrual cycle, 
rising estrogen levels from the growing ovarian follicle induce proliferation of the 
tissue (Brosens et al., 2002; Gray et al., 2001). Increasing levels of estrogen 
positively regulates luteinising hormone (LH) through a positive feedback, 
resulting in a LH surge that controls ovulation and stimulates progesterone 
production. By contrast, the post-ovulatory increase in progesterone inhibits the 
proliferative activity and drives the differentiation of the endometrium, which 
renders this tissue transiently receptive to blastocyst implantation during the mid-
luteal phase of the cycle (Gellersen & Brosens, 2003). Acquisition of a receptive 
phenotype coincides with profound changes in the stromal compartment, 
characterised by influx of specialized immune cells (predominantly uterine natural 
killer cells, uNK cells) (Brighton et al., 2017), vascular remodelling, and 
transformation of endometrial fibroblasts into specialized decidual cells (Table 
1.1). In the absence of pregnancy, the corpus luteum will atrophy and 
progesterone production ceases.  
 
The fall in circulating progesterone levels then triggers breakdown of the 
functional endometrial layer and menstrual shedding. The underlying basal layer 
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remains intact and from it a new functional layer regenerates in the following 
menstrual cycle (Gellersen & Brosens, 2014).  
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Figure 1.1. Human endometrium. The endometrium lies on myometrium (grey 
cells). It consists into two compartments: a basal layer, basalis, that persists in 
each cycle and the functional layer, functionalis, which cyclically originates from 
the basalis each month. Blue cells represent endometrial fibroblasts; green cells 
represent stem progenitor cells located around the spiral arterioles (red vessels) 
and into the glandular epithelium. Blue vessels are the veins; orange tubular 
structures represent the glands. 
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Table 1.1 Endometrial stromal cell populations 
 
Cell types Markers/Properties References 
MSCs CD146+PDGFRβ+ Schwab & Gargett, 
2007; Masuda et al., 
2012  
SUSD2+ (W5C5+) 
 
 
clonogenic 
 
 
high proliferative/self-
renewing/multipotent 
 
 
self-renewing 
 
 
multipotent 
 
Transit amplyfing 
(TA) cells 
SUSD2- (W5C5-)  Gargett, 2007 
 
clonogenic 
 
Side population 
(SP) cells 
Low Hoechst 33342 fluorescence Masuda et al., 2010 
Mature fibroblasts SUSD2- (W5C5-)  Gellersen et al., 
2007  
non-clonogenic 
 
 
fibrobalst-like appearance 
 
 
higly responsive to decidual cues 
 
Decidual cells scretory, epithelioid-like stromal cells Gellersen & Brosens, 
2014  
high expression of decidual markers 
 
 
responsive to embryonic cues 
 
uterine natural 
killer (uNK) cells 
immune cells Brighton et al., 2017 
 
CD56+ CD16- 
 
 
clearence of decidual cells as decidual 
process unfolds 
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1.2 Decidualization of the human endometrium  
 
Decidualization, the process of transformation of endometrial stromal cells 
(EnSCs), is initiated in response to elevated progesterone levels and local rise in 
cyclic adenosine monophosphate (cAMP) levels, which in turn trigger sustained 
activation of the protein kinase A (PKA) pathway (Gellersen et al., 2007). 
Decidualization consists of a dramatic transformation of EnSCs into specialised 
secretory cells, which undergo integrated changes in morphology and at 
transcriptome and proteome levels (Gellersen & Brosens, 2014). In most 
placental mammals, decidualization of the endometrium is the maternal response 
to pregnancy and occurs only upon implantation of the blastocyst. The latter 
attaches and penetrates the epithelium by invading the endometrial connective 
tissue. However, in humans and a handful of other mammals, decidualization 
does not require the implantation of the blastocyst but is initiated ‘spontaneously’ 
in each ovulatory cycle. In the absence of pregnancy, falling circulating 
progesterone levels result in breakdown of the decidual superficial endometrial 
layer, menstrual shedding and tissue regeneration (Evers, 2002). Decidual 
reprogramming of the endometrium is critical in all placental species for 
pregnancy. It underpins the acquisition of specialized cell functions, such as the 
ability to deal with increased levels of reactive oxygen species, to modulate 
trophoblast invasion, to regulate vascular and immune responses, and hence 
tolerance to fetal antigens. On the other side, a growing body of evidence 
suggests that an impaired remodelling of the endometrium may cause a multitude 
of pregnancy complications, such as miscarriage, abruption, fetal growth 
restriction and pre-eclampsia (Brosens & Gellersen, 2006). 
 
1.3 Morphological and biochemical reprogramming of EnSCs 
 
During the menstrual cycle, the endometrium exhibits a unique ability to re-build 
itself in response to hormonal signals in order to be ready to accommodate a 
future pregnancy. Both in the proliferative phase of the cycle and in culture, 
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EnSCs are mesenchymal cells with a fibroblast-like appearance (Cornillie et al., 
1985). On the other hand, upon decidualization, endometrial cells undergo huge 
changes in morphology, consisting of a shift from an elongated, spindle shape to 
rounded, enlarged cells with abundant cytoplasm. Further changes include a 
well-expanded rough endoplasmic reticulum and Golgi apparatus, accumulation 
of glycogen and lipid droplets in the cytoplasm, a more rounded nucleus and an 
increase in numbers of nucleoli. Furthermore, multiple cytoplasmic processes 
from cell surface to engulf the extracellular matrix (ECM), or extend into the 
cytoplasm of adjacent cells. Decidualized cells also produce ECM proteins, such 
as laminin, decorin, type IV collagen, fibronectin and heparin sulphate 
proteoglycans (Aplin et al., 1988). 
EnSCs provide a nutritive matrix that is essential for embryo implantation and 
placental development and hence critical for successful pregnancy. In order to 
facilitate this intercellular communication, cadherin-11, a protein belonging to the 
cadherin family, is upregulated in decidualizing cells, especially in stromal cells 
located around spiral arteries. Another highly expressed protein in endometrial 
stromal compartment is protein connexion 43 (CX43), which forms gap junctions, 
between decidualizing stromal cells. In patients with recurrent early pregnancy 
loss, a decrease in the expression of CX43 has been observed, a finding that 
underscores the importance of gap junction-mediated communication (Nair et al., 
2011). 
Decidualization also denotes a biochemical reprogramming of the proliferative 
EnSCs into specialized secretory cells. The major products highly secreted by 
decidualizing cells are prolactin (PRL) and insulin-like growth factor binding 
protein-1 (IGFBP1), two proteins widely used as phenotypic markers of decidual 
EnSCs and to establish the differentiation status of human EnSCs in culture 
(Gellersen & Brosens, 2003). In pregnancy, multiple functions have been 
ascribed to decidual PRL, including stimulating trophoblast growth and invasion 
in the utero-placental interface, regulating uNK cell survival, immune-
suppression, promoting angiogenesis, and modulating the transport of water from 
the amnion towards the maternal compartment. Decidual secretion of IGFBP1, 
also known as placental protein 12, reaches its peak around 16 weeks of 
gestation. However, decidualized stromal cells also produce other secretory 
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products, including a huge number of cytokines (for instance, interleukin-11 [IL-
11]), growth factors (e.g., epidermal growth factor [EGF]), heparin-binding (HB-) 
EGF, Lefty-A, activin A and several neuropeptides. It is thought that these 
secretory products play a role in amplifying the decidual process in an autocrine 
or paracrine way (Dimitriadis et al., 2005). 
This morphologic and biochemical reprogramming of endometrial stromal 
fibroblasts into decidual cells is underpinned by integrated changes observed at 
transcriptome level. In particular, genes encoding superoxide dismutase-2 
(SOD2), growth arrest- and DNA damage-inducible protein of 45kd (GADD45), 
CCAAT enhancer-binding protein b (C/EBPβ), and forkhead transcription factors 
are highly expressed upon differentiation of the endometrial stromal compartment 
in the mid- to late-secretory phase of the cycle, and induced upon decidualization 
of primary stromal cells in vitro. Microarray studies confirmed that decidualization 
involves profound transcriptional changes, which in turn have enabled a 
molecular definition of this differentiation process based on reprogramming of 
gene families that are functionally associated and involved in ECM organization, 
cell adhesion, organization of cytoskeleton, signal transduction, stress response, 
metabolic pathways, differentiation and apoptosis (Giudice, 2004). 
 
1.4 Decidualizing hormonal cues  
 
The physiology of the uterus is regulated by the steroid hormones estrogen and 
progesterone produced by the ovary (Figure 1.2). Luteinizing granulosa cells 
within the ovary produce progesterone, whose levels increase during the 
postovulatory phase of the cycle and play a central role in driving the 
differentiation process of the endometrium. 
Differentiation of the stromal compartment, which starts in cells near the terminal 
spiral arteries and under the luminal epithelium, only becomes apparent 
approximately 10 days after the postovulatory rise in progesterone levels. This 
suggests that the cells require additional signals to initiate this reprogramming 
process. Similarly, treatment of cells in culture with progesterone, alone or with 
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estradiol, induces decidualization, but requires 8 to 10 days to be effective (Bra 
et al., 1997). 
The initiating trigger for decidualization is a rise in the cellular levels of cAMP, a 
ubiquitous second messenger molecule produced by adenylate cyclase. The 
binding of extracellular ligands to Gs protein-coupled receptors activate Gs protein 
and the subsequent activation of adenylate cyclase generates cAMP from 
adenosine triphosphate (ATP). cAMP modifies the gene expression of EnSCs, 
acting through the protein kinase A (PKA) pathway. PKA phosphorylates and 
hence activates target molecules such as cAMP response element binding 
protein (CREB) and cAMP response element modulator (CREM). Consequently, 
CREB and CREM form a dimer and bind to cAMP response elements (CRE) in 
target DNA and also allow the binding of CREB-binding protein (CBP), a histone 
acteyltransferase, to promoter regions of target genes (Maruyama & Yoshimura, 
2008). 
Primary cultures treated with a cAMP analogue express PRL and IGFBP1, the 
phenotypic markers of decidualized cells, within hours, but levels decrease after 
6 to 8 days of culture, suggesting decidualization is not sustained in response to 
cAMP signalling alone. Addition of a progestin not only enhances the cAMP 
response but also maintains the induction of decidual markers in long-term 
cultures. Progesterone acts through the activation of the progesterone receptor 
(PR), a member of the human superfamily of nuclear receptors. It is a receptor 
with multiple functional domains which allow ligand-mediated activation and 
signalling to bind DNA and modulate transcription. PR is present as two major 
isoforms, PR-A and PR-B, which are encoded by a different use of promoter in a 
single gene (Gellersen & Brosens, 2014). The two variants of the receptor differ 
from each other in amino acid content, and in particular PR-B has additional 164 
amino acids at the N-terminal compared to PR-A. However, PR-A is thought to 
be predominant isoform in decidualizing human EnSCs. In female mice, the 
selective ablation of PR-A causes sterility and negatively affects the 
decidualization process, in response to an artificial stimulus (Mulac-Jericevic & 
Conneely, 2004; Richer et al., 2002). 
Cross-talk between cAMP and progesterone signalling pathways drives the 
decidualization process, inducing changes in both transcriptional and proteomic 
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landscape (Gellersen & Brosens, 2003). The mechanisms underlying the synergy 
between cAMP and progesterone signalling in human EnSCs has been studied 
intensely. PR is a nuclear receptor and, in common with other nuclear receptors, 
induces or represses the expression of target genes, depending on its interaction 
with co-activators and corepressors, respectively. In other cell systems, cAMP 
has been shown to disrupt the recruitment of co-repressors in favour of the 
interaction with coactivators. Furthermore, a wide range of transcriptor factors, 
such as SP1, FOXO1, signal transducers and activators of transcription (STAT) 
-3 and -5, and C/EBPβ, are induced by cAMP and have the ability to interact 
directly with the progesterone receptor. (Lynch et al., 2011) found that, in 
placental mammals, some genes expressed in the endometrium that were 
located within transposable elements of the genome. These transposons function 
as enhancers, repressors and insulators and, in response to cAMP and 
progesterone, they interact directly with transcription factors indispensable for 
pregnancy outcome, co-operating in the modulation of gene expression (Lynch 
et al. 2011). 
The transcriptional activity of PR is also tightly regulated by post-translational 
modifications, including phosphorylation, ubiquitination and sumoylation. 
Sumoylation is a process whereby small ubiquitin-related modifier (SUMO) family 
proteins, in an enzymatic reaction similar to the ubiquitin pathway, covalently 
attach a small peptide to target proteins, mainly transcription factors. This 
covalent attachment profoundly modifies the subnuclear position and functions of 
transcription factors. PR-A and PR-B are regulated by SUMO-1 and in particular 
the binding of small ubiquitin modifiers confers the PR-A repressive properties. 
Experimental data demonstrated that the mutation of the single SUMO binding 
site in PR-A changes this isoform into a strong transcriptional activator. It has 
been observed that cAMP second messenger pathway affects the expression of 
several conjugating and deconjugating SUMO enzymes. A consequent loss of 
PR-A sumoylation and increase in receptor activity seems to be related to the 
cAMP pathway (Jones et al., 2006). 
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Figure 1.2. Circulating steroid hormones regulate the human menstrual 
cycle.  Schematic representation of the menstrual cycle, which is divided into 
three main parts, such as menstrual, proliferative and secretory phase, regulated 
by the steroid hormones estrogen and progesterone. The postovulatory increase 
in the progesterone levels and cAMP production initiate the decidual 
transformation of EnSCs during the mid-secretory phase of the cycle. 
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1.5 Regulation of decidual gene expression 
 
Decidualization is featured by a profound reprogramming in the transcriptome. 
Changes in gene expression are finely regulated at transcriptional and epigenetic 
level (Gellersen & Brosens, 2014). 
 
Transposable elements 
 
PRL human gene is expressed in anterior pituitary and stromal cells of the 
endometrium, and in human B-lymphoblastoid cell line IM-9-P3 (Gellersen et al., 
1989). Scientific evidence shows that decidual and lymphoid cells use an 
alternative promoter of human PRL gene compared to pituitary cells. This 
regulatory region is located 5.9 kilobase (Kb) upstream the pituitary promoter. 
Selective activation of this promoter results in transcription of a longer PRL 
transcript. However the resulting protein coding region remains unchanged 
(Gellersen et al., 1989; Di Mattia et al., 1990). Further studies identified CRE-like 
element in the decidual promoter, regulated by cAMP signalling, but resulting in 
a modest transcriptional regulation. Further, a new regulatory region was mapped 
to -332/-270 upstream the transcriptional start site (TSS) (Telgmann et al., 1997). 
This enhancer resulted in a consistent increase in PRL expression in response 
to cAMP signalling (Telgmann et al., 1989; Al-Sabbagh et al., 2011). Interestingly, 
this enhancer is part of a transposable element, named MER20. Transposable 
elements are DNA sequences that can move within the genome. Insertion of 
transposable elements within the chromatin landscape results in addition of 
active regulatory elements, for example promoters, enhancers, repressors, that 
alter gene expression (Fedoroff, 2012). Interestingly, MER20 transposons map 
near genes differentially regulated during decidualization in response to cAMP 
and progestin signalling, for example PRL, Wnt family member 5A (WNT5A), 
hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1). Further, MER20 
transposons contain short sequence binding motifs for transcription factors (TFs), 
essential during decidual transformation, such as progesterone receptor (PGR), 
forkhead box transcription factors of the O subclass (FOXOs), homeobox (HOX) 
proteins and CCAAT/enhancer-binding proteins (C/EBPβ) (Lynch, 2011). 
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Taken together, these observations highlight the role of transposable elements in 
the transcriptional regulation of decidual genes. 
 
Key decidual TFs for decidualization 
 
Several TFs have been implicated in driving changes in gene expression of 
decidual genes. In this section, I will describe the core decidual TFs implicated in 
decidualization of human EnSCs. 
 
CEBPs 
 
During early phase of decidualization, EnSCs express increased level of C/EBPs. 
The latter are members of basic leucine-zipper (bZIP) superfamily of TFs that 
bind DNA sequences (Lekstrom and Xanthopoulos, 1998). C/EBP β-isoform, 
C/EBPβ, has been shown to bind to an enhancer located within MER20 
transposon (Pohnke et al., 1999). Subsequently, C/EBPβ enables binding of 
other TFs, such as FOXO1 and PGR-A (Christian et al., 2002; Christian et al., 
2002). Immunochemistry shows high levels of C/EBPβ in the nuclei of decidual 
cells during the midsecretory phase of the menstrual cycle (Christian et al., 2002; 
Plante et al., 2009). Several lines of evidence indicate that C/EBPβ is implicated 
in interleukin 11 (IL-11) and in cell cycle during decidualization (Wang et al., 
2012). Further, deficiency in C/EBPβ levels in female mice impairs decidual 
transformation of EnSCs and results in infertility (Mantena et al., 2006). Finally, 
absence of C/EBPβ correlates with decreased expression of bone morphogenetic 
protein 2 (BMP2), a morphogen playing a critical role in mouse and human 
decidual EnSCs, and in the regulation of WNT4 (Wang et al., 2012). 
 
FOXOs 
 
FOXOs are proteins belonging to subfamily of forkhead TFs. FOXOs play a role 
in increase accessibility of genomic regions within chromatin, thereby enabling 
recruitment of other TF binding (Lalmansingh et al., 2012). FOXOs regulate 
expression of genes involved in cell growth, differentiation, apoptosis and 
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senescence (Accili & Arden, 2004). cAMP and progesterone signalling positively 
regulate FOXO1 expression upon decidualization. Activation of FOXO1 results in 
cell cycle exit of EnSCs and induce expression, amongst others, of decidual 
markers, PRL and IGFBP-1  (Takano et al., 2007). In response to progesterone 
withdraw, FOXO1 translocate into the nucleus of decidual stromal cells and 
promote apoptosis (Labied et al., 2006). In addition, recent evidence has 
highlighted the role of FOXO1 in driving senescence of EnSCs in an IL-8 
dependent manner (Brighton et al., 2017). Hence, FOXO1 is central role in 
orchestrating cell cycle exit, differentiation and senescence of EnSCs during 
decidualization. 
 
HOX proteins 
 
HOX proteins are a family of TFs controlling body plan along the anterior-
posterior axis. They are featured by conserved sequence, the homeobox (Favier 
& Dolle, 1997). In the human endometrium, HOXA10 and HOXA11 are markedly 
upregulated in the midluteal phase of the menstrual cycle (Taylor et al., 1999). 
Silencing of HOXA10 in vitro negatively impact on PRL and IGFBP1 gene 
expression and result in higher expression of IL-11 and IL-15 (Godbole & Modi, 
2010). Interestingly, a combination between HOXA10 and FOXO1 seem to 
modulate transition from proliferation to differentiation of stromal compartment, 
through differential regulation of the same target genes (Lu et al., 2008). Finally, 
HOXA11 and FOXO1 converge to regulate PRL expression. Specifically, 
HOXA11 binds MER20 transposon within PRL promoter and negatively regulate 
gene expression. Conversely, in the presence of FOXO1, HOXA11 acts an 
activator (Lynch et al., 2009). 
 
Genome-wide chromatin remodelling governs decidual gene expression 
 
Different cellular phenotypes result from distinct gene expression profiles. 
Chromatin organization and a dynamic epigenetic code regulate gene 
transcription. Epigenetic modifications, including nucleosome positioning, DNA 
modifications, TF binding and chromatin regulators, alter genomic structure, 
  
35 
 
thereby sequestering some DNA regions and leaving others open or accessible 
to TF binding (Chen & Dent, 2014).  
 
Gene expression profiling study revealed that genes coding for epigenetic 
modulators are up-regulated during decidualization, and they include histone-
modifiers and binding proteins, DNA methyltransferases and CpG-binding 
proteins. This suggests that a dynamic epigenetic code operates on the 
chromatin landscape of the EnSCs during decidualization and is responsible of 
the acquisition of the decidual identity (Grimaldi et al., 2012). Specifically, an 
example is provided by declining expression level for the histone 
methyltransferase enhancer of Zeste homolog 2 (EZH2) during decidualization. 
This results in a gradual loss of trimethylation of histone 3 on lysine 27 
(H3K27me3) within the proximal promoters PRL and IGFBP1. A coordinated loss 
of methylation and gain of acetylation at the same loci results in increased 
accessibility of the chromatin, which is indicative of a positive regulation of the 
transcription. This chromatin remodelling underpins the acquisition of decidual 
phenotype (Grimaldi et al., 2011).  
 
Also, another study indicates that the use of the DNA methylation inhibitor 5-aza-
2’-deoxycytidine in human EnSCs alters genomic conformation and results, 
amongst others, in the up-regulation fo decidual genes involved in cellular 
properties that feature decidual cells, for example ECM organization and cell 
adhesion (Logan et al., 2010). Conversely, inhibition of methylation prior to and 
after implantation in the mouse impairs decidualization and correlates with 
pregnancy failure (Gao et al., 2012). 
 
These observations suggest that a dynamic epigenetic code operates on the 
chromatin structure as decidualization unfolds. This results in wholesale 
chromatin remodelling underpinning profound changes occurring in the 
transcriptome of the endometrial decidual cells. 
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1.6 Endometrial regeneration requires stem/progenitor cells 
 
The human endometrium exhibits an extraordinary ability to cyclically regenerate 
during each menstrual cycle. As mentioned, endometrial tissue undergoes 
menstrual shedding in response to estrogen and progesterone withdrawal in the 
absence of pregnancy (Gellersen & Brosens, 2014). Menstruation is a rare event 
occurring only in a few species all characterised by spontaneous decidualization, 
such as higher primates, elephant shrews, fruit bats and the common (Cairo) 
spiny mouse (Bellofiore et al., 2017; Emera et al., 2012). One of the theories 
about the evolutionary purpose of menstruation infers its unique role in restarting 
the next reproductive cycle (Emera et al., 2012), through cyclic activation of 
stem/progenitor cells (Evans et al., 2016). 
Human endometrium harbours two stem cell populations, such as epithelial 
stem/progenitor cells and mesenchymal stem cells (MSCs) (Chan et al., 2004; 
Garget et al., 2009; Masuda et al., 2012). The latter represents the major fraction 
of stem cells within the endometrial cell population (about 1-5%) (Gargett et al., 
2009). Endometrial MSCs (eMSCs) exhibit high proliferative potential, self-
renewal capacity in vitro, and ability to differentiate into more mature progeny in 
vivo (Gargett et al., 2016; Miyazaki et al., 2012; Wolff et al., 2007). Bone marrow-
derived cells have been shown to migrate into the endometrium of both human 
and mice, although at low levels. These observations suggest that human 
endometrium regeneration mainly depends on the endogenous stem cell 
population (Gargett et al., 2012).  
Several approaches have been employed to isolate endometrial stromal 
populations enriched in MSCs, including flow activated cell sorting of cells that 
co-express cluster of differentiation 140b (CD140b), also known as platelet-
derived growth factor receptor β (PDGFRβ) and CD146 (also known as 
melanoma cell adhesion molecule, MCAM) (Schwab & Gargett, 2007). Recently, 
a monoclonal antibody (W5C5) has been identified to selectively isolate 
clonogenic perivascular eMSCs using magnetic-activated cell sorting (Masuda et 
al., 2012). Subsequent studies demonstrated that W5C5 antibody binds the type 
1 integral membrane protein Sushi domain containing 2 (SUSD2) 
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(Sivasubramaniyan et al., 2013). This method makes it possible to overcome 
damaging effects on cell viability associated with the use of flow cytometry 
(Schwab & Gargett, 2007).  
 
Identity and gene profile of eMSCs 
 
eMSCs exhibit the ability to both self-renew and differentiate. Cell fate decisions 
are determined by signals emanating from the cellular niche (Li & Xie, 2005). 
Understanding of the gene signature defining eMSC identity provides insights into 
their role in the endometrial regeneration. A recent genome-wide expression 
profiling study compared freshly isolated CD146+ PDGFR-β+ eMSCs to 
endometrial fibroblasts and endothelial cells. The study showed increased 
expression in eMSCs of genes associated with Notch, insulin-like growth factor 
(IGF), epidermal growth factor (EGF), Hedgehog, transforming growth factor β 
(TGF-β), WNT and G-protein-coupled receptor signalling pathways, which have 
been associated with both self-renewal and differentiation, highlighting the role of 
eMSCs in endometrial regeneration and remodelling (Spitzer et al., 2012). 
CD146+ PDGFR-β+ eMSCs express high levels of SUSD2, the integral protein 
used as single marker for eMSC prospective isolation (Spitzer et al., 2012; 
Masuda et al., 2012). 
eMSCs locate in the perivascular niche of the endometrium and express pericyte 
markers, genes associated with angiogenesis, immunomodulation and 
responses to hypoxia (Spitzer et al, 2012). A gene profiling study comparing 
SUSD2+ and SUSD- cells showed that cells derived from SUSD2+ cells are 
characterised by a perivascular gene signature. Interestingly, SUSD2+ cells 
become the major source of cytokines and chemokine production during 
decidualization. This suggests a role for eMSCs in promoting trophoblast 
migration towards maternal vessels and mediating maternal immune response in 
pregnancy (Murakami et al., 2014). 
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eMSCs in regenerative medicine 
 
eMSCs hold great promise for cell-based therapy for women with reproductive 
disorders. eMSCs are clonogenic, self-renewing, highly proliferative, 
immunomodulatory and multipotent, hence they are attractive candidates of cell-
based therapy in regenerative medicine (Darzi et al., 2016).  
 
eMSCs represent an easily accessible source of cells. They can be selectively 
isolated from endometrial biopsy, which can be obtained in a routine office 
procedure without anaesthesia (Garget et al., 2016). They have been detected 
also in post-menopausal endometrium. This enables an autologous use of 
eMSCs for reproductive disorders, including pelvic organ prolapse (POP) in post-
menopausal women (Ulrich et al., 2014). Synthetic polypropylene meshes have 
mainly been used for POP treatment. However, adverse side effects, including 
contraction and pain, raised warnings on their clinical use (Darzi et al., 2016). 
Ulrich et al. (2012) developed a new kind of mesh, composed of polyamide and 
gelatin, with enhanced mechanical properties. eMSCs seeded with these new 
meshes promoted angiogenesis and collagen deposition, compared with mesh 
alone, when implanted into an immunocompromised rat model. Furthermore, an 
early inflammatory response was observed and characterized by an influx of M1 
macrophages, that switched to M2 would healing phenotype and then gradually 
decreased (Edwards et al., 2015). In vitro, eMSCs seeded with polyamide/gelatin 
meshes have been shown to differentiate into smooth muscle cells and 
fibroblasts, suitable to regenerate vaginal tissue structure and ultimately restore 
its function. Further studies have been undertaken to determine if delivered 
eMSCs function through paracrine effect or they differentiate themselves and 
reconstitute the vaginal wall (Gargett et al., 2016). 
Altered endometrial stem/progenitor cell function may potentially hinder 
endometrial regeneration and ultimately compromise the ability of the 
endometrium to support embryo implantation (Yu et al., 2008). Women with a thin 
endometrial layer unable to respond to estrogen stimulation are particularly 
challaging in IVF treatment. Asherman’s syndrome is a reproductive disorder 
characterized by a thin dysfunctional endometrium and it has been hypothesized  
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that it might be related to lack of eMSCs or compromised eMSC function (Gargett 
et al., 2016). In a rat model of Asherman’s syndrome, adipose-derived MSCs 
administrated in the uterine horn promoted angiogenesis and cell proliferation, 
and together with estrogen, reduced fibrosis. Even though, a local delivery of 
MSCs resulted in an apparent improved endometrial regeneration, results in 
terms of endometrial receptivity were not assessed (Kilic et al., 2014; Gargett et 
al., 2016). In several case studies, cultured autologous bone-marrow cells were 
injected into the uterine cavity or the sub-endometrial zone, together with 
estrogen administration. This cell-based approach resulted in a modest increase 
of thickness of the endometrium, no sufficient to guarantee a successful 
pregnancy outcome. However, because of lack of controls, data need to be 
interpreated with caution (Singh et al., 2014; Gargett & Healy, 2011).  
Endometrium is a promising, alternative source of MSCs for autologous and 
allogenic cell-based therapy, that might be exploited to treating gynaecological 
disorders, including POP and Asherman’s syndrome. However, because of their 
rarity the use of eMSCs for clinical trials first requires their expansion in culture 
(Ulrich et al., 2013). As in the case of MSCs from other cell systems (Baxter et 
al., 2004), cultured eMSCs undergo spontaneous differentiation (Gurung et al., 
2015). Further, the telomeres of eMSCs become shortened due to replicative 
stress. Consequently, eMSCs lose their proliferative capacity as well as the ability 
to reconstitute tissue in vivo (Baxter et al., 2004; Banfi et al., 2002). These 
observations predate the realization that prolonged culture of eMSCs results in 
reduced clinical efficacy (Darzi et al., 2016). Gurung et al., (2015) showed that 
culturing eMSCs in medium containing TGF-β Receptor (TGF-β-R) inhibitor, A83-
01, in serum free conditions, maintains eMSCs in an undifferentiated state in 
prolonged culture. Their findings describe the use of small molecules, to 
selectively inhibit signalling pathways associated to differentiation and improve 
the purity of cells during culture expansion for therapeutical applications. 
Nevertheless, for clinical trials it is of paramount importance to understand 
molecular ‘programming’ underlying pharmacological approaches. Development 
of novel techniques, such as Assay for Transposase-Accessible Chromatin with 
High-Throughput Sequencing (ATAC-seq), for fast and sensitive epigenomic 
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profiling of chromatin structure of defined cell populations provides a powerful 
strategy to address this question (Buenrostro et al., 2013). 
 
1.7 ATAC-seq 
 
The human genome contains approximately two metres of DNA, which is 
hierarchically packed into chromatin within a five-micron nucleus. DNA is 
wrapped around a core of proteins, called histones, to form nucleosomes, and 
nucleosomes are compacted into chromatin (Figure 1.3) (Kornberg, 1974; Sha & 
Boyer, 2009). This hierarchical packaging plays a central role in the regulation of 
gene expression (Gross & Grarrard, 1988; Bell et al., 2011). In the genome, two 
different varieties of chromatin are distinguishable, heterochromatin and 
euchromatin. The former identifies inactive genomic regions, whereas the latter 
refers to regions where DNA is lightly packed and hence accessible to 
transcription factors, and therefore is potentially biologically active (Buenrostro et 
al., 2015). Chromatin states are regulated by a dynamic epigenetic code which 
include DNA methylation, histone modification, chromatin remodellers, 
nucleosome positioning, non-coding RNAs, as well as changes due to the 
interaction with transcriptions factors (Kouzarides, 2007). Epigenetic 
mechanisms manipulate chromatin structure and its compaction level, regulating 
chromatin accessibility. Hence, their role in determining cellular phenotypes is 
obvious (Chen & Dent, 2014).  
Open chromatin profiling methods are highly effective means to understand the 
epigenetic code governing chromatin remodelling. They interrogate chromatin 
accessibility and probe regions of nucleosome positioning and TF binding. 
Mapping of differential chromatin opening enables identification of the cis-
regulatory landscape responsible for different cellular functions, including cell 
proliferation and differentiation (Tsompana & Buck, 2014). ATAC-seq is a 
recently developed method for genome-wide analysis of the chromatin structure. 
By contrast to earlier techniques, including DNase-seq (Song & Crawford, 2010), 
ATAC-seq does not require many cells as starting material. The number of cells 
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required to successfully map chromatin accessibility by ATAC-seq ranges 
between 500 and 50,000. Hence, ATAC-seq provides a powerful new method for 
genome-wide chromatin analysis of rare cell types, including stem cells 
(Buenrostro et al., 2013). It uses hyperactive Tn5 transposase to probe DNA 
accessibility by inserting sequencing adapters into relatively open regions of 
chromatin (Figure 1.4).  
ATAC-seq simultaneously reveals information on chromatin compaction, allows 
mapping of nucleosome positions and genomic locations of transcription-factor 
binding. Finally, the whole assay requires less complex and time-consuming 
protocols when compared to previous genome-wide analysis methods 
(Buenrostro et al., 2013).  
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Sha and Boyer, StemBook 2009 
 
Figure 1.3. Chromatin organization. The DNA is wrapped around a core of 
eight proteins, called histones, to form nucleosome (light blue). The latter is the 
basic unit in which the chromatin is organized. Nucleosome packaging into higher 
order structures generates two varieties of chromatin organization, such as 
euchromatin and heterchromatin. The level of the packaging regulates chromatin 
accessibility and consequently gene expression.   
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Buenrostro JD et. al, Nat Methods 2013 
 
Figure 1.4. Schematic representation of ATAC-seq reaction. Tn5 
transposase (green) simultaneously cuts and tagments accessible genomic 
regions (mapped between nucleosomes, in gray) with unique sequencing 
adapters (blue and red). This reaction generates genomic fragments that can be 
amplified via PCR and subjected to high-throughput sequencing.  
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Nucleosome positions 
 
ATAC-seq discloses detailed genome-wide information on chromatin 
compaction. In particular, paired-end reads generated by high-throughput 
sequencing reveal nucleosome positioning in regulatory elements. 
Specifically, the DNA winds 1.7 turns around the nucleosome wrapping a total 
length of 147 bp (McGinty & Tan, 2015). Buenrostro et al., (2013) showed that 
the fragment size distribution of sequenced paired-end reads from human 
chromatin has a periodicity of 200 bp, suggesting that some regions in the DNA 
are protected by steric hindrance which makes the transposition less probable 
(Buenrostro et al., 2013).  Hence, fragments with a length of 200 bp may include 
a single nucleosome and larger fragments may be protected by multiple 
nucleosomes. Therefore, high molecular weight fragments may contain 
chromatin in a more compact state compared to short fragments, hence refractory 
to the transcription machinery that drives differential gene expression.  
 
Buenrostro et al. (2013) also demonstrated that ATAC-seq provides information 
about the different functional states of chromatin, showing that short fragments 
of DNA were enriched in CCCTC-binding factor (CTCF)-bound regions, whereas 
transcription start sites (TSSs) were differentially reduced to fragments 
associated with one, two and three nucleosomes.  Furthermore, this study 
showed that transcribed sequences of DNA and regions mapped to promoters 
had longer multi-nucleosomal fragments, and were hence less accessible 
compared to TSSs. These large fragments of the DNA were enriched in 
heterochromatin that is inaccessible to nuclease digestion (Ghirlando et al., 
2004). This body of evidence suggests that ATAC-seq reveals functional states 
of chromatin that are differentially accessible.  
In order to show the efficacy of ATAC-seq to map nucleosomes within the 
genome, Buenrostro et al. (2013) separated sequencing datasets into shorter 
reads generated from nucleosome-free regions and reads generated by 
nucleosome-associated chromatin, based on the observations related the 
periodicity of the insert size distributions (about 200 bp).  Then, a data track was 
calculated and used to map nucleosomes within accessible regions of chromatin 
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using a simple heuristic model, which measures positively nucleosome-
associated fragments and negatively weights nucleosome-free fragments. The 
nucleosome-free regions were massively enriched in TSSs when compared to 
distant elements, which tended to be enriched in nucleosomes.  
Thus, ATAC-seq allows high-resolution readouts of regions protected by 
nucleosomes and nucleosome-free regions in the regulatory chromatin 
landscape (Buenrostro et al., 2013). 
 
ATAC-seq discloses the position of DNA-binding proteins and the interplay 
between their genomic location and nucleosome positioning 
 
According to Buenostro et al. (2013), transposition is less probable in chromatin 
regions bound by DNA-binding proteins. Footprints generated from ATAC-seq 
inferred the presence of DNA-binding proteins at specific sites in the genome, 
similar to data obtained from DNase digestion footprints; thus providing 
information on transcription factor occupancy. In other words, ATAC-seq 
promises to be a powerful technique to delineate genome regulatory frameworks 
(Hesselberth et al., 2009). 
As aforementioned, ATAC-seq allows detailed mapping of nucleosome positions. 
With respect to the nucleosome locations mapped through ATAC-seq data, 
Buenrostro et al. (2013) identified the position of four major classes of DNA-
binding proteins. A class of proteins has been shown to strongly avoid 
nucleosomes, with binding sites approximately at 180 nucleotides from the 
closest nucleosome positions (NFYA, C-FOS and IRF3 included). A gradation of 
different behaviours, resulting in avoiding or overlapping nucleosome, has been 
mainly ascribed to transcription factors (TFs). The other two groups include 
cohesin-complex subunits RAD21 and SMC3 and chromatin looping factors, 
which belong to a group of factors whose binding sites locate next to nucleosome 
boundary, and proteins which tend to bind DNA associated to nucleosomes 
(Buenrostro et al., 2013). 
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Epigenomic profiling on clinical timescales 
 
ATAC-seq is a rapid and information-rich genome-wide analysis method and thus 
might provide a powerful tool to generate epigenomic analysis on a diagnostic 
timescale. In order to show that clinically remarkable information might be inferred 
by ATAC-seq, Buenrostro et al. (2013) applied the assay to a healthy volunteer’s 
T cells to profile their regulatory chromatin landscape. In particular, IL2 locus was 
the subject of this study. IL-2 is a cytokine which plays a key role in autoimmune 
and inflammatory diseases and is responsible of T-cell growth (Fraser et al., 
1991).  ATAC-seq data revealed the drug target involved in the therapeutic IL-2 
inhibition in proband T cells. Through footprints the method enabled the profiling 
of personalised gene regulatory networks and demonstrated that ATAC-seq 
might be compatible with future diagnostic applications. 
Taken together, ATAC-seq might have a wide applicability to understand genome 
regulatory networks and thus gene expression and offer the possibility to be 
applicable to the translational research for mapping an individual’s epigenome. It 
may potentially be applied to rare, relevant cellular subtypes during the different 
stages of differentiation to improve the understanding of the development of 
human diseases (Buenrostro et al., 2013). 
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1.8 Research Justification and Aims 
 
ATAC-seq is a newly developed technique that utilizes the highly active 
transposase Tn5 to interrogate accessibility of the genome and map open 
chromatin regions. These putative cis-regulatory DNA regions can be further 
explored for “footprints” of transcription factor (TF) binding (Buenrostro et al., 
2013). In the first part of this study, I applied ATAC-seq to investigate the 
regulatory mechanisms underlying decidualization of the human endometrial 
cells, an obligatory transformation for embryo implantation (Gellersen & Brosens, 
2013).  As part of my Monash-Warwick alliance studentship, I joined the 
laboratory of Professor Gargett in Melbourne, Australia, where I studied the 
impact of TGF-β receptor inhibition on endometrial mesenchymal stem cells 
(eMSCs) maintained in prolonged culture. 
 
To address these questions: 
 
1. I established ATAC-seq on EnSCs and mapped dynamic changes in the 
cis-regulatory DNA landscape underpinning decidualization of EnSCs. 
2. I integrated ATAC-seq and RNA-seq analyses to probe changes in the 
chromatin landscape and the transcriptome of cultured eMSCs in 
response to TGF-β inhibition. 
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2.1 Materials and Methods Part 1 
 
The first part of this work has been carried out in the laboratory of Professor Jan 
J Brosens, at the Universtity of Warwick, UK. 
 
2.1.1 Human endometrium tissue sampling 
 
These studies were conducted on endometrial biopsies obtained from women 
undergoing uterine Natural Killer cell test, in the Implantation Clinic, at University 
Hospitals Coventry and Warwickshire (UHCW) National Health Service Trust. 
Pipelle biopsies, timed from mid-secretory phase of the cycle, were obtained from 
patients who gave written informed consent in according with the guidelines in 
The Declaration of Helsinki 2000. Experiments were performed on 
undifferentiated and decidualizing EnSC cultures, established from one patient 
awaiting IVF treatment and 2 recurrent miscarriage (n = 3). None of the patients 
received hormonal therapy for at least 2 cycles prior the biospsy cycle. The study 
was approved by the NHS National Research Ethics-Hammersmith and Queen 
Charlotte’s & Chelsea Research Ethics Committee (1997/5065). 
 
2.1.2 Primary cell culture 
 
2.1.2.1 Isolation of EnSCs 
 
Endometrial biopsies were collected individually in DMEM-F12 medium 
(Invitrogen) supplemented with 10% dextran coated charcoal (DCC) fetal bovine 
serum and processed for primary culture as previously described (Barros et al., 
2016). Briefly, after removing the excess media, biopsies were cut into small 
pieces using sterile scalpels in a Petri dish and enzymatically dissociated in 
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phenol-free DMEM-F12 (Invitrogen) containing 0.5mg/ml collagenase (Sigma 
Aldrich) and 0.1mg/ml deoxyribonuclease type I (DNAse I, Roche) for 1 hour at 
37°C, with vigorous shaking every 20 minutes to aid digestion. DNase and 
collagenase were inactivated by 10% DCC supplemented DMEM-F12 followed 
by centrifugation at 200g for 5 minutes. After centrifuge, cell pellets were re-
suspended in DMEM-F12 containing 10% DCC, 1nM estradiol (Sigma-Aldrich), 
2mg/ml insulin (Sigma-Aldrich), 100 IU/mL penicillin (Gibco), 100g/mL 
streptomycin (Gibco) and 2mM L-glutamine (Gibco), and then transferred to 
tissue culture flasks, mixed gently to ensure distribution of cells and incubated in 
a humidified environment at 37°C and 5% CO2 overnight. Media was changed 
the following day. EnSCs were separated from epithelial cells by attachment 
timings. Here, any suspended cells (epithelial and blood cells), were removed by 
washing attached cells with fresh 10% supplemented media, which was 
subsequently changed every other day. Confluent monolayers of EnSCs were 
passaged by washing with Dulbecco’s Phosphate Buffered Saline (PBS) and 
lifted with 1ml trypsin-EDTA (0.25%, Gibco) for 5 min at 37°C. Any remaining 
attached cells were dislodged by gentle agitation. Subsequently, trypsin activity 
was inhibited by the addition of 9ml 10% DCC supplemented media. Cells were 
collected by centrifugation for 5 min at 200g and seeded into 6-well plates and 
35mm dishes, as required, and cultured in 10% DCC-supplemented media. 
 
2.1.2.2 Decidual timecourse  
 
Confluent monolayers of EnSCs were placed in phenol red-free DMEM/F-12 
containing, L-glutamine, antibiotic/antimycotic and 2% DCC overnight at 37°C. In 
order to induce the differentiated phenotype, human EnSCs were treated with 0.5 
mM 8-bromo-cAMP (Sigma-Aldrich) and 1μM medroxyprogesterone acetate 
(MPA, Sigma-Aldrich) in DMEM-F12 containing 2% DCC, for the indicated time-
points. All experimental treatments were carried out before the third cell passage. 
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2.1.3 ATAC-seq  
 
Decidualized and control EnSC monolayers were subjected to ATAC-seq as 
previously described (Buenrostro et al., 2013; Buenrostro et al., 2015), albeit with 
some modifications.   
 
2.1.3.1 ATAC-seq Nuclei Harvest and Library Preparation 
 
Extract nuclei 
 
Nuclei EZ prep kit (Sigma-Aldrich) was used to harvest nuclei from 
undifferentiated and decidualizing human EnSC cultures. Confluent cell 
monolayers were washed with ice cold PBS and then lysed using ice cold lysis 
buffer (10mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2 and 0.1% IGEPAL CA-
630, Sigma-Aldrich).The cells were scraped and then transferred to pre-labelled 
cold RNase/DNase free 1.5ml eppendorfs. The tubes were vortexed, left on ice 
for 5 min and then pelleted in a fixed-angle refrigerated benchtop centrifuge. The 
latter was used to avoid losing nuclei and the supernatant was carefully discarded 
by pipetting away from the pellet.  
 
Transposase reaction (tagmentation) 
 
Following the nuclei preparation, the pellet was re-suspended in the transposase 
reaction mix, containing 25μl Tagment DNA Buffer, 5μl Tagment DNA Enzyme 
and 20μl nuclease free water (Nextera DNA sample preparation kit – Illumina). In 
order to optimize the time of incubation, the transposition reaction was carried out 
for 30, 45, 60, 90 and 120 min at 37°C. Directly after incubation, samples were 
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pulse-spun to collect reaction and purified using a Zymo DNA Clean and 
Concentrator-5 Purification kit. 
 
Purify DNA 
 
Transposome may bind tightly to DNA ends and interfere with the subsequent 
steps. It is therefore critical to purify tagmented DNA from transposome. Zymo 
DNA binding buffer was added to the 50μl sample which was vortexed and 
transferred to the column. Samples were then spun at 17g for 30 seconds (s) at 
room temperature (RT). The resulting flow through was discarded and 200μl DNA 
wash buffer  (Zymo DNA Clean and Concentrator-5 Purification kit, Zymo 
Research) added, which was centrifuged as described previously.  The wash and 
centrifugation steps were repeated twice. After removing the residual liquid, the 
columns were changed to clean tubes and 23μl pre-warmed elution buffer (Zymo 
DNA Clean and Concentrator-5 Purification kit) added to the columns. The 
samples were incubated for 2 min at RT. To elute the DNA, columns were 
centrifuged for 2 min. 
 
PCR 
 
Following purification, library fragments were re-suspended 20μl sample in a 
0.2mL PCR tube containing the following reagents (Nextera DNA preparation kit 
and Nextera DNA sample preparation index kit, Illumina): 
 5μl Primer Cocktail (PPC) 
 15 μl Master mix (NPM) 
 5μ index 1 
 5μ index 2 
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Subsequently, they were amplified in a traditional PCR machine (AB Applied 
Biosystem, Vetri 96 Well Thermal Cycler, Foster City, CA, USA), using the 
following PCR conditions:  
 
 1 cycle:  72°C for 3 min 
 98°C for 30 s 
 15 cycles:  98°C for 10 s 
63°C for 30 s 
72°C for 1 min 
 
 
PCR clean up 
 
The libraries were purified using AMPure XP, as recommended on the Illumina 
Nextera kit protocol. Each sample was added to 1.5mL Eppendorf lobind tubes 
and then re-suspended in 30μl AMPure beads. The samples were first incubated 
for 5 min at RT and then placed on the magnetic stand. The supernatant was 
carefully aspirated and 200μl of freshly prepared 80% EtOH was added to wash 
the pellet. After 30 s, the supernatant was aspirated and the washing step was 
repeated. All supernatant was then removed and the beads were allowed to air 
dry for 15 min at RT. The samples were removed from the magnetic stand and 
23μl Resuspension Buffer (RSB) (Nextera DNA preparation kit – Illumina) was 
added. The beads were re-suspended, incubated for 2 min at RT and then placed 
on magnet for 2 min. The supernatant was carefully collected into clean tubes. 
 
2.1.3.2 Quantification of amplified DNA library 
 
The amplified libraries were quantified by using Qubit HS DNA Assay, according 
to the manufacturer’s instructions. Briefly, Qubit dsDNA HS dye and Buffer (Qubit 
Assays kit, Invitrogen by life technology Qubit 2.0 Fluorometer) at a ratio 1:200 
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were used to prepare working solution. Qubit dsDNA HS Standard 1 and 
Standard 2 (Qubit Assays kit, Invitrogen by life technology Qubit 2.0 Fluorometer) 
were re-suspended separately in 190μl working solution. They were vortexed and 
left to stand at RT for 2 min. 1μl of the sample was added to 199μl of working 
solution, vortexed and incubated for 2 min at RT. Qubit 2.0 Fluorometer machine 
was used to measure both standards and samples, according to the 
manufacturer’s instructions. 
 
2.1.3.3 Quality Control 
 
Library sizes were assessed on an Agilent Technologies 2100 Bioanalyzer and 
the High Sensitivity DNA chip was used. 
 
2.1.3.4 Sequencing 
  
ATAC-seq library samples were sequenced on an Illumina HiSeq 2500 at Source 
Bioscience. A depth of thirty million paired end reads were sequenced per 
sample, with a read length of 100 bp. 
 
2.1.3.5 Sequencing data analysis 
 
Sequencing data and bioinformatics analysis have been performed in 
collaboration with Pavle Vrljicak, PhD (Tommy’s national Centre for Miscarrigae 
Research, Warwick Medical School) and Associate Professor (A/P) Sascha Ott 
(Tommy’s National Centre for Miscarriage Research, Department of Computer 
Science). Sequenced paired-end reads were aligned to the University of 
California Santa Cruz (UCSC) human genome 19 (hg19) assembly using 
bowtie2-2.2.6 (Langmead and Salzberg, 2012) and samtools-1.2.0 (Li et al., 
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2009) and peak calling performed using MACS-2.1.0 (Zhang et al., 2008). 
185,087 out of 202,169 identified peaks were significant (q < 1 x 10-4).  
HTSeq-0.6.1 (Anders et al., 2015) was used to count the reads overlapping the 
peaks and differential expression analysis of sequencing data 2 (DESeq2) 
(Anders and Huber, 2010) was used to determine opening and closing regions of 
the chromatin. Significant ATAC-seq peaks were ranked based on their p-value 
(p) and their fold change, so that opening and closing peaks correspond to lower 
and higher values, respectively. Data have been submitted to Gene Expression 
Omnibus (GEO) (accession number GSE104720). 
 
2.1.3.6 Comparison between ATAC-seq data and other sequencing 
datasets 
 
ATAC-seq data were cross-referenced with other sequencing data. The analysis 
was performed in collaboration with Pavle Vrljicak, PhD (Tommy’s national 
Centre for Miscarrigae Research, Warwick Medical School) and A/Professor 
Sascha Ott (Tommy’s National Centre for Miscarriage Research, Department of 
Computer Science). More accurately, chromatin immunoprecipitation followed by 
sequencing (ChIP-seq) data obtained from decidualizing EnSCs from GEO, for 
FOSL2 (GSM1703568), PGR (GSM1703567) and FOXO1 (GSM1703607). Also, 
Formaldehyde-Assisted Isolation of Regulatory Elements through high-
throughput sequencing (FAIRE-seq) data from whole endometrial tissue from 
GEO, GSM1011119, and DNase I hypersensitivity (HS) data obtained from 
decidualized EnSCs from GEO, GSE61793. Finally, ATAC-seq data were 
compared to ENCODE DNaseI HS dataset from other cell systems, from the 
UCSC genome browser (The Encyclopedia of DNA Elements (ENCODE) Project 
Consortium, 2012; Thurman et al., 2012; Karolchic et al., 2004). 
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2.1.3.7 Mapping of differential ATAC-seq peaks to proximal genes 
 
Differential open chromatin regions were mapped to cis-regulatory elements of 
their proximal genes using ENCODE DNaseI hypersensitivity data (Thurman et 
al., 2012). Physical interaction and distance no greater than 10 kb were used as 
criteria to assess association between ATAC-seq peak and proximal gene 
regulatory element. The analysis was carried out in collaboration with Pavle 
Vrljicak, PhD (Tommy’s national Centre for Miscarrigae Research, Warwick 
Medical School) and A/Professor Sascha Ott (Tommy’s National Centre for 
Miscarriage Research, Department of Computer Science). 
 
2.1.3.8 Binding Motif Discovery  
 
Hypergeometric Optimization of Motif EnRichment (HOMER) v.4.8 was used to 
determine enrichment and depletion of TF short sequence binding motifs in the 
differential ATAC-seq peaks. Footprint analysis was performed using Wellington 
(Piper et al., 2013). TFs associated to high affinity binding motifs were cross-
referenced with RNA-seq data obtained from three independent undifferentiated 
and decidualizing primary EnSC cultures. The analysis was performed in 
collaboration with Pavle Vrljicak, PhD (Tommy’s national Centre for Miscarrigae 
Research, Warwick Medical School) and A/Professor Sascha Ott (Tommy’s 
National Centre for Miscarriage Research, Department of Computer Science). 
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2.1.4 RNA Sequencing 
 
2.1.4.1 RNA Extraction 
 
To reduce the risk of RNA degradation, RNase and DNase free 1.5 mL 
eppendorfs and nuclease-free water were used. Supernatant was collected from 
the cells and frozen at -80°C for further future studies. Total RNA was extracted 
from EnSCs cultures using 200μl RNA Stat-60 reagent per well in a 6 well plate 
ensuring all cells were covered. The cells were scraped thoroughly with 
appropriate cell scraper, transferred to pre-labelled RNase-free 1.5ml 
eppendorfs, left at room temperature for 5 mins and then placed on ice. 
Subsequently, 40μl of 100% chloroform was added to the Stat-60 solution. The 
samples were mixed vigorously, left to stand at room temperature for 3 mins and 
then centrifuged. This step separates the samples into three distinct phases, such 
as, an aqueous phase, a white layer and a pink phase. RNA remains exclusively 
in the colourless upper aqueous phase. The aqueous phase was carefully 
transferred into ½ a volume of 100% isopropanol, vortexed and centrifuged at 
12,000 g at 4°C for 15 minutes, washed twice with 1ml 75% ice cold ethanol and 
dried at RT and dissolved in an appropriate volume of nuclease free water. RNA 
concentration and quality assessed by nanodrop. Satisfactory values were 
considered equal to or greater than 1.80 on the 260/280 absorbance scale, 
indicating pure RNA without contamination of protein. Samples were stored at -
80°C. 
 
2.1.4.2 RNA Quality Control and RNA Libraries 
 
RNA quality control was assessed on an Agilent Technologies 2100 Bioanalyzer 
according to the manufacturer’s instructions RNA samples with RNA Integrity 
Number (RIN) > 8 were used to generate RNA libraries.  High quality RNA 
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samples were used to generate RNA libraries according to the Illumina Stranded 
mRNA protocol at Source Bioscience. Library size was assessed on an Agilent 
Technologies 2100 Bioanalyzer and quantified by Qubit and quantitative 
polymerase chain reaction (qPCR).  
 
2.1.4.3 RNA Sequencing  
 
RNA libraries were sequenced on the Illumina HiSeq3000 at Source Bioscience. 
Fifty million single end reads were sequenced per sample with a read length of 
100 bp. 
 
2.1.4.4 Sequencing data analysis 
 
RNA-seq data analysis was performed in collaboration with Pavle Vrljicak, PhD 
(Tommy’s National Centre for Miscarriage Research, Warwick Medical School) 
and Associate Professor Sascha Ott (Tommy’s National Centre for Miscarriage 
Research, Department of Computer Science, University of Warwick). 
Transcriptomic maps were identified using bowtie-2.2.3, samtools-0.1.19 and 
tophat-2.0.12 against the UCSC hg19 transcriptome reference from the Illumina 
iGenomes resource (2014). Counts were assessed using HTSeq -0.6.1 and 
transcripts per million (TPM) were calculated. Three different methods for 
detection of differentially expressed genes were used to analyse count data, such 
as DESeq2, baySeq and edgeR. To characterize differentially expressed genes, 
the latter were subjected to Gene Ontology (GO) enrichment analysis using the 
Database for Annotation, Visualization and Integrated Discovery (DAVID) version 
6.8. 
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2.2 Materials and Methods Part 2 
 
The second part of this work has been carried out in the laboratory of Professor 
Caroline Gargett, at Monash University, The Ritchie Centre, Hudson Institute, 
Australia. 
 
2.2.1 Human endometrium tissue sampling 
 
The study was approved by the Monash Health and Monash University Human 
Research Ethics committees. Endometrial biopsies were obtained from pre-
menopausal women (n = 3), without endometrial pathologies, who gave written 
informed consent according to The Declaration of Helsinki (2000) guidelines. 
Women were excluded if they had taken any hormonal treatment for the 
preceding three months. 
 
2.2.2 Primary cell culture 
 
2.2.2.1 Isolation and magnetic-activated cell sorting of eMSCs 
 
Endometrial biopsies were processed and single-cell suspension of eMSCs 
obtained as previously described (Masuda et al., 2012). Briefly, endometrial 
tissue was finely minced and enzymatically digested in Dulbecco’s modified 
Eagle’s medium (DMEM-F12) supplemented with 0.5 collagenase type I 
(Worthington Biochemical Corporation) and 40 µg/ml DNase I (Worthington 
Biochemical Corporation) at 37°C on a rotating MACSmix (Miltenyi Biotech) for 
60 min. The digested tissue was filtered through 40 µm nylon mesh cell strainer 
(BD Bioscience) to remove epithelial glandular cells then centrifuged at 1100rpm 
for 5 min. Supernatant was carefully aspirated and red blood cells removed using 
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Ficoll-Paque (GE healthcare Bio-science), a density gradient media. After 
centrifuge at 1500 rpm for 15 min, the interface containing EnSCs was carefully 
aspirated and washed in DMEM/F12 containing 10% fetal calf serum (FCS, 
Thermo Fisher) (Invitrogen), 1% antibiotic/antimycotic (Life Technologies) and 
2mM glutamine (Invitrogen). EnSC single-cell suspension were re-suspended in 
separation buffer, such as 0.5% FCS/PBS, and 10 µg/ml phycoerythrin (PE)-
conjugated anti-human SUSD2 (BioLegend) added. Cells were incubated for in 
the dark at 4°C for 30 min. After incubation, the cells were washed to remove 
unbound primary antibody in separation buffer and centrifuged at 1100rpm for 5 
min. The supernatant was then carefully aspirated and the pellet was re-
suspended in separation buffer (80 µl/107 total cells, according to the 
manifacturer’s instructions) and 20 µl of anti-PE magnetic active cell sorting 
(MACS) microbeads (Miltenyi Biotec) in the dark at 4°C for 30 min. The cells were 
washed in separation buffer and centrifuged at 1100rpm for 5 min. The 
conjugated pellet was re-suspended in separation buffer (500 µl/107) and applied 
to a Miltenyi column (Myltenyi Biotec) in the magnetic field (MACS separator). 
Columns were flushed three times with buffer and unlabelled cells that passed 
through were collected in a sterile tube. Magnetically labelled cells, such as 
SUSD2+ eMSCs, were eluted with buffer away from the magnetic field and  cell 
number was determined using glasstic slide 10 with grids according to the 
manufacturer’s instructions. 
 
2.2.2.2 Cell culture   
 
SUSD2+ eMSCs yielded from MACS separation were cultured in DMEM-F12 
medium containing 10% FCS (Invitrogen), 1% antibiotic/antimycotic (Life 
Technology) and 2mM glutamine (Invitrogen), supplemented with 10 ng/ml basic 
fibroblast growth factor (bFGF) and slowly scaled-down to an in-house 
DMEM/F12 serum free medium (SFM) at 37 °C, 5% CO2, as previously described 
(Rajaraman et al., 2013) in the presence or absence of 1 µM TGF-β-R inhibitor, 
A83-01) (Tocris Bioscience). Cells were seeded at conventional density (5,000 
cells/cm2) and media was changed every 48h. Both untreated and A83-01 treated 
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eMSC cultures were passaged on day 15, 22, 29 and 36 in fibronectin-coated 
T25 culture flasks (10 µg/ml; Becton Dickinson, BD, Bioscience) as previously 
described (Gurung et al., 2015). At each passage, cells were counted as 
described above and cumulative cell population (total cell number) was 
calculated by multiplying total number of cells yielded at the current passage by 
total number of cells yielded at the previous passage, and then divided by the 
number of cells seeded at the current passage, as previously described (Gargett 
et al., 2009). Cell proliferation at each passage was also assessed by calculating 
the number of population doublings (PDs) using the following formula: PD = 
3.322logN/N0, where N is the total cumulative cell number calculated at each 
passage and N0 represents the initial number of seeded primary cells (Pellegrini 
et al., 1999). At day 36, untreated and A83-01 treated eMSC cultures were 
subjected to flow cytometry, RNA-seq and ATAC-seq. 
 
2.2.3 Flow cytometry 
 
Surface phenotype for untreated and A83-01 treated eMSCs was assessed by 
flow cytometry for three stem cell markers, such as SUSD2, CD140b and CD90, 
as previously described, albeit with some modifications (Gurung et al., 2015). 
eMSCs were incubated with 1:20 allophycocyanin (APC)- and PE- conjugated 
primary antibodies or matched isotype control antibodies, in PBS containing 2% 
FCS for 1h at 4°C in dark. The primary antibodies used were APC-conjugated 
SUSD2 (Biolegend), PE- conjugated CD140b (R&D) and APC- conjugated CD90 
(BD Pharmingen). After incubation, cells were washed with PBS containing 2% 
FCS to remove unbound cells and then fixed with 4% paraformaldehyde (PFA) in 
PBS containing 2% FBC. Untreated and A83-01 treated eMSCs were analysed 
using BD FACSCanto II (BD Bioscience) (10,000 events captured/sample per 
flow) and software FlowJo v.10. 
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2.2.4 RNA Sequencing 
 
2.2.4.1 RNA Extraction 
 
Total RNA was extracted from untreated and A83-01 treated eMSCs using 
RNeasy Mini kit (Qiagen) according to the manifacturer’s instructions, albeit with 
some variations. Briefly, eMSC monolayers were washed with PBS and 
trypsinised using TryLETM (Life Technologies). DMEM/F12 containing 5% heat-
inactivated newborn calf serum was added to cell-suspension to inactivate trypsin 
and cells were transferred to an RNase-free centrifuge tube to minimize risk of 
RNA degradation. Cell suspensions were then centrifuged at 300g for 5 min. To 
disrupt the cells, RNeasy Lysis (RLT) Buffer, containing β-mercaptoethanol, was 
added to cell pellets (600 µl up to 107 cells) and mixed by pipetting/vortexing. 
After adding 1 volume of 70% ethanol, cell suspensions were transferred to an 
RNeasy spin column placed in a 2 ml collection tube. Samples were centrifuged 
at maximum speed (≥ 8000 g) for 15 sec. Flow-through was discarded. To 
minimize genomic DNA contamination, the optional four steps were performed. 
350 µl RNA wash (RW1) Buffer was added to the RNeasy spin column to wash 
column membrane. Samples were centrifuged at maximum speed for 15 sec and 
flow-through discarded. 80 µl DNase I incubation mix, prepared according to the 
manufacturer’s instructions, were added carefully on the membrane of the 
RNeasy spin column and left at room temperature for 15 min. To wash the 
membrane, 350 µl Buffer RW1 were added to the RNeasy spin column and 
samples were centrifuged and flow-through discarded. To further wash the 
column membrane, 500 µl Buffer RPE were added to tube. Samples were 
centrifuged at maximum speed for 15 sec. The washing step was repeated again, 
but this time samples were centrifuged for 2 min to further wash the column 
membrane. Flow-through was discarded and, to eliminate Buffer RPE 
completely, the RNeasy spin column was placed in another 2 ml collection tube 
and centrifuged at maximum speed for 1 min. To elute the RNA, the RNeasy spin 
column was transferred to a new collection tube and 30 to 50 µl RNase-free water  
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was added carefully to the membrane of the column.  
 
2.2.4.2 RNA Quality Control and RNA Libraries 
 
RNA quality control and RNA libraries were performed at the Monash Health 
Translation Precinct (MHTP) Medical Genomic Facility.  The former was 
assessed on an Agilent Technologies 2100 Bioanalyzer according to the 
manufacturer’s instructions RNA samples with RNA Integrity Number (RIN) > 8 
were used to generate RNA libraries.  The latter were produced according to the 
Illumina Stranded mRNA protocol. Library size was assessed on an Agilent 
Technologies 2100 Bioanalyzer and quantified by Qubit and quantitative 
polymerase chain reaction (qPCR).  
 
2.2.4.3 RNA Sequencing  
 
RNA libraries were sequenced on the Illumina HiSeq3000 at MHTP Medical 
Genomic Facility. Fifty million single end reads were sequenced per sample with 
a read length of 50 bp. 
 
2.2.4.4 Sequencing data analysis 
 
RNA-seq data analysis was performed as described in 2.1.4.4 in collaboration 
with Pavle Vrljicak, PhD (Tommy’s National Centre for Miscarriage Research, 
Warwick Medical School) and Associate Professor Sascha Ott (Tommy’s 
National Centre for Miscarriage Research, Department of Computer Science, 
University of Warwick).  
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2.2.5 ATAC-seq 
 
Freshly isolated MSCs were treated with or without TGF-β-R inhibitor for 36 days 
and then subjected to ATAC-seq. ATAC-seq libraries were processed as 
described in 2.2.3 and data analysed in collaboration with Pavle Vrljicak, PhD 
(Tommy’s National Centre for Miscarriage Research, Warwick Medical School) 
and Associate Professor Sascha Ott (Tommy’s National Centre for Miscarriage 
Research, Department of Computer Science, University of Warwick). 
 
2.2.6 in vitro colony-forming unit-fibroblast (CFU-F) assay 
 
eMSCs were cultured with or without A83-01 for 2 passages (29 days) and then 
seeded at a low density (50 cells/cm2) to assess colony efficiency as previously 
described, albeit with some modifications (Gurung et al., 2015). Briefly, untreated 
and A83-01 treated eMSCs were seeded on fibronectin (10 µg/ml) pre-coated 10 
mm culture dishes (BD Falcon) and cultured in SFM, supplemented with bFGF 
(1 µl/ml, Peprotech) and EGF (1ul/ml; Invitrogen), in the presence or absence of 
A83-01 (0.1 µl/ml, Tocris Bioscience) at 37°C 5% CO2, further for 2 weeks. Media 
was changed every 48h. Untreated and treated eMSC cultures were fixed in 10% 
formalin for 10 min and stained with haematoxylin (Amber Scientific). Samples 
were washed twice with distilled water and the Scott’s tap water was used to 
enhance blue colour of the colonies stained. The number of colonies was counted 
and colony efficiency percentage estimated by dividing total number of colonies 
yielded by number of cells seeded x 100. 
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2.2.7 Statistical Analysis 
 
Statistical analyses were performed with GraphPad Prism 6. Where appropriate, 
two-way analysis of variance (ANOVA) or paired non parametric Wilcoxon test 
was applied. Data represent mean ± standard error of the mean (S.E.M). Values 
of p-value (p) < 0.05 were considered statistically significant.  
For RNA-seq data analysis, statistical significance was assessed on a large 
number of variables (i.e. genes). Benjamini-Hochberg procedure was applied to 
control the false discovery rate. Changes in gene expression were deemed 
statistically significant if the adjusted p-value (q-value) was less than 0.05. 
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Chromatin profiling  
in decidualizing human 
endometrial stromal cells 
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3.1 Introduction 
 
Decidualization is a profound transformation of EnSCs from fibroblast-like to 
secretory decidual cells that occurs ‘spontaneously’ in menstruating species 
(Brosens et al., 2006). Decidual transformation involves large-scale gene 
expression changes (Gellersen & Brosens, 2014; Takano et al., 2007). Genome-
wide remodeling of the chromatin architecture underlies the wholesale 
transcriptomic reprogramming upon decidualization (Munro et al., 2010; Zelenko 
et al., 2012). Gene expression profiling studies revealed that genes coding for 
epigenetic modulators are up-regulated during decidualization, and they include 
histone-modifiers and binding proteins, DNA methyltransferases and CpG-
binding proteins. This suggests that a dynamic epigenetic code operates on the 
chromatin landscape of the EnSCs during decidualization and is responsible of 
the acquisition of the decidual identity (Grimaldi et al., 2012). Specifically, an 
example is provided by declining expression level for the histone 
methyltransferase enhancer of Zeste homolog 2 (EZH2) during decidualization. 
This results in a gradual loss of trimethylation of histone 3 on lysine 27 
(H3K27me3) within the proximal promoters PRL and IGFBP1. A coordinated loss 
of methylation and gain of acetylation at the same loci results in increased 
accessibility of the chromatin, which is indicative of a positive regulation fo the 
transcription. This chromatin remodelling underpins the acquisition of decidual 
phenotype (Grimaldi et al., 2011).  Also, another study indicates that the use of 
the DNA methylation inhibitor 5-aza-2’-deoxycytidine in human EnSCs alters 
genomic conformation and results, amongst others, in the up-regulation fo 
decidual genes involved in cellular properties that feature decidual cells, for 
example ECM organization and cell adhesion (Logan et al., 2010). Conversely, 
inhibition of methylation prior to and after implantation in the mouse impairs 
decidualization and correlates with pregnancy failure (Gao et al., 2012). These 
observations suggest that a dynamic epigenetic code operates on the chromatin 
structure as decidualization unfolds. 
 
Recent technological advances have enabled the rapid profiling of open 
chromatin landscapes using genome-wide analysis techniques, such as ATAC-
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seq. This assay probes regions of increased accessibility and further interrogates 
them for “footprints” of TF binding (Buenrostro et al., 2013). Footprints are 
sequences of tens of basepairs (bp) that infer the presence of DNA-binding 
proteins (Hesselberth et al., 2009). The latter makes the chromatin less 
accessible and hence refractory to transposase activity (Buenrostro et al., 2013). 
Previous work has characterized whole endometrial open chromatin signatures 
by Formaldehyde-Assisted Isolation of Regulatory Elements through high-
throughput sequencing (FAIRE-seq) and DNase-seq in decidualized EnSCs 
(Lynch et al., 2015; Thurman et al., 2012). This provided genome-wide views of 
open chromatin regions, but did not show what changes occur in decidualization. 
 
In this chapter, I performed ATAC-seq to map global changes in the chromatin 
landscape of EnSCs upon decidualization. The most enriched short sequence 
binding motifs were determined in opening and closing genomic regions. To 
examine factor occupancy, footprint analysis was performed and resulting 
footprints inferring DNA-binding proteins were interrogated. Finally, ATAC-seq 
data were integrated with RNA-seq data to examine gene expression of potential 
binding TFs and ultimately identify novel transcriptional regulators implicated in 
decidualization. 
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3.2 Results 
 
3.2.1 Optimization of incubation time for transposase 
reaction  
 
ATAC-seq uses hyperactive Tn5 that simultaneously cuts and probes accessible 
regions of chromatin. This process generates genomic libraries that can be 
subjected to high-throughput sequencing (Buenrostro et al., 2013). High quality 
library size distribution varies between 250 and 1000 bp (Illumina guidelines). To 
successfully perform ATAC-seq, I optimized incubation time for transposase 
reaction on undifferentiating and decidualizing human EnSCs. 
 
Briefly, primary human EnSCs were decidualized in response to 8-br-cAMP and 
MPA for 4 days. Paired undifferentiated and decidualizing cultures were 
subjected to ATAC-seq. Buenrostro et al. (2015), optimized 30 min as incubation 
time for transposase reaction on lymphoblastoid cells. To determine the optimal 
reaction time for primary endometrial cells, the transposase reactions were run 
for either 120, 90, 60, 45 or 30 min. To determine the fragment length distribution 
of the genomic libraries, samples were subjected to quality control on Agilent 
Technologies 2100 Bioanalyzer using the High Sensitivity DNA chip. As shown 
in Figure 3.1, subjecting cultures to a transposase reaction lasting 120 min 
resulted genomic libraries with a fragment lenght distribution with a predominant 
peak at lower range (200-300 bp). Short fragments can map to inaccessible 
regions of the genome, generating noise during sequencing. A 90 min reaction 
yielded larger fragments (average ~500 bp) and a modest increase in fragment 
length was observed when the transposase reaction was stopped after 60 and 
45 min.  For the latter, as the sample was too concentrated the software was not 
able to assign the bp scale to the x-axis, but measured the detection of 
fluorescence intensity over time (seconds). The ladder was used to manually 
calculate the approximate fragment size (e.g. fragments 200 bp long were 
detected at 60 seconds). Finally, the 30 min reaction resulted in the largest 
fragment size, suggesting insufficient transposition. The 30 min incubation time 
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generated too large molecular fragments, that can result in a reduced clustering 
efficiency during sequencing (Figure 3.1).  
 
Considering the length of DNA wrapped around a nucleosome (~200 bp), I 
inferred that fragments containing a single nucleosome were likely to be present 
in the genomic library of the 120 min. On the other hand, 90, 60 and 45 min 
incubation times were all likely to yield similar library size distributions. However, 
Bioanalyzer traces were not really indicative of the average fragment size 
generated. Hence, I arbitrarily chose 90 min and 45 min (half of the former) as 
incubation times and make the data more informative by sequencing.  
 
Taken together, data suggested that subjecting cell cultures to a transposase 
reaction lasting 120 and 30 min results in average library fragment size as small 
as 250 bp and as big as 1000 bp. On the other hand, incubation times in between 
seemed to be all equivalent and Bionalyzer traces not to be predictive of 
successfully sequenced genomic libraries. Hence, to infer if 45 and 90 min 
incubation time could generate libraries with high clustering efficiency, I 
proceeded with sequencing.   
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Figure 3.1 Different times of incubation for transposase reaction generated 
different library size distributions. EnSCs were seeded in 35 mm dishes, 
nuclei were harvested and subjected to ATAC-seq. Representative genomic 
library size distribution generated from 120, 90, 60, 45 and 30 min incubation time 
was assessed on Agilent Technologies 2100 Bioanalyzer. The graphs show 
detection of fluorescence by the genomic fragments. The Y-axis shows 
fluorescent intensity (FU).  The X-axis represents the size (bp) of the fragments 
or time of detection, for samples that were too concentrated. The standard in 
each experimental sample is shown as two peaks labelled as the lower (a) and 
upper (b) marker.  
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3.2.2 Chromatin profiling in primary human EnSCs 
 
 
To map genome-wide dynamic changes in the chromatin landscape upon 
decidualization, undifferentiated and decidualizing human EnSCs were subjected 
to ATAC-seq. 
 
Briefly, primary human EnSCs were decidualized in response to 8-br-cAMP and 
MPA for 4 days. ATAC-seq libraries were sequenced on the Illumina HiSeq1500. 
Thirty million paired end reads were sequenced per sample, with a read length of 
100 bp.  Surprisingly, data revealed that despite Bioanalyzer data were not 
convincing, subjecting genomic libraries to transposase reaction lasting either 45 
or 90 min, results in high clustering efficiency. As both incubation times generated 
the same sequencing data, they could be equally chosen for future experiments 
and I chose 45 min to further optimize the time of the whole procedure. 
 
More accurately, ATAC-seq analysis identified a total of 185,087 significant 
differential ATAC-seq peaks, revealing profound chromatin remodelling in 
response to decidual cues. The resulting ATAC-peaks were ranked from the most 
strongly opening to the most strongly closing peak. Transition of closed to open 
chromatin at major differentiation genes, such as PRL and IGFBP1 (Figure 3.2A-
B), confirmed ATAC-seq as powerful tool to accurately probe genomic regions 
that change dynamically upon decidualization.  
 
Previous work had interrogated the chromatin landscape of the decidualized 
EnSCs and the whole endometrium, using DNase-seq and FAIRE-Seq, 
respectively (Lynch et al, 2015). Therefore, the profile of the chromatin 
architecture resulting from the ATAC-seq analysis was compared to the previous 
data to investigate if the use of ATAC-seq provided additional enrichment in the 
description of genome-wide landscape of chromatin of EnSCs. Results showed 
that less than 20% of the genomic regions of the decidual cells and of the whole 
endometrium were previously identified showed that compared to the proportion 
of the ATAC-seq data. Furthermore, a comparison with Encyclopedia of DNA 
Elements (ENCODE) project’s DNase-seq data from 125 human cells and tissue 
  
73 
 
types (Thurman et al., 2015) confirmed that more than 90% of the ATAC-seq 
peaks represent true regions of differential opening (Figure 3.3). More accurately, 
when DNase I hypersensitivity sites (DHSs) identified by DNase-seq were 
compared to the ATAC-seq peaks, they overlapped with the closing ATAC-seq 
peaks rather than with the opening peaks (Figure 3.4). 
 
Even though, prediction of gene expression cannot exclusively be based on 
opening or closing chromatin because it likely results from a combination of 
different TFs at different genomic locations, analysis of 100 genes associated 
with the most open and closed ATAC-seq peaks revealed that genes with 
opening ATAC-seq peaks were also upregulated during decidualization, whereas 
closing ATAC-seq peaks were associated to genes that were down-regulated 
upon decidualization (p = 2.65 10-9, t-test) (Figure 3.5). 
 
Taken together the data revealed that ATAC-seq strongly contributes to increase 
our knowledge of the chromatin architecture of EnSCs before and after 
decidualization. 
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Figure 3.2. Transition of closed to open chromatin exemplified by ATAC-
seq peaks. Examples of ATAC-seq peaks showing significant opening and 
closing in the chromatin landscape at major decidual markers, such as PRL (A) 
and IGFBP1 (B). Black and red traces represent ATAC-seq signal in the 
undifferentiated and differentiated cells, respectively. For both PRL and IGFBP1, 
ATAC-seq peaks preferentially localize around the promoters. Additionally, 
IGFBP1 has differential opening peaks upstream of the transcription start site and 
downstream of the termination site.  
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Figure 3.3. Decidualized EnSC chromatin landscape profiled by ATAC-seq 
in comparison to other endometrium assays.  DNase I hypersensitivity (HS) 
sites and FAIRE-seq in decidualized EnSCs and in the whole endometrium, 
respectively, identified less than 20% of the open chromatin regions described by 
ATAC-seq. More than 90% of the ATAC-seq regions have been identified in other 
cell systems. 
 
 
 
 
 
 
 
 
 
Figure 3.4. Previous DNase I HS sites in decidualizaed EnSCs described 
chromatin regions overlapping with closing genomic regions. ATAC-seq 
peaks were ranked from the ones that strongly open down to the ones that 
strongly close during decidualization and grouped according to this ranking; then, 
the number of peaks that overlapped with previously identified genomic regions 
was calculated. A cross-referencing with ENCODE showed a uniform distribution 
of the overlapping regions across this ranking (A). Previously identified DNase I 
HS sites in decidualized EnSCs mainly overlapped with closing ATAC-seq peaks 
(B). 
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Figure 3.5. Correlation between differential organized chromatin and 
differential gene expression in decidualizing EnSCs. Opening and closing of 
chromatin correlate to changes in gene expression during decidualization. Box 
plots showing increase or decrease in transcript levels of 100 genes (within 10 
kb of the TSS) associated with the most open and closed ATAC-seq peaks. Y-
axis shows relative changes in transcript levels, expressed as log2-fold change: 
+ve and –ve values relate to up- and down-regulated genes, respectively. X-axis 
shows ATAC-seq peaks clustered in opening, no changing (N/C) and closing 
peaks. Green dots represent the genes and the red asterisk represents mean 
log2-fold change (p = 2.65 10-9, t-test). 
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3.2.3 Binding Motif Enrichment in decidualizing EnSCs 
 
 
Differential chromatin opening makes the chromatin more accessible in some 
genomic regions rather than in others and therefore more accessible to the 
binding of specific TFs, likely involved in the regulation of nearby gene 
expression. Hence, de novo binding motif enrichment analysis, using 
Hypergeometric Optimization of Motif EnRichment (HOMER), was performed on 
statistically significant opening and closing ATAC-seq peaks (Bonferroni adjusted 
p < 0.05) to identify the overepresented binding motifs and putative TFs that 
underly changes in gene expression upon decidualization. 
 
A total of 17 motifs, named differentiated motifs 1-17 (DiffM1-17), were 
significantly enriched in 1,225 differential ATAC-seq peaks that significantly open 
upon decidualization and 7 motifs, named undifferentiated motifs 1-7 (UndiffM1-
7), were significantly overepresented in 278 closing ATAC-seq peaks (Figure 
3.6). Data showed that closing or opening of genomic regions could also be 
predicted by the occurrence of the motifs (Figure 3.7). Within regions of chromatin 
opening, TF occupancy should result in a footprint. To investigate if the identified 
motifs were indicative of TF binding, ATAC-seq signal was averaged over all 
expected locations of the identified conserved motif sequences. Average ATAC-
seq signal profile centered at each motif revealed sequence footprint reflecting 
factor occupancy (Figure 3.8). DNA-protein binding makes the occupied genomic 
region refractory to transposition, causing enrichment of positive strand reads 5’ 
of the binding motif paired with excess of negative strand reads 3’ of the motifs. 
Evidence of footprints revealed the presence of DNA-binding protein in all the 
conserved motifs except for Opening motif 10 and Closing motif 2. Absence of 
footprint at these genomic sites suggested that there was no evidence of TF 
occupancy. However, these chromatin regions might still play a role in the 
regulation of gene expression. For example, they might be involved in the folding 
of the chromatin to facilitate interactions between functionally related genes 
spatially separated along the genome. 
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Next, to identify the putative TFs that might bind at these genomic locations, the 
short sequence motifs were matched against known TF datasets and their 
expression level was examined. HOMER motif analysis revealed 
overepresentation of binding sites representing high affinity binding motifs for 
known decidual TFs, including CCAAT/enhancer binding protein beta and delta 
(CEBPB/CEBPD), Fos-like antigen (FOSL2 or FRA2), forkhead box O1 
(FOXO1), progesterone receptor (PGR), and signal transducer and activator of 
transcription 3 and 5 (STAT3/STAT5) (Mazur et al., 2015; Kaya et al., 2015; Jiang 
et al., 2015; Kim et al., 2005). Depletion of TEA domain transcription factor 1 
(TEAD1) binding motif was dectected upon decidualization (Figure 3.9). 
Interestingly, TEAD1 was previously shown to negatively regulate the expression 
of PRL, a well-established decidual marker (Kessler et al., 2008). A full list of the 
best match of TFs for all of the binding motifs enriched in the opening and closing 
motifs are shown in Appendix 1 and 2, respectively.  
 
Cross-referencing the resulting ATAC-seq regions with available chromatin 
immunoprecipitation followed by sequencing (ChIP-seq) data (e.g. ENCODE 
database), for PGR, FOXO1 and FOSL2 in EnSCs, provided confidence in the 
identified binding domains (Vasquez et al., 2015). In agreement with their key 
role in decidualization, ChIP-seq data revealed that FOXO1 and PGR binding 
sites were overepresented in open chromatin regions. Particularly, chromatin 
regions enriched with both PGR and FOSL2 binding motifs were associated to 
open chromatin in decidualized EnSCs, whereas in absence of PGR binding site, 
FOSL2 binding domain was enriched in closing chromatin regions (Figure 3.10). 
 
Taken together, data showed that ATAC-seq accurately mapped dynamic 
changes upon decidual transformation. It identified binding sites for TFs known 
to play an essential role in promoting decidualization. However, ATAC-seq 
yielded novel candidate TFs likely to be involved in licensing genomic regions for 
remodelling in response to decidual transformation. The role of these putative 
novel transcriptional regulators in decidual transformation of EnSCs requires 
further investigations. Experimentally, RNA-seq or RT-qPCR and western blot 
could be applied to validate the induction of TFs of interest at a transcript and 
protein level. ChIP-qRT-PCR or cross-referencing with available ChIP-seq data 
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(e.g. ENCODE database) would provide confidence in the transcriptional 
regulation of genes of interest by specific TFs. Furthermore, silencing of the most 
highly ranked conserved TFs by siRNA-mediated gene silencing could be 
performed to validate their role during the decidual process. In this work, RNA-
seq was performed to examine gene expression of new putative decidual TFs. 
However, time limitations prevented me of persuing this line of investigation even 
further.  
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Figure 3.6. Enriched TF binding motifs in opening and closing chromatin 
regions. De novo short sequence binding motif enrichment analysis revealed 
overrepresentation of 17 and 7 binding sites in statistically significant opening 
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and closing ATAC-seq, respectively. The frequency (%) of peaks (blue bars) 
containing a given motif is shown relative to genomic regions randomly selected 
from the genome (orange bars) (±50 Kb from TSS, matching size, and GC/CpG 
content). 
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Figure 3.7. Occurrence of TF binding motifs correlates to differential 
chromatin opening. The short sequence binding motifs resulted from HOMER 
motif analysis were associated with chromatin opening and closing over the 
whole ATAC-seq dataset. The frequency of opening and closing motifs (Y-axis) 
was identified in all ATAC-seq peaks. Peaks were sorted from most opening to 
most closing peak and ranks of peaks containing motifs were plotted as 
histograms (X-axis). ATAC-seq peaks containing Opening Motifs 1-17 are most 
frequently opening, whereas ATAC-seq peaks containing Closing Motifs 1-7 are 
more frequently closing. Empty bars indicate random expectation based on 
genomic background frequency. 
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Figure 3.8. Footprint analysis. Footprint at the enriched motifs indicating 
evidence of TF occupancy. Graphs show average ATAC-seq signal profile 
centred at the opening (A) and closing (B) binding motifs, calculated within ±200 
bp on enriched motif. Red and blue represent positive and negative strand cuts, 
respectively. Reduced read numbers in the region of the motif together with 
increase in positive and negative strand reads at 5’ and 3’ of the motif indicate 
enrichment of fragments that span the uncut (protected) region of DNA binding.  
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Figure 3.9. Top 5 enriched and depleted binding motifs and coupled high 
binding affinity TFs. Bar graphs showing top 5 binding motifs, enriched in the 
opening and closing ATAC-seq peaks, matched with the most plausible 
differentially expressed TFs, based on motif specificity. In the bar graphs, the 
frequency (%) of peaks (blue bars) containing the motif is shown relative to 
genomic regions randomly selected from the genome (orange bars) (±50 Kb from 
TSS, matching size, and GC/CpG content). P indicates the p of the short 
sequence binding motifs.   
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Figure 3.10. Mapping of known FOXO1, PGR and FOSL2 binding domains 
in the differential ATAC-seq peaks in decidualized EnSCs. Cross-reference 
of ATAC-seq data with public ChIP-seq data for the indicated key transcription 
factors during decidualization, revealed enrichment of FOXO1 and PGR binding 
motifs in the opening genomic regions; FOSL2 binding motif was enriched in 
closing chromatin regions, whereas FOSL2 in the presence of PGR binding 
domain was associated to opening chromatin regions. Again, ATAC-seq peaks 
were ranked from the most strongly opening to the most strongly closing peak.  
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3.2.4 Transcriptomic profile of human undifferentiated and 
decidualizing EnSCs 
 
Microarray studies described profound changes in the transcriptome of EnSCs 
as the decidual transformation unfolds (Gellersen & Brosens, 2014; Giudice, 
2004; Clock et al., 2008; Takano et al., 2007). Compelling lines of evidence 
indicate the presence of a dynamic epigenetic code governing differential gene 
expression upon decidualization (Munro et al., 2010; Zelenko et al., 2012). For 
the first time, ATAC-seq accurately mapped changes in chromatin accessibility in 
undifferentiated and decidualizing human EnSCs upon decidualization. Binding 
motif discovery confirmed enrichment in cis-regulatory regions of the genome for 
short sequence binding motifs with high affinity for TFs known as key decidual 
core TFs. However, ATAC-seq data potentially revealed novel candidate TFs that 
might play a role in the acquisition of the decidual phenotype. To examine gene 
expression of TFs likely to bind high specificity short sequence motifs, EnSCs 
decidualized in response to 8-br-cAMP and MPA for 4 days were subjected to 
RNA-seq. 
 
RNA libraries, generated using high integrity samples with a RIN > 8.0, were 
sequenced on the Illumina HiSeq3000. Fifty million single end reads were 
sequenced per sample, with a read length of 50 base pairs (bp). Principal 
Component Analysis (PCA), a multivariate analysis, was performed on the 
regularized log (rlog) transformation of the counts from differential expression 
analysis of sequencing data (DESeq) to explore how the samples clustered or 
segregate. In this work, PCA was perfomed in an unsupervised manner, i.e. 
undifferentiated and decidualizing samples were not ‘labeled’ as such. PC1, 
which accounted for 83% of variation in gene expression segregated 
undifferentiated from decidualizing EnSCs, thus reflecting the cellular response 
to deciduogenic cues. PC2, which accounted for 12% of variation, clustered the 
undifferentiated samples 198 and 200, apart from the 208; and the decidualizing 
samples 208, apart from 200 and 198, thus reflecting intrinsic interpatient 
variability (Figure 3.11).  
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Based on Benjamini adjusted p (q) < 0.05, DESeq identified a robust list of 2,931 
differentially expressed genes between undifferentiated and decidualizing 
cultures (Figure 3.12). Out of 2,931 differentially expressed genes, 1,432 (49%) 
were up-regulated and 1,499 (51%) were down-regulated upon decidualization. 
Amongst the most highly enriched genes, data confirmed up-regulation of key 
decidual markers, such as PRL (q = 2.60 x 10-93) and IGFBP1 (q = 5.32 x 10-98) 
(Gellersen & Brosens, 2003). A full list of differentially up- and down- regulated 
genes is shown in Appendix 3 and 4, respectively.  
 
Mining of RNA-seq data to infer gene expression of putative candidate TFs likely 
to bind short sequence motifs mapped in opening and closing motifs confirmed 
gene expression for known key decidual TFs, including CEBPB/CEBPB, FOSL2 
(or FRA2), FOXO1, PGR and STAT3/STAT5. However, data revealed differential 
gene regulation for several candidates (Figure 3.13). For example RAR related 
orphan receptor A (RORA), aryl hydrocarbon receptor nuclear translocator like 
(ARNTL) and Meis homeobox 1 (MEIS1). Conversely, combined RNA-seq and 
ATAC-seq revealed downregulation of runt related transcription factor 1 and 2 
(RUNX1/RUNX2), SRY-box 12 (SOX12), transcription factor 3 (TCF3), and ETS 
Proto-Oncogene 1 (ETS1) in parallel with depletion of genome-wide depletion of 
high affinity binding sites in decidualized EnSCs. 
 
Gene Ontology (GO) enrichment analysis was performed using DAVID version 
6.8 to characterize differentially expressed genes in EnSCs upon decidualization 
and infer associated biological functions, cellular components and molecular 
functions and ultimately confirm if the EnSC cultures were properly decidualized. 
Amongst the most up-regulated GO categories, data showed enrichment for 
extracellular matrix organization (p = 3.30 x 10-7), inflammatory response (p = 
1.29 x 10-6) and angiogenesis (p = 5.85 x 10-6). Down-regulated genes were 
enriched for cell division (p = 3.99 x 10-21), DNA replication (p = 1.08 x 10-19) and 
mitotic nuclear division (p = 5.34 x 10-18) (Figure 3.14A-B). Enrichment and 
depletion of the identified GO categories were consistent with the known 
spectrum of functions differentially regulated upon decidualization, confirming 
what was already broadly studied (Gellersen & Brosens, 2014). 
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Taken together, data confirmed a broadly wholesale reprogramming of gene 
expression upon decidualization and captured expression of novel putative 
modulators that might be implicated in promoting the acquisition of the decidual 
phenotype.   
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Figure 3.11. PCA of undifferentiated and decidualizing EnSCs. PCA of RNA-
sequencing data from three independent EnSC cultures, decidualized in 
response to 8-br-cAMP and MPA for 4 days. PC1 distinguished between 
undifferentiated and decidualizing samples, whereas PC2 segregated different 
primary cultures. 
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Figure 3.12. Differential gene expression profile upon decidualization. 
Clustered heatmap representing differential gene expression pattern in EnSCs 
decidualized in response to 8-br-cAMP and MPA for 4 days. The colour key is 
represented on the right side of the heatmap, with the most highly enriched genes 
indicated in green.  
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Figure 3.13. Differential expression of candidate TFs upon decidualization. 
Graph showing changes in the transcript levels of selected significantly up- and 
down-regulated TFs, expressed as log2-fold change. +ve and -ve values indicate 
increase and decrease in gene expression, respectively. 
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Figure 3.14 Enrichment and depletion of GO categories in primary EnSCs 
upon decidualization. GO enrichment analysis was applied to differentially 
expressed genes and the significant GO annotations (p < 0.05) summarized 
using REVIGO and clustered based on semantic similarities, which means that if 
they are described by a common ontology they cluster close in the graph.  (A) 
GO categories associated to the up-regulated genes. (B) GO categories enriched 
for down-regulated genes. The colour key is represented on the right. The most 
highly enriched GO categories are indicated in green. The size of the circles 
indicates the number of genes in the GO term and reflects the frequency of the 
GO term. The results were consistent with the known spectrum of biological 
processes differentially regulated upon decidualization and hence validated 
previous findings. 
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3.3 Discussion 
 
Cyclic decidualization of the endometrium is a coordinated process essential for 
embryo implantation and placental development, and hence is critical for 
successful reproductive outcome (Gellersen & Brosens, 2014; Salker et al., 
2011). Several lines of evidence show that a dynamic epigenetic code operates 
atop the cis-regulatory landscape of the genome and governs decidual cell 
identity (Grimaldi et al., 2012; Zelenko et al., 2010; Munro et al., 2010).  
 
In this work, I used ATAC-seq to accurately probe regions of differential chromatin 
opening in undifferentiated and decidualizing human EnSCs. ATAC-seq data 
showed wholesale remodelling of the chromatin structure. A total of 185,084 open 
DNA loci were accurately mapped in EnSC.  Changes in genomic accessibility at 
major decidual genes, such as PRL and IGFBP1 confirmed the ability of ATAC-
seq to accurately map changes in the cis-regulatory elements of the chromatin. 
Combined ATAC-seq and RNA-seq revealed a strong association between 
changes in DNA accessibility and in gene expression. 
 
De novo binding motif discovery using HOMER revealed enrichment and 
depletion of 17 and 7 short sequence motifs, respectively. Analysis of footprints 
confirmed factor occupancy in 22 out of 24 binding motifs, highlighting the 
presence of DNA-binding proteins in the majority of the biding sites. Highly 
enriched motifs in the opening ATAC-seq peaks showed high binding affinity for 
known decidual TFs, including CEBPB/CEBPD, FOSL2, FOXO1, PGR, and 
STAT3/STAT5 (Gellersen & Brosens, 2014; Mazur et al., 2015). Previous studies 
reported that interactions between TFs can differently modify chromatin 
accessibility (Christian et al., 2002; Christian et al., 2002; Lynch et al., 2009). 
More accurately, cross-referencing of ATAC-seq data with ChIP-seq data 
showed that enrichment for both FOXO1 and PGR binding sites correlated to 
opening chromatin (Mazur et al., 2015; Vasquet et al., 2015). Additionally, FOSL2 
is a putative PGR co-regulator (Mazur et al., 2015). Interestingly, the presence of 
both FOSL2 and PGR binding sites correlated with opening chromatin. However, 
binding sites with high affinity for FOSL2 in the absence of PGR were enriched in 
closing chromatin regions. 
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Cross-referencing the identified binding motifs with RNA-seq data revealed 
induction of novel putative TFs not yet implicated in decidualization, in parallel 
with genome-wide enrichment for high affinity binding sites, for example RORA, 
ARNTL, and MEIS1. Conversely, down-regulation of other TFs, including 
RUNX1/RUNX2, SOX12, TCF3 and ETS1 upon decidualization correlated with 
depletion of high affinity binding sites. 
 
The role of these putative transcriptional regulators in decidual transformation of 
EnSCs requires further investigation. Experimentally, Real Time quantitative 
PCR (RT-qPCR) and western blot could be applied to validate the induction of 
TFs of interest at a transcript and protein level. ChIP-qRT-PCR or cross-
referencing with available ChIP-seq data (e.g. ENCODE database), would 
provide confidence in the transcriptional regulation of genes of interest by specific 
TFs. Furthermore, silencing of the most highly ranked conserved TFs by siRNA-
mediated gene silencing could be performed to validate their role upon 
decidualization. Time limitations prevented me of persuing this line of 
investigation even further, although a graduate student subsequently 
demonstrated that siRNA-mediated knockdown of ARNTL, NFE2L1 and TFC3 
perturbated the induction of PRL and IGFBP1 in decidualizing cultures.  
 
The ATAC-seq analysis of undifferentiated and decidualizing EnSCs is important 
on multiple levels. First, it provides an important resource to analyse chromatin 
changes associated with differential gene expression at specific loci. The footprint 
analysis provides insight into the transcriptional drivers of genes of interests, 
although confirmation still requires ChIP-PCR or cross-referencing with existing 
ChIP-seq data sets. Nevertheless, the ATAC-seq data will greatly facilitate 
mechanistic analysis of the pathways and downstream TFs that regulate specific 
genes or gene networks. Finally, my analysis provided proof of principle that 
ATAC-seq is a powerful tool to screen rapidly for dynamic chromatin changes in 
human endometrial cells. I envisage that applying this technique to various 
reproductive disorders associated with aberrant endometrial function, such as 
endometriosis, endometrial cancer, infertility and recurrent miscarriage, will yield 
important mechanistic insights into the underlying pathological pathways.  
  
97 
 
 
 
  
98 
 
 
 
 
 
 
 
 
Chapter 4 
 
 
 
 
Characterization of endometrial 
mesenchymal stem cells 
expanded in culture in 
response to TGF-β-Receptor 
blockade  
_______________________ 
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4.1 Introduction 
 
The endometrium is a highly dynamic tissue that undergoes cyclic waves of 
proliferation, differentiation (decidualization) and menstruation. Its extraordinary 
ability to adapt to changes, physiological or otherwise, depends on eMSCs 
(Gargett et al., 2016).  
 
eMSCs are a rare group of cells (around 1-4%) recently identified in the 
perivascular niche of the endometrium (Masuda et al., 2012; Schwab & Gargett, 
2007) from where they can be selectively isolated on basis of co-expression of 
two cell surface markers, CD140b and CD146 (Schwab & Gargett, 2007), or with 
a single marker, SUSD2. By using a single marker, eMSCs can be isolated using 
magnetic-activated cell sorting, which results in a higher yield of viable cells when 
compared to flow cytometry and cell sorting (Masuda et al., 2012). 
 
eMSCs are immune-privileged, clonogenic and self-renewing cells. eMSCs also 
exhibit high proliferative potential and have the ability to differentiate into more 
mature progeny and regenerate tissue (Gargett et al., 2016; Miyazaki et al., 2012; 
Wolff et al., 2007). The perivascular niche is a privileged site for eMSCs to 
contribute to cyclic endometrial regeneration and formation of the placenta during 
pregnancy (Murakami et al., 2014). eMSCs are also promising candidates for cell-
based therapy for women’s reproductive health disorders, including pelvic organ 
prolapse, urinary incontinence and regeneration of scarring endometrium in 
women affected by Asherman’s syndrome (Darzi et al., 2016; Emmerson & 
Gargett, 2016; Gargett & Healy, 2011). 
 
Because of their rarity, the use of eMSCs for clinical trials first requires their 
expansion in culture (Ulrich et al., 2013). As in the case of MSCs from other cell 
systems (Baxter et al., 2004), eMSCs spontaneously differentiate over several 
passages (Zhu et al., 2011; Ulrich et al., 2014; Barragan et al., 2016; Gargett et 
al., 2016). During prolonged expansion in culture, the telomeres of eMSCs 
become shortened due to replicative stress. Consequently, eMSCs lose their 
proliferative capacity as well as the ability to reconstitute tissue in vivo (Baxter et 
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al., 2004; Banfi et al., 2002). Therefore, the effectiveness of eMSCs in cell-based 
therapies is curtailed by the need for extended cultures. 
 
The use of small molecules that modulates stem cell specification and function 
offers significant opportunities to study the cell biology and enhance our 
knowledge of the therapeutic potential of stem cells (Yu et al., 2014; Li et al., 
2013). Small molecules can act as activators or repressors of signalling 
pathways. In this way, they regulate downstream gene transcription (Yun et al., 
2014). The use of a TGF-β type I receptor ALK4, 5 and 7 kinase inhibitor, A83-
01, to maintain self-renewal of induced pluripotent stem (iPS) cells in prolonged 
culture exemplified such approach (Li et al., 2009). A recent study showed that 
the use of a small molecule, A83-01, a selective inhibitor of TGF-β type I receptor 
ALK4, 5 and 7 kinase, increases eMSC proliferation and prevents senescence, 
thereby maintaining the functional properties of eMSCs (Gurung et al., 2015). The 
use of small molecules, such as A83-01, which are purported to control self-
renewal and proliferative ability of eMSCs, might be an effective strategy to 
maintain eMSCs in a stem cell-like state during prolonged culture. 
 
For clinical application, it is of paramount importance to understand the 
mechanisms underlying pharmacological expansion of eMSCs in culture. In this 
chapter, I validated the effect of A83-01-induced TGF-β-Receptor (TGF-β-R) 
blockade on the proliferative capacity of cultured eMSCs and the expression of 
stem cell markers. Furthermore, I combined RNA-sequencing with ATAC-
sequencing to define the impact of TGF-β-R inhibition on the transcriptome and 
chromatin landscape of cultured eMSCs. 
 
 
4.2 Results 
 
4.2.1 TGF-β-R signalling pathway negatively regulates 
eMSC expansion in prolonged culture.  
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To assess the effect of the TGF-β-R inhibitor A83-01 on proliferation, eMSCs 
isolated from three independent human endometrial biopsies using SUSD2-
magnetic bead sorting were expanded in culture in the presence or absence of 1 
µM A83-01 for 36 days. The cells were seeded at low density (10,000 cells/well 
in 24-well plate) and passaged on day 15, 22, 29 and 36. The plating density at 
passaging was 5,000 cells/cm2. At each passage, the cells were counted using 
glasstic slide 10 with grids and cumulative cell population calculated as an 
indicator of proliferative potential. 
 
As shown in Figure 4.1A, the effect of A83-01 on eMSC proliferation was 
consistent between different primary cultures (Figure 4.1A). Cumulative cell 
population was comparable between A83-01 treated and untreated cells up to 22 
days in culture, after which cells treated with A83-01 exhibited a clear proliferation 
advantage (Figure 4.1B; p < 0.05). The relative difference in cumulative cell 
population in 3 paired treated and untreated primary cultures at day 36 was 
400%, 500%, and 1,800% (Figure 4.1C).  
 
The effect of the TGF-β-R inhibitor on cell proliferation was evaluated further by 
calculating the number of population doublings (PDs) using the following formula: 
PD = 3.322logN/N0, where N is the total cumulative cell number calculated at 
each passage and N0 represents the initial number of seeded primary cells 
(Pellegrini et al., 1999). The effect of A83-01 on the number of population 
doublings was consistent between different samples (Figure 4.2A).  Figure 2B 
shows that, after the first 15 days of culture, A83-01 treatment progressively 
increased the number of PDs, confirming that A83-01 positively regulates the 
proliferative potential of eMSCs. A83-01 treatment consistently resulted in 
increased population doubling, although statistical significance, as determined by 
ANOVA, was not reached (p > 0.05).   
 
Taken together, the data suggest that TGF-β-R signalling plays a role in limiting 
the proliferative potential of eMSCs maintained in continuous cultures. As the 
proliferative capacity of freshly isolated eMSCs is very high, A83-01 treatment 
conferred proliferation advantage only after 3 weeks in culture.  
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Figure 4.1. TGF-β-R inhibitor improves expansion of eMSCs in culture. 
Primary human eMSCs, isolated using SUSD2 magnetic bead sorting, were 
cultured with or without 1 µM A83-01 for 5 weeks. (A) Individual biological 
replicates. (B) Relative change in cumulative cell population in 3 independent 
cultures. Data represent mean ± SEM; * indicates p < 0.05. Note the logarithmic 
scale of the Y-axis. (C) Percentage change in cumulative cell population in eMSC 
cultures treated with A83-01 compared to untreated cultures at the indicated time-
points.  
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Figure 4.2. A83-01 increases population doubling (PD) in 
eMSCs.  Proliferative activity was assessed by calculating the number of PDs 
according to the formula: PD = 3.322logN/N0, where N is the total cumulative cell 
number calculated at each passage and N0 represents the initial number of 
seeded primary cells.  (A) Impact of A83-01 on PD of 3 individual primary cultures 
at the indicated time-points. (B) Relative change in population doublings. Data 
represent mean ± SEM of three independent samples. 
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4.2.2 Phenotyping of A83-01 treated eMSCs 
 
eMSCs express specific surface markers that are widely used to define cell 
identity and stemness, including CD146, CD140b, SUSD2 and CD90 (Gargett & 
Masuda, 2010). Co-expression of CD146 and CD140b (Schwab & Gargett, 
2007),  or single marker SUSD2 (Masuda et al., 2012) can be used to selectively 
isolate eMSCs, using magnetic flow cytometry and magnetic bead sorting, 
respectively. However, magnetic isolation of clonogenic eMSCs increases the 
number of viable cells compared with flow cytometry, as it is less damaging to the 
cells (Schwab & Gargett, 2007; Masuda et al., 2012). The percentage of CD146+ 
cells has been already previously shown not to change upon A83-01 treatment 
(Gurung et al., 2015), hence it was excluded for this analysis. CD90 is a marker 
of endometrial stromal cells, but not epithelial cells and it has been shown that 
SUSD2+ cells are predominantely CD90+ perivascular cells (Schwab et al., 2008; 
Gargett et al., 2016). Hence, it is been included in this study. To assess the effect 
of TGF-β-R inhibition on the expression of these phenotypic markers, A83-01 
treated and untreated primary eMSCs were subjected to flow cytometry at day 
36. This time-point was chosen as the impact of A83-01 on cell proliferation was 
apparent.  
 
The effect of A83-01 on the expression of these surface markers was consistent 
between different eMSC cultures (Figure 4.3aA). The percentage of CD90 
positive cells did not change upon TGF-β-R blockade. By contrast, A83-01 
treatment resulted in an increase in the percentage of CD140b- and SUSD2-
positive cells when compared to untreated eMSCs, although statistical 
significance was not reached (p > 0.05) (Figure 4.3aB-C; 43b).  
 
Mean Fluorescence Intensity (MFI) was also calculated to evaluate if there was 
an increase in the abundance of cell surface molecules per cell. Again, A83-01 
cellular effects were consistent between different primary cultures (Figure 4.4A, 
4.5A and 4.6A). The MFI for CD90 expression did not change significantly upon 
A83-01 treatment, although the response was variable between cultures (Figure 
4.4A-B). By contrast, the MFI of CD140b consistently increased in response to 
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A83-01treatment (Figure 4.5B) although statistical significance was not reached 
(p > 0.05). For SUSD2 expression, the MFI increased markedly in 2 out of 3 
primary cultures (Figure 4.6A). This induction was not statistically significant 
when paired non parametric Wilcoxon test was applied (Figure 4.6B). 
 
Altogether, these results confirm that A83-01 has a positive effect on the 
percentage of CD140b- and SUSD2-positive cells in prolonged culture. However, 
the data also reveal marked variation in the responsiveness of primary cultured 
eMSCs to A83-01. This intrinsic variability between primary cultures accounted 
for the lack of statistically significance.  
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Figure 4.3a. Surface phenotype of eMSCs cultured with or without A83-01. 
A83-01 cellular effects were consistent on different eMSC primary cultures (A). 
Flow cytometry analysis for three eMSC surface markers in 3 independent eMSC 
culture (B). Mean change (± SEM) in positive cells for the indicated cell surface 
markers. (C) Representative flow cytometry histograms of SUSD2 positive cells 
in eMSC cultures, treated with or without A83-01. The X-axis shows the 
fluorescence intensity and the Y-axis the number of cells (count); the grey curves 
represent the isotype control IgG.  
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Figure 4.3b. Representative flow cytometry representation. These graphs 
show representative flow cytometry figures for SUSD2 marker in untreated (A-B-
C) and A83-01 treated eMSC (D-E-F) cultures, showing serial gating strategies. 
(A) Forward versus side scatter density plot used to gate cells of interest based 
on size and granularity. Based on light refraction, forward scatter area (FSC-A) 
indicates cell size and side scatter area (SSC-A) relates to granularity of the cells. 
(B). Forward scatter height (FSC-H) versus FSC-A density plot is used to exclude 
doublets. (C). Single paramenter histogram for identifying cells expressing 
SUSD2 marker. Similar gating strategies were used for flow cytometry analysis 
in A83-01 treated eMSC cultures.    
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Figure 4.4. Mean Fluorescence Intensity (MFI) of CD90 in A83-01 treated 
eMSCs. (A) MFI for CD90 in 3 independent eMSC cultures cultured for 36 days 
in the presence or absence of A83-01. Each graph represents an individual 
culture. (B) Relative change (mean ± SEM) in CD90 MFI. 
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Figure 4.5. CD140b MFI in response to A83-01 treatment of primary eMSCs 
cultured for 36 days. (A) MFI for CD140b in 3 independent eMSC cultures 
cultured in the presence or absence of A83-01. Each graph represents an 
individual culture. (B) Relative change (mean ± SEM) in CD140b MFI. 
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Figure 4.6. SUSD2 MFI in response to A83-01 treatment of primary eMSCs 
cultured for 36 days. (A) MFI for SUSD2 in 3 independent eMSC cultures 
cultured in the presence or absence of A83-01. Each graph represents an 
individual culture. (B) Relative change (mean ± SEM) in SUSD2 MFI. 
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4.2.3 Impact of A83-01 treatment on clonogenicity of cultured 
eMSCs 
 
Inhibition of TGF-β-R signalling pathway has been purported to increase eMSC 
colony efficiency in late passage (Gurung et al., 2015). To validate this 
observation, in vitro colony-forming unit-fibroblast (CFU-F) assay was performed 
to investigate the impact of A83-01 treatment on colony formation. 
 
eMSCs were cultured with or without A83-01 for 2 passages (29 days) and then 
seeded at a low density (50 cells/cm2) to allow colony formation and treated 
further for 2 weeks. Again, the response to A83-01 treatment was consistent 
between primary cultures, although the magnitude of the response markedly 
varied (Figure 4.7A). Blockade of TGF-β-R signalling increased the ability of 
eMSCs to form colonies when compared to control cultures (Figure 4.7B), 
although statistical significance was not reached (p > 0.05). Haematoxylin stained 
representative colonies of three independent cultures are shown in Figure 4.7C. 
In addition, colonies generated by A83-01 treated eMSCs were smaller and more 
rounded (Figure 4.7C, bottom right panel), compared to more elongated clonal 
cells resulting from control (untreated) cultures (Figure 4.7C, top right panel).  
 
Data showed that TGF-β-R signalling blockade increases the ability of eMSCs to 
form colonies, although the magnitude of the A83-01 effect differs between 
primary cultures. 
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Figure 4.7. A83-01 positively regulates eMSC clonal efficiency. (A). Colony 
forming unit efficiency was determined in 3 primary eMSC cultures treated with 
or without A83-01. Each graph represents an individual culture. (B) Mean change 
(± SEM) in colony forming capacity upon A83-01 treatment compared to 
untreated cultures.. (C) Representative images of eMSC colonies established 
from untreated (control) and A83-01 treated cultures. The right panel shows 
higher magnification (10X) images of colonies. Typically, clonal cells following 
A83-01 were smaller and lacked the elongated fibroblast-like morphology of 
untreated cells  
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4.2.4 Changes in gene expression as result of A83-01 
treatment 
 
My next aim was to define the molecular mechanisms through which A83-01 
maintains cells in a more undifferentiated state upon prolonged culture. Hence, 
total RNA obtained from three paired eMSC cultures, treated with or without of 
the TGF-β-R inhibitor for 36 days, was subjected to RNA-sequencing. This time-
point was chosen because it clearly showed the proliferation advantage of A83-
01 treated compared to control cultures (Figure 4.1). 
 
Briefly, eMSCs were selectively isolated from 3 independent endometrial biopsies 
using magnetic bead sorting and treated with or without TGF-β-R inhibitor for 36 
days. RNA libraries, generated using RNA samples with a RIN > 8.0, were 
sequenced on the Illumina HiSeq3000. Fifty million single end reads were 
sequenced per sample, with a read length of 50 bp. PCA was performed on the 
rlog transformation of the counts from DESeq to explore how the samples 
clustered or segregated. In this analysis, Principal Component 1 (PC1), which 
accounted for 48.10% of variation in gene expression, reflected intrinsic 
differences in primary cultures. It clustered the treated samples 63 and 64 apart 
from the 74; and the control samples 64 and 74 apart from 63. As 
aforementioned, intrinsic variation in the responsiveness of primary cultures was 
also observed in the functional assays (Figure 4.2-4.7). PC2, which accounted 
for 28.44% of variation in gene expression, separated control from A83-01 treated 
cultures, thus reflecting the effect of TGF-β-R blockade on gene expression 
(Figure 4.8). Based on q < 0.05, DESeq identified a robust list of 1,463 
differentially expressed genes between control and treated cultures (Figure 4.9). 
Out of 1,463 differentially expressed genes, 759 (52%) were up-regulated and 
704 (48%) were down-regulated following A83-01 treatment. All the differentially 
up- and down- regulated genes are listed in Appendix 5 and 6, respectively.  
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Figure 4.8. PCA of A83-01 treated and untreated eMSCs. PCA of RNA-
sequencing data from three independent eMSC cultures, treated with or without 
A83-01 for 36 days. PC1 segregated different primary cultures, whereas PC2 
reflects the response to treatment.  
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Figure 4.9. Average gene expression levels between A83-01 treated and 
untreated eMSC cultures. The scatter plot shows the average expression of 
differentially expressed genes between control and A83-01 treated libraries. Red 
dots represent significantly differentially expressed genes (q < 0.05), whereas 
black dots are no differentially expressed genes. The axes show the average 
gene expression levels expressed as log2 transformed counts normalized to 
library size. 
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Identification of the most A83-01 responsive genes 
 
To identify genes most enriched or depleted upon A83-01 treatment, differentially 
expressed genes were ranked according to the log2-fold change. The top three 
most up-regulated genes were DMKN (q = 8.28 x 10-28), DPP6 (q = 1.35 x 10-19) 
and CPVL (q = 4.09 x 10-18). DMKN encodes for dermokine, a protein up-
regulated in inflammatory diseases (Naso et al., 2007); DPP6 encodes for 
dipeptidyl-peptidase 6, a transmembrane protein (Van Es et al., 2008); and CPVL 
encodes a carboxypeptidase that cleaves a single amino acid from the carboxyl 
termini of peptides (Mahoney et al., 2001). 
 
The top three most down-regulated genes were CST1 (q =2.80 x 10-64), PMEPA1 
(q = 1.67 x 10-57) and LINC00643 (q = 7.08 x 10-37). CST1 encodes for cystatin 
SN, a cysteine protease inhibitor (Cao et al., 2015); PMEPA1 encodes for 
prostate transmembrane protein androgen induced 1, a transmembrane protein 
with a SMAD interacting motif (Koido et al., 2016); and LINC00643 encodes for 
long intergenic non-protein coding RNA 643 (Figure 4.10). 
 
Next, I ranked all genes differentially regulated by A83-01 in prolonged cultures 
on basis of the abundance of transcript levels, i.e. transcripts per million (TPMs). 
Out of the top 50 most abundantly expressed genes in prolonged eMSC cultures, 
7 were up-regulated in response to A83-01 treatment and 43 were down-
regulated. Interestingly, 20 out of the 43 down-regulated genes encode ECM 
proteins or factors involved in ECM turn-over. Figure 4.11 shows the repression 
of these genes in response to A83-01 treatment. The TPMS of these genes 
ranged between 342.33 to 14,586.59. Notable examples of A83-01 repressed 
ECM genes include COL1A1 (collagen type I alpha chain; q = 1.37 x 10-9), 
COL1A2 (collagen type I alpha 2 chain; q = 1.44 x 10-3) and SPARC (secreted 
protein acidic and cysteine rich; q = 8.43 x 10-4). 
 
ECM production by fibroblasts is a well characterized response to injury. In the 
case of tissue damage, fibroblasts transit from a quiescent to an activated state, 
where TGF-β signalling, amongst others signalling pathways, activates genes 
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encoding for ECM proteins and cytoskeletal remodelling (Nakerakanti & 
Trojanowska, 2012; Biernacka et al, 2011).  
 
Taken together, the results suggest that inhibition of TGF-β-R signalling 
maintains eMSCs in a less differentiated state by preventing fibroblast activation 
in prolonged culture. 
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Figure 4.10. Top A83-01 responsive genes. The data show relative changes in 
gene expression, shown as log2-fold change, of the most A83-01 responsive 
genes in eMSC cultures treated with A83-01 compared to control. 
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Figure 4.11. ECM genes down-regulated in response to A83-01 treatment. 
Graphs showings changes in level of gene expression of ECM genes negatively 
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regulated by TGF-β-R inhibitor, represented as changes in TPMs. Data represent 
mean ± SEM; Y-axis shows TPMs; * indicates q < 0.05, ** q < 0.01 and *** q < 
0.001. 
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4.2.5 Gene ontology analysis and genes of interest 
 
GO analysis  
 
GO enrichment analysis was performed using the Database for Annotation, 
DAVID v. 6.8 to characterize differentially expressed genes in eMSC A83-01 
treated compared to untreated cultures. Based on p < 0.05, GO analysis revealed 
that up- and down- regulated genes in response to A83-01 treatment were 
enriched for 61 and 72 categories, respectively, encompassing biological 
processes, cellular components, and molecular functions (Appendix 7 and 8, 
respectively). As shown in Figure 4.12A, up-regulated genes were enriched for 
intracellular receptor signalling pathways (p = 4.54 x 10-4) and regulation of cell 
growth (p = 7.76 x 10-4). Collagen catabolism (p = 1.73 x 10-13) and cell fate 
commitment (p = 4.29 x 10-3) were GO terms enriched in genes negatively 
regulated upon A83-01 treatment. Significantly enriched GO terms for both up- 
and down-regulated genes were visualized using Reduce and Visualize Gene 
Ontology (REVIGO) server (Figure 4.12).  
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Figure 4.12. Enrichment and depletion of biological processes upon A83-01 
treatment. GO enrichment analysis was applied to differentially expressed genes 
and the significant GO annotations (p < 0.05) summarized using REVIGO and 
clustered based on semantic similarities, which means that if they are described 
by a common ontology they cluster close in the graph.  (A) GO categories 
associated to the up-regulated genes. (B) GO categories enriched for down-
regulated genes. The colour key is represented on the right. The most highly 
enriched GO categories are indicated in blue. The size of the circles reflects the 
frequency of the GO term. 
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eMSC and perivascular markers 
 
Mining of the RNA-seq sequencing data for established eMSC markers revealed 
that A83-01-induced TGF-β-R blockade markedly upregulated the expression of 
SUSD2, consistent with increase in the SUSD2- positive cells and MFI for the 
same marker shown by flow cytometry (Figure 3.3 and 3.6). However, manual 
mining of the RNA-seq data also revealed that A83-01 treatment resulted in the 
downregulation of other notable perivascular markers (Murakami et al., 2014, 
including MCAM (q = 3.97 x 10-2), ELN (q = 7.83 x 10-15) and MYH11 (q = 4.43 x 
10-2) (Figure 4.13). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13. eMSC and perivascular markers. Selected eMSC and perviscular 
markers. The data show relative change, expressed as log2-fold change, in gene 
expression in cultures treated with A83-01 compared to control. 
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4.2.6 Identification of eMSC-associated genes regulated by 
A83-01 
 
In a previous study in our laboratory, RNA-sequencing was used to determine the 
transcriptome profiles of clonal eMSCs and time-matched unselected 
perivascular cells (PVCs). Briefly, total mRNA was isolated of eMSCs subjected 
to clonal assay for 12 days and matched to primary PVCs also cultured for 12 
days. To determine if A83-01 maintains cultured eMSCs in a less differentiated 
state, I examined the overlap in differentially expressed genes in both datasets. 
Figure 4.14 shows a graphic representation of the two datasets compared in this 
part of the study. 
 
 
 
 
Figure 4.14. ‘Untreated vs A83-01 treated eMSCs’ vs ‘Clonal eMSCs vs 
short-term cultured PVCs’. Graphic representation of the two datasets 
compared. (A) shows dataset one where freshly isolated eMSCs were cultured in 
the presence or absence of TGF-β-R inhibitor for 36 days and then subjected to 
ATAC-seq and RNA-seq. (B) represent dataset two where clonal eMSCs were 
subjected to CFU assay for 12 days and compared to primary PVCs cultured for 
12 days. At day 12 clonal eMSCs and PVCs were subjected to RNA-seq.
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Comparison between the two dataset showed that A83-01 treated cells and clonal 
eMSCs share 38 commonly upregulated genes, including SUSD3 (q = 1.36 x 10-
11), LPAR3 (q = 2.67 x 10-5) and ITGA8 (q = 7.07 x 10-6) (Figure 4.15A-B). The 
Human Protein Atlas was used to  determine the spatial expression of these 
genes in the endometrial tissue (Uhlén et al, 2015), particularly in the perivascular 
niche. As shown in Figure 4.16 (left panel), immunohistochemistry analysis 
revealed that SUSD3 (sushi domain containing 3), LPAR3 (lysophosphatidic acid 
receptor 3), and ITGA8 (integrin subunit alpha 8) are indeed expressed in cells 
surrounding the terminal spiral arteries, in keeping that eMSCs reside 
predominantly in the perivascular niche (Masuda et al., 2012). 
  
A total of 120 genes were commonly down-regulated in both A83-01 and clonal 
eMSCs and included several genes coding for extracellular matrix (ECM) proteins 
such as MFAP5 (q = 1.07 x 10-5), FN1 (q = 2.35 x 10-8), and VCAN (q = 2.72 x 
10-7) (Figure 4.17). Again, the Human Protein Atlas was used to annotate the 
cellular distribution of these genes in the perivascular regions of the endometrial 
tissue. As shown in Figure 4.16B, MFAP5 (microfibrillar associated protein 5), 
FN1 (fibronectin) and VCAN (versican) were abundantly expressed in the stromal 
compartment but less prominently in perivascular cells around the terminal spiral 
arteries. 
 
Taken together, these results suggest that A83-01-induced TGF-β-R blockade 
upon prolonged eMSC culture only partly recapitulates the gene signature of 
clonal eMSCs. In keeping with the known role of TGF- in regulating ECM 
(Verrecchia & Mauviel, 2002), the effect of A83-01 on eMSCs in prolonged culture 
may equally relate to the inhibition of ECM components in prolonged cultures. 
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Figure 4.15. A83-01 treated and clonogenic eMSCs share a set of commonly 
upregulated genes. (A) Venn diagram showing overlap of 38 genes commonly 
upregulated both in A83-01 treated and clonogenic eMSCs (Log2-fold change ≥ 
1; q < 0.05). (B) Heatmap representing the gene expression level of the 38 
commonly upregulated genes, which are listed on the right. The colour key is 
represented above the heat map, the most highly enriched genes are indicated 
in red. 
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Figure 4.16. Cellular distribution of A83-01 responsive genes in cycling 
human endometrium. (A) The Human Protein Atlas was mined to determine the 
tissue distribution of 3 proteins (SUSD3, LPAR3, and ITGA8) associated with 
clonal eMSCs and induced at mRNA level in prolonged cultures in response to 
A83-01. (B) The same resource was also mined to determine the tissue 
distribution of 3 proteins (MFAP5, FN1, and VCAN) down-regulated in clonal 
eMSCs as well as in response to A83-01 treatment of prolonged eMSC cultures. 
Overall, the selected A83-01 induced genes were more prominent expressed at 
protein level around the terminal spiral arteries whereas the opposite pattern of 
expression was apparent for A83-01 repressed genes.  
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Figure 4.17. A83-01 treated and clonogenic eMSCs share a set of commonly 
downregulated genes. (A) Venn diagram showing overlap of 120 genes 
commonly downregulated both in A83-01 treated and clonogenic eMSCs (log2-
fold change ≤ -1; q < 0.05). (B) Heatmap showing gene expression level of 120 
commonly downregulated genes, which are listed on the right. The colour key is 
represented above the heat map, the most highly enriched genes are indicated 
in red. The heatmap was divided into two parts because of the size. 
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GO analysis of eMSC-associated genes induced by A83-01 
 
 
GO enrichment analysis of the 38 commonly upregulated genes, i.e. eMSCs 
versus PVCs and A83-01 treated versus untreated cultures, was performed to 
identify relevant biological processes. 
 
Based on p < 0.05, GO analysis showed enrichment for eight GO terms, including 
‘positive regulation of collateral sprouting’ (p = 1.56 x 10-2), ‘oxidation-reduction 
process’ (p = 2.79 x 10-2) and ‘negative regulation of endothelial cell migration’ (p 
= 3.48 x 10-2). GO term associated to ‘positive regulation of collateral sprouting’ 
included EFNA5 (ephrin A5) and LPAR3 (lysophosphatidic acid receptor 3); 
‘oxidation-reduction process’ included PTGS2 (prostaglandin-endoperoxide 
synthase 2; also known as cyclooxygenase-2 or COX-2) and VATL1 (vesicle 
amine transport 1 like); and ‘negative regulation of endothelial cell migration’ 
included DLL4 (delta-like canonical Notch ligand 4) and SLIT2 (slit guidance 
ligand 2). Interestingly, enrichment analysis of the 38 commonly up-regulated 
genes for Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
revealed enrichment of the ‘vascular endothelial growth factor (VEGF) signalling 
pathway’ (p = 9.57 x 10-3), that included RAC2 (Rac family small GTPase 2), 
PTGS2 (prostaglandin-endoperoxide synthase 2) and PLA2G4A (phospholipase 
A2 group IVA) (Figure 4.18A). 
 
GO analysis of the 120 commonly downregulated genes showed depletion of ten 
biological processes. The most significantly (p < 0.05) down-regulated were ‘ECM 
organization’ (p = 2.95 x 10-5) and ‘cell adhesion’ (p = 1.28 x 10-4). ‘ECM 
organization’ category included ELN (elastin) and FN1; ‘cell adhesion’ included 
TGFBI (transforming growth factor beta induced) and CDH2 (cadherin 2). 
Enrichment analysis of KEGG pathway showed depletion for seven categories, 
for example ‘signalling pathways regulating pluripotency of stem cells’ (p = 1.17 
x 10-2) and ‘cell adhesion molecules (CAMs)’ (p = 1.23 x 10-2) (Figure 18B). 
‘Signalling pathways regulating pluripotency stem cells’ included FGFR2 
(fibroblast growth factor receptor 2) and WNT2 (Wnt family member 2); and ‘cell 
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adhesion molecules (CAMs)’ included JAM2 (junctional adhesion molecule 2) 
and CLDN1 (claudin 1).   
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Figure 4.18. A83-01 treatment partly recapitulates stem cell features. 
Enrichment analysis of biological processes and KEGG pathways associated 
with the 38 and 120 commonly up- (A-B) and down-regulated (C-D) genes, 
respectively, in both RNA-sequencing datasets: A83-01 treated versus untreated 
cultured eMSCs and clonal eMSCs versus PVCs. The pie charts showed the 
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significantly enriched (A-B) or depleted categories (C-D), and the numbers 
indicate the number of genes contained in each identified biological process or 
KEGG pathway. 
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Divergent transcriptomic profiles between clonal and A83-01 treated 
eMSCs in prolonged culture 
 
Inhibition of TGF-β-R signalling differentially regulated genes that partly 
recapitulated gene signature of clonal eMSCs, but also resulted in a unique gene 
signature. Specifically, A83-01 treatment induced 160 genes that were 
downregulated in the clonal eMSCs when compared to PVCs (Figure 4.19). Also, 
TGF-β-R blockade negatively regulated 58 genes, which were enriched in clonal 
eMSCs when compared to PVCs (Figure 4.20). To identify biological processes 
associated with these discordant genes, I performed further GO analysis. The top 
three most significant (p < 0.05) GO terms uniquely induced in the A83-01 treated 
eMSCs were ‘negative regulation of substrate adhesion-dependent cell 
spreading’ (p = 1.43 x 10-4), ‘response to retinoic acid’ (p = 3.4 x 10-4) and 
‘regulation of systemic arterial blood pressure by renin-angiotensin’ (p = 9.07 x 
10-4). The top three most negatively downregulated by A83-01 whereas were 
‘collagen catabolic process’ (p = 7.13 x 10-4), ‘extracellular matrix disassembly’ 
(p = 0.02), and ‘cellular response to vitamin D’ (p = 0.02). It is notable that GO 
terms related to ECM were down-regulated in prolonged eMSC cultures treated 
with A83-01. 
 
Taken together, the comparison of the two RNA-seq data sets revealed that TGF-
β-R blockade upon prolonged culturing of eMSCs partly recapitulates the identity 
of clonal eMSCs, but also modulates a distinct gene network, consisting of 218 
genes. A preponderance of genes selectively inhibited by A83-01 in prolonged 
eMSC culture relate to ECM proteins and ECM turnover.  
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Figure 4.19. Discordant genes between A83-01 treated and clonogenic 
eMSCs. (A) Venn diagram showing overlap of 160 genes differentially regulated 
in A83-01 treated and clonogenic eMSCs (q < 0.05). (B) Heatmap representing 
expression level of the 160 discordant genes, which are listed on the right. Again, 
the heatmap was divided into two parts because of its size. 
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Figure 4.20. Discordant genes between A83-01 treated and clonogenic 
eMSCs. (A) Venn diagram showing overlap of 58 genes differentially regulated 
in A83-01 treated and clonogenic eMSCs (q < 0.05). (B) Heatmap representing 
expression level of 58 discordant genes, which are listed on the right. 
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4.2.7 Disease state associated to A83-01-responsive genes 
 
Next, DAVID v6.8 was used to determine the association between A83-01 
responsive genes in prolonged eMSC cultures and disease states.  
 
Interestingly, a conspicuous association was apparent between genes 
upregulated upon A83-01 treatment of eMSCs and metabolic and vascular 
disorders (Figure 4.21), especially ‘carotid artery diseases’ (fold enrichment = 23) 
and ‘diabetes mellitus type 2’ (fold enrichment = 23). Term related to ‘carotid 
artery diseases’ included three genes encoding APOE (apolipoprotein E), AGT 
(angiotensin) and ACE (angiotensin I converting enzyme); and ‘diabetes mellitus 
type 2’ included NOS3 (nitric oxide synthase 3), APOE and ACE.  
 
Interestingly, ‘endometrial neoplasms’ (fold enrichment = 13) and ‘breast and 
prostate cancer’ (fold enrichment = 4) were depleted upon A83-01 treatment 
(Figure 4.22). ‘Endometrial neoplasm’ included MMP2 (matrix metallopeptidase 
2), MMP7 (matrix metallopeptidase 7) and ESR1 (estrogen receptor 1); and 
‘breast and prostate cancer’ included HSD17B2 (hydroxysteroid 17-beta 
dehydrogenase 2), IGF2 (insulin like growth factor 2) and PRL (prolactin 
receptor). 
 
This analysis revealed a potential association between genes differentially 
regulated upon A83-01 and disease state. However, this does not necesserarly 
mean that induction or depletion of a particulary set of genes, related to a specific 
disease, is translated in a disorder. However, alterations of these genes might 
increase the risk. As the number of genes in each enriched GO term was limited, 
the data should be interpreted with caution.  
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Figure 4.21. Selected disease states associated to upregulated genes upon 
A83-01 treatment. Enrichment analysis of the significantly upregulated genes 
and their correlation with disease states. The size of the words describing the 
identified disorders is directly proportional to their fold enrichment (fold change 
values between 10 and 23). 
 
Figure 4.22. Selected disease states associated to downregulated genes 
upon A83-01 treatment. Enrichment analysis of the significantly downregulated 
genes and their correlation with disease states. The size of the words describing 
the identified disorders is directly proportional to their fold enrichment (fold 
change values between 3 and 13). 
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4.2.8 Differential regulation of transcription factors upon A83-
01 treatment 
 
Differentially expressed genes in A83-01 treated and untreated cultures were 
further interrogated to identify transcription factors (TFs) regulated in response to 
TGF-β-R inhibition. 
 
Based on q < 0.05, a robust list of 104 differentially expressed TFs in response 
to A83-01 treatment was identified. RARB (retinoic acid receptor beta; q =1.06 x 
10-33); WT1 (Wilms tumor 1; q = 4.94 x 10-16), and HEYL (hes related family bHLH 
transcription factor with YRPW motif-like; q = 2.21 x 10-10) were amongst the most 
highly enriched TFs. Highly repressed TFs included MEOX1 (mesenchyme 
homeobox 1; q = 1.06 x 10-12), ESR1 (estrogen receptor 1; q = 7.04 x 10-29), and 
EGR2 (early growth response 2; q = 6.59 x 10-11) (Figure 4.23).  
 
Out of the 104 A83-01 responsive TFs, only 8 were concordantly regulated 
between clonal eMSCs and matched PVSCs. A83-01-responsive TFs enriched 
in clonal eMSCs included TFAP2C (transcription factor AP-2 gamma), HOXB3 
(homeobox B3) and TOX2 (TOX high mobility group box family member 2). 
Conversely, A83-01-responsive TFs downregulated upon differentiation of clonal 
to PVSCs included DLX5 (distal-less homeobox 5), ZFHX2 (zinc finger homeobox 
2) and ZNF853 (zinc finger protein 853).  
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Figure 4.23. Changes in TF expression upon A83-01 treatment. Inhibition of 
TGF-β-R signalling pathways alters expression of genes encoding TFs. Graph 
shows expression of selected significantly up- and down-regulated TFs (log2-fold 
change ≥ 1 and ≤ -1). 
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4.3 Discussion 
 
Cell reprogramming via the use of small molecules that modulates stem cell 
specification and function offers significant opportunities to study the cell biology 
and enhance our knowledge of the therapeutic potential of stem cells (Yu et al., 
2014; Li et al., 2013). Compared to genetic tools, the use of small molecules for 
cell reprogramming provide several advantages, for example their effect is 
reversible, that means that they can temporally regulate cellular function. This 
allows to yield sufficient amounts of homogeneous cells for clinical applications. 
Also, small molecules can be used in synergy with other factors, and this may 
improve their efficacy (Li et al., 2012). Small molecules can act as activators or 
repressors of signalling pathways. In this way, they regulate downstream gene 
transcription (Yun et al., 2014). The use of a glycogen synthase kinase (GSK) 3 
inhibitor to maintains the pluripotency of induced pluripotent stem (iPS) cells 
exemplified such approach (Takahashi & Yamanaka, 2006; Li et al., 2009; Ying 
et al., 2008; Silva et al., 2008). 
 
A recent study showed that inhibition of TGF-β-R signalling, through TGF-β-R 
inhibitor A83-01, promotes eMSC proliferation, maintaining their clonogenic 
phenotype and preventing spontaneous differentiation (Gurung et al., 2015). The 
use of A83-01 as a signalling pathway modulator has provided a robust tool to 
generate amount in the large scale manufacture of homogenous eMSC 
populations for clinical applications. Understanding gene expression programs 
and mapping of altered chromatin accessibility in response to A83-01 treatment 
is required to realize regulatory mechanisms that maintains eMSCs in an 
undifferentiated state. 
 
Data confirmed that TGF-β-R inhibition enhances proliferative ability of eMSCs 
as shown by increased cumulative cell population and number of PDs upon 
treatment. Furthermore, data revealed that TGF-β-R blockade maintains 
clonogenic phenotype of MSCs. Specifically, A83-01 positively regulated the 
number of CD140b- and SUSD2- positive cells in prolonged culture and increase 
for the same markers. Also, results confirmed that TGF-β-R blockade improves 
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the ability of cultured eMSCs to form colonies, preventing loss of clonogenicity. 
Notably, results showed marked variation in the responsiveness of primary 
cultured eMSCs to treatment, underlying the intrinsic variability between primary 
cultures.  
 
Gene profiling of cultured eMSCs upon A83-01 treatment revealed that TGF-β-R 
blockade involves wholesale reprograming of the transcriptome. The resulting 
differentially expressed genes are implicated a broad range of functions. For 
example, A83-01 treatment resulted in upregulation of genes involved in 
intracellular receptor signalling pathways and regulation of growth, and 
downregulation of genes encoded for collagen catabolism and cell fate 
commitment. Notably, RNA-seq revealed upregulation of SUSD2, consistent with 
flow cytometry data showing increase in the percentage of SUSD2- positive cells 
and MFI for the same marker. Conversely, transcriptomic profiling revealed 
depletion of perivascular markers, such as MCAM, MYH11 and ELN.  
 
Mining of the data revealed that TGF-β-R inhibition repressed the expression of 
numerous genes encoding for ECM components, including COL1A1, COL1A2 
and SPARC. ECM production is a well characterized response to injury and TGF-
β signalling is master regulator. More accurately, in the case of tissue damage, 
fibroblasts transit from a quiescent to an activated state, where TGF-β signalling, 
amongst others signalling pathways, activates genes encoding for ECM proteins 
and cytoskeletal remodelling (Nakerakanti and Trojanowska, 2012; Biernacka, 
A., et al, 2011). This suggests that the effect of TGF-β-R blockade in maintaining 
eMSCs in a less differentiated state might be mediated by preventing fibroblast 
activation and limiting ECM deposition in prolonged culture. Hence, it would be 
interesting to validate the induction of ECM genes at a mRNA and protein level 
through RT-qPCR and western blot, although time limitations prevented me of 
pursuing this line of investigation any further. 
 
To determine if A83-01 induces a stem cell signature, I compared the 
transcriptome profile of A83-01 treated and untreated eMSCs with the RNA-seq 
data obtained from another dataset, comparing clonal eMSCs to time-matched 
unselected PVCs. 
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This analysis revealed a dataset of shared genes accounting for 38 concordant 
up- and 120 concordant down- regulated loci. Interestingly, functional annotation 
of the commonly down-regulated genes highlighted an abundance of genes 
encoding for ECM components or associated to ECM organization. 
 
For therapeutic application, it is of paramount importance to ensure that A83-01 
treatment does not alter expression level of transcripts associated to clinical 
disorders. Functional annotation revealed a majority to be associated with 
metabolic and vascular disorders, which might alert in terms of clinical use. On 
the other hand, analysis of the data showed that TGF-β-R blockade correlates 
with downregulation of genes associated to cancer, reassuring for a safe use of 
these cells in regenerative medicine.  
 
Taken together, the current findings suggest that A83-01 effect might be related 
to prevention of fibroblast activation. 
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Chapter 5 
 
 
 
 
Analysis of dynamic chromatin 
changes in cultured eMSCs 
upon TGF-β-R inhibition 
 _______________________ 
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5.1 Introduction 
 
eMSCs are a rare and promising source of cells for cell-based therapy for women 
with reproductive disorders, largely because of their self-renewal and 
differentiation properties (Darzi et al., 2016). As in the case for other cell types, 
eMSC identity results from a specific gene expression pattern. Chromatin 
organization and a dynamic epigenetic code govern differential expression of the 
transcripts. Epigenetic modifications, including nucleosome positioning, TF 
binding and chromatin regulators, DNA modifications (e.g. acetylation, 
methylation, sumoylation etc.) alter genomic structure, thereby sequestering 
some DNA regions and leaving others open or accessible to TF binding (Chen & 
Dent, 2014).  
 
Chromatin profiling of bone-marrow MSCs in prolonged culture revealed that 
changes in acetylation level of histone 3 (H3) negatively regulated the expression 
of pluripotency factors, such as octamer-binding transcription factor 4 (OCT4) and 
SRY-box 2 (SOX2) (Li et al., 2011). Other studies also showed that during MSC 
differentiation, changes in gene expression pattern correlate, amongst others, 
with dynamic changes in histone modifications (Herlofsen et al., 2013). 
Understanding of the interplay between genomic modifications and TFs 
regulating chromatin remodelling is a prerequisite for clinical applications of 
MSCs.  
 
Gurung et al. (2015) provided a promising approach to promote eMSC 
proliferation in prolonged culture while preventing differentiation. In the previous 
chapter, I examined the impact of TGF-β-R blockade on the transcriptome of 
cultured eMSCs. Transcriptomic analysis of the differentially expressed genes 
revealed a wholesale transcriptomic reprogramming in cultured eMSCs treated 
with A83-01 compared to untreated cultures.  
 
These changes in gene expression pattern must be underpinned by a dynamic 
genomic remodelling. I postulated that TF binding sites enriched or depleted in 
opening or closing chromatin loci, respectively, will provide further insights into  
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the mechanisms of A83-01 action. To test this hypothesis, in this chapter I used 
ATAC-seq as a robust method to accurately probe regions of differential 
chromatin opening effective also on rare group of cells. 
 
 
 5.2 Results 
 
 
5.2.1 Analysis of chromatin landscape in cultured 
eMSCs  
 
 
To map the changes in chromatin accessibility, primary eMSCs were treated with 
or without TGF-β-R inhibitor for 36 days. The nuclei were harvested and 
processed for ATAC-seq. ATAC-seq libraries, with a size distribution between 
150 and 600 bp, were sequenced on the Illumina HiSeq1500. Twenty-five million 
paired end reads were sequenced per sample, with a read length of 50 bp. As for 
the RNA-sequencing, PCA was performed to assess the effect of TGF-β-R 
inhibition on chromatin landscape of cultured eMSC. In this analysis, PC1, which 
accounted for 43.26% of variation in chromatin opening, separated A83-01 
treated and untreated cultures, reflecting the effect of TGF-β-R inhibition on 
chromatin accessibility. PC2, which accounted for 27.01% of variation in 
chromatin opening, reflected intrinsic differences in primary cultures. It separated 
the control samples 63 and 64 from 74; and treated samples 63 and 64 from 74 
(Figure 5.1). 
 
DESeq was used to identify differential ATAC-seq peaks, reflecting genomic 
regions of active chromatin opening or closing. Based on q < 0.05, DESeq 
revealed a total of 5,967 differential ATAC-seq peaks. Specifically, 3,555 (60%) 
and 2,412 (40%) genomic regions significantly opened or closed following A83-
01 treatment over 36 days, respectively. Out of 5,967 peaks, 31% and 29% of 
the opening and closing ATAC-seq peaks, respectively, fell within - 10 to + 1 
kilobases (kb) around TSSs. For example, RARB, TGFBR3 (transforming growth 
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factor beta receptor 3) and SUSD2 showed increased chromatin accessibility at 
and upstream of their proximal promoters upon inhibition of TGF-β-R signalling 
(Figure 5.2A-C). Cross-referencing with RNA-seq data showed a significant 
increase in RARB, TGFBR3 and SUSD2 transcript levels in response to A83-01 
treatment (q < 1.1 x 10-32, q < 1.23 x 10-21 and q < 2.72 x 10-4, respectively). 
Conversely, CADM1, WNT5A and COL1A1 are three examples of genes 
repressed upon TGF-β-R inhibition. As shown in Figure 5.3, downregulation of 
CADM1 and COL1A1 is associated with closure of their proximal promoters 
whereas silencing of WNT5A is mediated by closure of a distal enhancer. Again, 
cross-referencing of the ATAC-seq data with transcriptomic analysis data 
revealed an association between chromatin remodelling and differential gene 
expression. Specifically, TGF-β-R inhibition negatively regulated the expression 
levels of CADM1 (q < 1.93 x 10-46), COL1A1 (q < 1.37 x 10-9) and WNT5A (q < 
5.0 x 10-30). 
 
Dynamic chromatin changes at specific loci alter binding of TFs and thus gene 
expression. Because TFs can both activate and repress transcription, the 
correlation between dynamic changes in chromatin landscape and gene 
expression is not necessarily linear. Nevertheless, analysis of 200 loci associated 
with the most dynamic ATAC-seq peaks revealed that opening and closing loci 
(within 10 kb of the TSS) correlate with increased and decreased expression of 
nearby genes, respectively (p = 1.0 x 10-6) (Figure 5.4). 
 
Taken together, the ATAC-seq data provided a genome-wide map of chromatin 
remodelling in response to TGF-β-R inhibition in prolonged eMSC cultures. Next, 
I interrogated the informative ATAC-seq peaks to gain insight into the cis-
regulatory landscape that underpins the transcriptional reprogramming of eMSCs 
upon A83-01 treatment. 
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Figure 5.1. PCA of A83-01 treated and untretaed eMSCs. PCA of ATAC-seq 
data from three paired eMSC cultures, treated in the presence or absence of 
TGF-β-R inhibitor for 36 days. PC1 explains variation due to A83-01 treatment, 
whereas PC2 explians variability due to different primary cultures.  
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Figure 5.2. Representative opening ATAC-seq peaks. Representative ATAC-
seq peaks showing transition from closing to opening chromatin upstream the 
promoter of RARB (A), TGFBR3 (B) and SUSD2 (C). Black and red traces 
represent untreated and A83-01 treated eMSC cultures. The X-axis shows the 
genomic location of the ATAC-seq peaks and genes. The Y-axis shows the 
frequency of Tn5 cutting.  
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Figure 5.3. Representative closing ATAC-seq peaks. Differential ATAC-seq 
peaks showing closing transition from opening to closing chromatin of the 
proximal promoter of CADM1 (A) and COL1A1 (B) and of a distal enhancer of 
WNT5A (C) in response to A83-01. Black and red traces represent untreated and 
A83-01 treated eMSC cultures. The X-axis shows the genomic location of the 
ATAC-seq peaks and genes. The Y-axis shows the frequency of Tn5 cutting.  
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Figure 5.4. Differential chromatin opening correlates with gene expression 
changes in A83-01 treated eMSCs. Changes in chromatin landscape of eMSCs 
in response to TGF-β-R inhibition correlate with differential regulation of gene 
expression. Box plots showing increase or decrease in transcript levels of 200 
genes (within 10 kb of the TSS) associated with the most open and closed ATAC-
seq peaks. Y-axis shows relative changes in transcript levels, expressed as log2-
fold change: +ve and –ve values relate to up- and down-regulated genes, 
respectively. X-axis shows ATAC-seq peaks clustered in opening and closing 
peaks. Green dots represent the genes and the red asterisk represents mean 
log2-fold change (p = 1.0 x 10-6, t-test). 
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5.2.2 TF Binding Motif Discovery 
 
To gain insights into cis-regulatory landscape underpinning differential gene 
expression in response to TGF-β-R inhibition, de novo short sequence motif 
enrichment analysis using HOMER was performed on 3,555 opening and 2,412 
closing ATAC-seq peaks.  
 
A total of 19 motifs (Opening M1-19) were significantly enriched in opening 
ATAC-seq peaks and 17 motifs (Closing M1-17) were significantly 
overrepresented in closing ATAC-seq peaks (Figure 5.5). To identify putative TFs 
likely to be involved in the binding of the identified motifs, I integrated the short 
sequence motifs with known TF databases and further examined the expression 
level of the presumable binding TFs. This analysis revealed a number of motifs 
enriched in opening and closing ATAC-seq peaks corresponded to high affinity 
binding sites for TFs enriched or depleted in response to A83-01 treatment, 
respectively. CEBPB, CEBPD, nuclear receptor subfamily 4 group A member 1 
(NR4A1; also known as NUR77), RAR related orphan receptor A (RORA) and 
forkhead box P2 (FOXP2) were amongst the most plausible differentially induced 
TFs with high binding affinity for motifs enriched in opening ATAC-seq peaks. 
Conversely, downregulation of transcription factor 21 (TCF21), TGF induced 
factor homeobox 2 (TGIF2) and nuclear transcription factor Y subunit alpha 
(NFYA) in response to A83-01 treatment corresponded to loss of accessibility of 
their respective high affinity binding sites (Figure 5.6). 
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Figure 5.5. Enrichment of TF binding motifs in opening and closing 
genomic regions. Total of 19 and 17 TF binding motifs enriched in the opening 
and closing ATAC-seq peaks, respectively. The frequency (%) of peaks (blue 
bars) containing a given motif is shown relative to genomic regions randomly 
selected from the genome (orange bars) (±50 Kb from TSS, matching size, and 
GC/CpG content. 
0 10 20 30 40 50 60 70
Closing M1
Closing M2
Closing M3
Closing M4
Closing M5
Closing M6
Closing M7
Closing M8
Closing M9
Closing M10
Closing M11
Closing M12
Closing M13
Closing M14
Closing M15
Closing M16
Closing M17
Closing Motifs
% Targets % of Background
  
163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6. Differentially regulated TFs matched to enriched and depleted 
short sequence binding motifs. Bar graph showing enriched and depleted 
binding motifs coupled with the most plausible differentially expressed TFs, 
based on motif specificity. In the bar graph, the frequency (%) of peaks (blu bars) 
containing the motif is shown relative to genomic regions randomly selected from 
the genome (orange bars) (±50 Kb from TSS, matching size, and GC/CpG 
content). P indicates the p-value of the short sequence binding motifs.  
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5.3 Discussion 
 
In this chapter, I examined the interplay between gene expression pattern and 
dynamic epigenetic code that govern the identity and function of eMSCs in 
extended culture. Because of their scarcity in tissues, it is challenging to 
investigate chromatin state of adult MSCs in general. ATAC-seq enables to 
overcome this limitation. It provides a robust method for genome-wide analysis 
of the chromatin structure of rare cellular types. 
 
It is quite apparent that A83-01-induced TGF-β-R blockade provides a powerful 
approach for eMSC expansion in prolonged culture. In Chapter 4, I provided 
evidence that TGF-β-R blockade prevents loss of proliferative capacity of eMSCs 
in prolonged culture. Transcriptional profiling indicated that A83-01 partly 
maintains the expression of genes associated with stemness and, importantly, 
inhibits genes associated with fibroblast activation. ATAC-seq analysis provided 
unbiased analysis of the changes in the cis-regulatory landscape that underpin 
the cellular responses to A83-01 treatment.  
 
By integrating the transcriptomic and ATAC-seq analysis, I was able to assign 12 
A83-01 induced TFs to high-affinity binding motifs enriched in opening chromatin 
loci. Conversely, 3 TFs repressed in response to A83-01 corresponded loss of 
high affinity binding sites. Some of the most highly enriched cis-regulatory motifs 
showed high affinity for TFs implicated in eMSC differentiation, for example 
CEBPB and RORA (Frith & Genever, 2008; Myamoto et al., 2012). Hence, their 
role in maintaining cultured eMSCs in an undifferentiated state needs further 
investigation. However, this analysis also revealed some interesting new 
pharmacological targets to enhance in vitro expansion of eMSCs even further.  
For example, induction of NR4A1 transcript levels in A83-01 treated cells 
corresponded to enrichment in putative NR4A1 binding sites. NR4A1, also known 
as NUR77, is an orphan nuclear receptor that belongs to steroid-thyroid hormone-
retinoid receptor superfamily. NR4A1 was recently identified as an endogenous 
inhibitor of TGF-β signalling (Palumbo-Zerr et al., 2015). Nr4a1-null mice exhibit 
pronounced dermal thickening, massive deposition of collagen, and higher 
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myofibroblast counts when compared to wild-type mice. Furthermore, lack of 
Nr4a1 in mice results in exacerbated fibrosis in two model of skin fibrosis. The 
use of small molecules that function as NR4A1 agonists can restore its activity, 
re-activating an endogenous negative regulation of TGF-β signalling. Hence, they 
can be used as potential treatment to inhibit fibrosis (Palumbo-Zerr et al., 2015). 
Importantly, cytosporone-B is a small molecule that acts as a selective agonist 
for NR4A1 (Zhan et al., 2008). Cytosporone-B increases the nuclear retention of 
NR4A1 in cultured fibroblasts. In wild-type mice with a constitutively active  TGF-
β-R type I, the use of Cytosporone-B results in a down-regulation  of TGF-β target 
genes, reduces collagen production and inhibits myofibroblast differentiation. 
Nr4A1-null mice are not responsive to Cytosporone-B. Moreover, it also has anti-
fibrotic effects, as exemplified by its therapeutical effects in TGF-β-R type I-
induced skin fibrosis and bleomycin-induced pulmonary fibrosis (Palumbo-Zerr et 
al., 2015). Hence, it would be interesting to test if cytosporone-B could either 
replace or synergise with A83-01 to enhance expansion of eMSCs in prolonged 
culture.  
 
Taken together, TF binding motif discovery and mining of the RNA-seq data 
revealed enrichment and depletion of putative TFs likely to be involved in the 
regulation of chromatin configuration underlying the wholesale transcriptomic 
reprogramming. Interestingly, this exercise yielded a potential novel 
pharmacological target that might be used enhance in vitro expansion of eMSCs. 
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Discussion  
 
Cell-specific responses to a given cue, whether hormones, growth factors, 
cytokines, chemokines or stress signals, are not only determined by the level of 
expression and activation status of relevant receptors, signal transduction 
pathways and downstream TFs but also by the organisation of the chromatin on 
which TFs act in conjunction with interacting partners, such as co-activators, co-
repressors, histone-modifying protein complexes and the basal transcriptional 
machinery (Chen & Dent, 2014).  
 
The structural subunit of chromatin is the nucleosome. It contains approximately 
147 bp of DNA wrapped almost twice around a central octamer composed of two 
molecules each of the four core histones: H2A, H2B, H3 and H4. Generally, the 
compact structure of the nucleosome prevents TF binding (Kornberg, 1974).  
Upon chromatin remodelling, active promoters are often depleted of 
nucleosomes, forming ‘nucleosome-depleted regions’ that are flanked by 
relatively unstable nucleosomes containing the histone variants H2A.Z and H3.3 
(Jin & Felsenfeld, 2007). Similarly, enhancers, which are regulatory elements 
typically located far from their target promoters, are often associated with 
nucleosomes containing H2A.Z and H3.3, and specific histone modifications. 
Further, high-throughput chromosome conformation capture (3C)-derived 
(Dekker et al. 2002) methods have revealed that chromatin is organised in open 
and closed compartments that tend to be spatially segregated depending on their 
transcriptional activity (Lieberman-Aiden et al. 2009). At a local level, functionally 
related genes have been shown to be brought close in space to be transcribed in 
a correlated fashion during cell differentiation. These genes, which may map to 
different chromosomes, are organized in spatial clusters that sometimes referred 
to as transcriptional “factories” (Osborne et al. 2004; Cavalli 2007).  
 
Modulation of chromatin architecture regulates differential exposure of DNA to 
binding of transcriptional regulators and hence dictates activation or repression 
of transcription (Voss & Hager, 2014). ‘Initiating factors’ localize chromatin 
remodelling proteins and histone modifiers at specific cis-regulatory elements of 
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the genome, partly due to the fact that they share common features with histone 
linkers and hence exhibit the ability of binding nucleosomes and chromatin (Zaret 
& Caroll, 2011). Pioneers factors, including FoxA and GATA proteins (Bossard & 
Zaret, 1998; Gualdi et al., 1996; Cirillo et al., 1998; Cirillo & Zaret, 1999), steroid 
receptors (Swinstead et al., 2016), are a special category of proteins capable to 
penetrate and open highly compacted DNA structures in coordination with ATP-
dependent chromatin remodelling complexes, allowing other TF binding (Zaret & 
Caroll, 2011). Single-molecule tracking (SMT) experiments showed that pioneer 
factors have highly transient genomic interactions, displaying a DNA residence 
time of about 9 sec. This suggests that highly dynamic chromatin/factor 
interactions initiate regulatory events that modulate chromatin accessibility and 
ultimately regulate gene expression (Swinstead et al., 2016). 
 
Genome-wide chromatin accessibility mapping assays, including DNase-seq 
(Thurman et al., 2012; Piper et al., 2013, Tsompana &Buck, 2014), FAIRE-seq 
(Giresi et al., 2007; Simon et al., 2012) and the recently identified ATAC-seq 
(Buenrostro et al., 2013; Buenrostro et al., 2015) directly probe accessible 
chromatin regions that contain cis-regulatory elements, such promoters, 
enhancers and other regulatory elements (Valouev et al., 2011; Consortium, 
2012; Thurman et al., 2012, Myong et al., 2016). Global identification of DNA-
protein interactions in the genome can be studied using ‘digital genomic 
footprinting’ (Hesselberth et al., 2009), where short sequence motifs refractory to 
nuclease digestion infer factor occupancy (Thurman et al., 2012; Baek et al., 
2012). This approach provides a good alternative to ChIP-seq, providing higher 
resolution and avoiding antibody issues (Sung et al., 2016).  
 
ATAC-seq is an advanced genome-wide analysis method that enables mapping 
of chromatin accessibility and regulatory networks through footprinting analysis 
and can be applied to rare populations of cells (Buenrostro et al., 2013). Hence, 
in this work, I applied ATAC-seq to identify dynamic changes in the cis-regulatory 
DNA landscape underpinning decidualization of EnSCs and in the maintenance 
of a stem-like phenotype of eMSCs in prolonged cultures. 
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Mapping of dynamic chromatin changes in decidualizing EnSCs 
 
 
Decidualization is a profound transformation of EnSCs from fibroblast-like to 
secretory decidual cells that occurs ‘spontaneously’ in menstruating species 
(Brosens et al., 2006). Decidual transformation involves large-scale gene 
expression changes (Gellersen & Brosens, 2014; Takano et al., 2007). Genome-
wide remodeling of the chromatin architecture underlies the wholesale 
transcriptomic reprogramming upon decidualization (Munro et al., 2010; Zelenko 
et al., 2012). Gene expression profiling studies revealed that genes coding for 
epigenetic modulators are up-regulated during decidualization, and they include 
histone-modifiers and binding proteins, DNA methyltransferases and CpG-
binding proteins. This suggests that a dynamic epigenetic code operates on the 
chromatin landscape of the EnSCs during decidualization and is responsible of 
the acquisition of the decidual identity (Grimaldi et al., 2012). Specifically, an 
example is provided by declining expression level for the histone 
methyltransferase enhancer of Zeste homolog 2 (EZH2) during decidualization. 
This results in a gradual loss of trimethylation of histone 3 on lysine 27 
(H3K27me3) within the proximal promoters PRL and IGFBP1. A coordinated loss 
of methylation and gain of acetylation at the same loci results in increased 
accessibility of the chromatin, which is indicative of a positive regulation fo the 
transcription. This chromatin remodelling underpins the acquisition of decidual 
phenotype (Grimaldi et al., 2011).  Also, another study indicates that the use of 
the DNA methylation inhibitor 5-aza-2’-deoxycytidine in human EnSCs alters 
genomic conformation and results, amongst others, in the up-regulation fo 
decidual genes involved in cellular properties that feature decidual cells, for 
example ECM organization and cell adhesion (Logan et al., 2010). Conversely, 
inhibition of methylation prior to and after implantation in the mouse impairs 
decidualization and correlates with pregnancy failure (Gao et al., 2012). These 
observations suggest that a dynamic epigenetic code operates on the chromatin 
structure as decidualization unfolds. 
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In this work, I first optimised ATAC-seq and applied the technique to primary 
EnSCs to map the genome-wide changes in chromatin landscape upon 
decidualization, a process critical for embryo implantation and placenta formation 
(Gellersen & Brosens, 2014; Salker et al., 2011). I reasoned that this 
differentiation model would be informative as several lines of evidence showed 
that a dynamic epigenetic code operates atop the cis-regulatory landscape in 
decidualizing cells (Grimaldi et al., 2012; Zelenko et al., 2012; Munro et al., 2010).  
 
A total of 185,084 regions of accessible chromatin were mapped in EnSCs and, 
based on a stringent criterion (Bonferroni adjusted p < 0.05), 1,225 and 278 loci 
opened or closed upon decidualization, respectively. Approximately 27 % of 
dynamic loci located within 10 kb upstream of TSSs. Changes in genomic 
accessibility at major decidual genes, such as PRL and IGFBP1, confirmed the 
ability of ATAC-seq to accurately map changes in the cis-regulatory elements of 
the chromatin. Independent primary cultures, either undifferentiated or 
decidualized for 4 days, were subjected to RNA-seq. In line with previous studies 
(Gellersen & Brosens, 2014; Kuroda et al., 2013; Brar et al., 2001; Giudice, 2004; 
Lu et al., 2008; Takano et al., 2012), RNA-seq revealed that decidualization is 
associated with wholesale reprogramming of EnSC functions, exemplified by the 
induction and repression of 1,432 and 1,499 genes, respectively. Although 
different cultures were used, integrated ATAC-seq and RNA-seq analyses 
revealed a strong association between changes in DNA accessibility within 10 kb 
of the promoter and in gene expression.  
 
De novo binding motif discovery using HOMER (Heinz et al., 2010) revealed that 
decidualization of EnSCs is associated with enrichment and depletion of 17 and 
7 short sequence motifs, respectively. Analysis of footprints confirmed protein 
occupancy in 22 out of 24 binding motifs, suggesting TF binding in the majority 
of the biding sites. Highly enriched motifs in the opening ATAC-seq peaks 
included high affinity binding sites for known decidual TFs, including 
CEBPB/CEBPD, FOSL2, FOXO1, PGR, and STAT3/STAT5 (Gellersen & 
Brosens, 2014; Mazur et al., 2015; Kaya et al., 2015; Jiang et al., 2015; Kim et 
al., 2005). Previous studies reported that interaction between TFs can differently 
modify chromatin accessibility (Christian et al., 2002; Christian et al., 2002; Lynch 
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et al., 2009). Evidence of TF cooperation in regulating decidual gene expression 
was also apparent in the footprint analysis. For example, cross-referencing of 
ATAC-seq data with published ChIP-seq data showed that enrichment for both 
FOXO1 and PGR binding sites correlate opening chromatin (Mazur et al., 2015; 
Vasquet et al., 2015).  However, binding sites with high affinity for FOSL2 in the 
absence of PGR were enriched in closing chromatin regions. These observations 
fit well with the fact that FOSL2 physically interacts with PGR in decidualizing 
cells, making it a member of the growing family of PGR co-activators (Mazur et 
al., 2015). 
 
Cross-referencing the binding motifs in the ATAC-seq data with RNA-seq data 
revealed putative TFs not yet implicated in decidualization. For example, 
transcript levels of RORA, ARNTL, and MEIS1 increase upon decidualization in 
parallel with enrichment of high-affinity binding sites for these TFs in opening 
ATAC-seq peaks. Conversely, down-regulation RUNX1, RUNX2, SOX12, TCF3 
and ETS1 upon decidualization correlated with depletion of high affinity binding 
sites. 
 
The role of these putative novel transcriptional regulators in decidual 
transformation of EnSCs requires further investigation. Time limitations 
prevented me of pursuing this line of investigation any further, although a 
graduate student subsequently demonstrated that siRNA-mediated knockdown 
of ARNTL, TCF3 and NFE2L1 perturbed the induction of PRL and IGFBP1 in 
decidualizing cultures. Knockdown of RUNX1 had little impact on the expression 
of decidual marker genes, although this does not necessarily preclude a role for 
this TF in other processes. 
 
The ATAC-seq analysis of undifferentiated and decidualizing EnSCs is important 
on multiple levels. First, it provides an important resource to analyse chromatin 
changes associated with differential gene expression at specific loci. The footprint 
analysis provides insight into the transcriptional drivers of genes of interests, 
although confirmation still requires ChIP-PCR or cross-referencing with existing 
ChIP-seq data sets. Nevertheless, the ATAC-seq data will greatly facilitate 
mechanistic analysis of the pathways and downstream TFs that regulate specific 
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genes or gene networks. Second, although beyond the scope of my 
investigations, additional bioinformatics analysis yielded important insights into 
the emergence of ‘spontaneous’ decidualization in evolution (Gellersen & 
Brosens, 2014). In most mammals, decidualization is triggered by the implanting 
embryo. However, in menstruating species, i.e. higher primates, four species of 
bats, the elephant shrew and the common (Cairo) spiny mouse, decidualization 
is ‘spontaneous’, meaning that it is initiated during the mid-luteal phase of each 
cycle, independently of an implanting embryo. It is thought that spontaneous 
decidualization in primates and other species evolved independently (Bellofiore 
et al., 2017; Emera et al., 2012). In keeping with this model, ATAC-seq analysis 
revealed overrepresentation of primate-specific transposable elements, 
especially Alu repeats, in opening chromatin loci in decidualizing cells. The 
overrepresented Alu elements are conserved in menstruating but not in non-
menstruating primates, suggesting that this transposable element was co-opted 
in the cis-regulatory landscape that drives spontaneous decidualization (Norris et 
al., 1995; Mason et al., 2010). Finally, my analysis provided proof of principle that 
ATAC-seq is a powerful tool to screen rapidly for dynamic chromatin changes in 
human endometrial cells. I envisage that applying this technique to various 
reproductive disorders associated with aberrant endometrial function, such as 
endometriosis, endometrial cancer, infertility and recurrent miscarriage, will yield 
important mechanistic insights into the underlying pathological pathways.  
 
 
Integrated ATAC-seq/RNA-seq analysis of eMSCs expanded in culture 
 
 
I spent the second half of my PhD in the laboratory of Professor Caroline Gargett 
where I explored strategies to improve our understanding of the therapeutic 
potential of eMSCs in regenerative medicine. 
 
The endometrium offers a new, readily available source of MSCs for cell-based 
therapy for women with reproductive health disorders, including Asherman’s 
syndrome and POP (Patel et al., 2008; Bockeria et al., 2013; Darzi et al., 2016). 
For example, it has been recently shown that eMSCs seeded on 
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polyamide/gelatin meshes could improve clinical outcomes for POP treatment. 
They promoted angiogenesis, showed anti-infallmatory properties and 
differentiated into smooth cells and fibroblasts, when transplanted in an 
immunocompromised mouse. Based on these promising findings, a large animal 
model, such as ovine, has been developing as new system to explore if 
autologous transplanted eMSCs function through paracrine effect or if they 
differentiated themselves into epithelial and muscle cells of the vagina (Gargett 
et al., 2016). However, as in the case for adult MSCs from other tissues, the 
relative scarcity of eMSCs necessitates significant expansion of cells in culture 
for clinical applications (Baxter et al., 2004; Ulrich et al., 2013). eMSCs 
spontaneously differentiate during prolonged culture (Zhu et al., 2011; Ulrich et 
al., 2014; Gargett et al., 2016), lose their clonogenicity as well as their ability to 
reconstitute tissue in vivo (Baxter et al., 2004; Banfi et al., 2002).  
 
A recent study showed that selective inhibition of TGF-β-R signalling using a 
small molecule, A83-01, increases proliferative potential and maintains the 
functional properties of eMSCs during prolonged culture (Gurung et al., 2015). 
For clinical application, it is of paramount importance to understand the 
mechanisms underlying pharmacological expansion of eMSCs in culture. My 
study was predicated on the  observation that A83-01 can be used as chemical 
approach to modulate cell identity (Li et al., 2013). My aim was to map the 
genome-wide changes in chromatin landscape and gene expression in response 
to A83-01 treatment of eMSCs and to provide insights into the mechanisms of 
action of this compound.  
 
First, I validated the effect of A83-01-induced TGF-β-R inhibition on the 
proliferative ability of eMSCs and expression of stem cell markers during 
prolonged culture. A83-01 conferred a clear proliferative advantage as 
demonstrated by cumulative population doubling. However, as freshly eMSCs 
are highly proliferative, the effect was only apparent after 22 or more days in 
culture. Next, flow cytometry analysis was used to assess expression of 
phenotypic markers. This analysis revealed that A83-01 treatment increases the 
percentage of CD140b- and SUSD2- positive cells as well as the MFI for the 
indicated markers. Hence, A83-01 maintains the surface phenotype of eMSCs 
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during prolonged culture. However, despite this effect of A83-01 on the 
expression of surface markers being consistent between different primary 
cultures, changes were not significantly difference. This underlies the intrinsic 
differences between different primary cultures, which should be taken into 
account for therapeutic use. Finally, CFU-F assays revealed that A83-01 
treatment increases clonal efficiency, thus attenuating loss of clonogenicity 
during culture expansion. Again, the magnitude of the effect of  treatment varied 
between primary cultures. A recent study showed that the abundance of eMSCs 
correlates inversely with increased body mass index (Murakami et al., 2014). In 
addition, eMSC deficiency has also been associated with recurrent pregnancy 
loss (Lucas et al., 2016). These observations raise the possibility that clinical 
variables determine the ability of eMSCs to be expanded in culture as well as the 
responsiveness of the cells to TGF-β-R inhibition. Hence, additional studies are 
required to determine the factors that determine the proliferative capacity of 
eMSCs in vitro.  
 
Next, I hypothesized that TGF-β-R blockade with A83-01 induced a 
reprogramming of gene expression responsible for the resulting undifferentiated 
state. Hence, to explore the effect of A83-01 on the genome-wide expression 
profile of expanded eMSCs, I performed RNA-seq. PCA revealed that TGF-β-R 
blockade results in a differential gene expression and, interestingly, underscored 
intrinsic variability between different primary cultures. Transcriptomic analysis of 
the differentially expressed genes showed, amongst others, that genes 
implicated in regulation of cell growth and cell fate commitment were induced and 
repressed, respectively. These observations supported the results generated 
from the functional analyses, demonstrating that A83-01 increases proliferative 
potential and prevents differentiation of expanded eMSCs. SUSD2 transcript 
levels were upregulated in response to A83-01 treatment in accordance with the 
flow cytometry data.  However, the RNA-seq analysis did not confirm an increase 
in transcript levels of genes encoding either CD140b (PDGFRB) or other 
perivascular markers (Murakami et al., 2014), such as MCAM, ELN and MYH11. 
 
Mining of the data revealed that TGF-β-R inhibition repressed the expression of 
numerous genes encoding for ECM components, including COL1A1, COL1A2 
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and SPARC. ECM production is a well characterized response to injury and TGF-
β signalling is master regulator. More accurately, in the case of tissue damage, 
fibroblasts transit from a quiescent to an activated state, where TGF-β signalling, 
amongst others signalling pathways, activates genes encoding for ECM proteins 
and cytoskeletal remodelling (Nakerakanti and Trojanowska, 2012; Biernacka, 
A., et al, 2011). Hence, this suggests that the effect of TGF-β-R blockade in 
maintaining eMSCs in a less differentiated state might be mediated by preventing 
fibroblast activation and limiting ECM deposition in prolonged culture.  
 
To determine if A83-01 induces a stem cell signature, I compared the 
transcriptome profile of A83-01 treated and untreated eMSCs with the RNA-seq 
data obtained from another dataset, comparing clonal eMSCs to time-matched 
unselected PVCs. Concordant and discordant differentially expressed genes 
were extracted from these data sets. This analysis revealed that TGF-β-R 
inhibition only partly recapitulates the transcriptional profile of clonal eMSCs. 
Interesting, attenuated expression of genes encoding for ECM constituents was 
both a feature of A83-01 treated eMSCs in prolonged cultures and clonal cells in 
CFU-F assays. These observations underscore my assumption that the effect of 
A83-01 on eMSCs in prolonged culture relate, at least in part, to the inhibition of 
genes coding ECM components.  
 
Transcriptional profiling revealed that A83-01 partly maintains the expression of 
some genes associated with stemness (e.g. SUSD2) and, importantly, inhibits 
genes associated with fibroblast activation. However, RNA-seq analysis does not 
provide insight into the TF network  that mediates the cellular responses to A83-
01 treatment. ATAC-seq analysis provided unbiased analysis of the changes in 
the cis-regulatory landscape that underpin the cellular responses to A83-01 
treatment. I hypothesized that the responsiveness to A83-01-induced TGF-β-R 
blockade was dependent upon genome-wide remodelling of the chromatin 
architecture, which in turn enables recruitment or release of TFs likely responsible 
of maintaining eMSCs in an undifferentiated state during culture.  
 
ATAC-seq revealed a wholesale remodelling of chromatin landscape and 
mapped genomic regions that dynamically change in response to the treatment. 
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Chromatin remodelling at specific loci alters binding of TFs and thus gene 
expression and because TFs can both activate and repress transcription, the 
correlation between dynamic changes in chromatin landscape and gene 
expression is not necessarily linear (Chen & Dent, 2014). Nevertheless, analysis 
of 200 genes associated with open and closed chromatin regions revealed a 
strong statistical correlation between changes in gene expression and 
differentially organized chromatin. There was ample evidence of the importance 
of chromatin remodelling at specific loci in modulating expression of nearby 
genes. For example, induction of RARB, TGFBR3 and SUSD2 correlated with 
increased chromatin accessibility at, and upstream, of their promoters. 
Conversely, down-regulation of CADM1, CLO1A1 and WNT5A was associated 
with loss of chromatin accessibility at proximal promoters and distal enhancers.  
 
De novo short sequence binding motifs using HOMER revealed enrichment and 
depletion of TF binding motifs upon opening or closing of chromatin. Combining 
ATAC-seq and RNA-seq identified several putative TFs likely to be involved in 
chromatin remodelling. Some of the most highly enriched cis-regulatory motifs 
showed high affinity for TFs implicated in eMSC differentiation, for example 
CEBPB and RORA (Frith & Genever, 2008; Miyamoto et al., 2012). Hence, their 
role in maintaining cultured eMSCs in an undifferentiated state merits further 
investigation. Interestingly, footprint analysis also yielded some novel putative 
pharmacological targets that ultimately may enhance in vitro expansion of eMSCs 
even further. For example, RNA-seq data showed that A83-01 markedly 
increases NR4A1 expression, which in the ATAC-seq data was paralleled by 
genome-wide enrichment for NR4A1 binding site in A83-01 treated eMSCs. 
NR4A1, perhaps better known as NUR77, is nuclear receptor that negatively 
regulates TGF-β signalling and prevents prolonged fibroblast activation, thereby 
limiting fibrosis (Palumbo-Zerr et al., 2015). These intriguing findings suggest that 
up-regulation of NR4A1 in A83-01 treated eMSCs functions as an endogenous 
inhibitor of TGF-β signalling. Further, Palumbo-Zerr et al. (2005) showed that 
NR4A1 reduces collagen production, which again is in accordance with the A83-
01 responses in prolonged cultures. Interestingly, NR4A1 is an orphan nuclear 
receptor and its transcriptional activity can be enhanced using small molecules 
such as cytosporone-B (Zhan et al., 2008). Hence, it would be interesting to test 
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if cytosporone-B, alone and in synergy with A83-01, promotes in vitro expansion 
of eMSCs. 
 
A83-01 treatment of cultured eMSCs exemplifies of how the use of small 
molecules can be an effective alternative to genetic approaches to regulate 
cellular states. In comparison to genetic manipulations, i.e. overexpression or 
silencing of specific TFs or signalling intermediates, reversibility is perceived as 
a major advantage of the use of chemically defined culture medium for MSC 
expansion (Li et al., 2013). However, in view of the extensive chromatin 
remodelling induced by A83-01, questions are raised regarding the degree of 
reversibility upon withdrawal of this inhibitor. Again, combined ATAC-seq and 
RNA-seq analyses provide a robust tool to answer these questions in exquisite 
detail. Arguably, total or near-total reversibility of the A83-01 effects is likely an 
important step in overcoming the regulatory hurdles associated with clinical 
translation.  
 
In summary, by integrating advanced genome-wide expression and DNA 
accessibility profiling techniques, my work has advanced our understanding of 
the dynamic changes in the cis-regulatory DNA landscape underpinning 
decidualization of primary endometrial cells and maintenance of a stem-like 
phenotype of eMSCs in prolonged cultures. Analyses of these two large data sets 
revealed novel transcriptional regulators in cycling endometrium and putative 
new targets that could be exploited to accelerate clinical translation of autologous 
endometrial stem cell therapies for a variety of reproductive disorders. 
Furthermore, the data sets generated during the course of my investigations 
constitute an important resource to interrogate fundamental molecular questions 
pertaining to human endometrial cell biology.  
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Future work 
 
Analysis of dynamic chromatin changes in human decidualizing endometrial 
stromal cells revealed novel transcriptional regulators that might play a role in 
licencing specific genomic regions for chromatin remodelling upon 
decidualization.  
 
The role of these putative transcriptional regulators in decidual transformation of 
EnSCs requires further investigation. Experimentally, Real Time quantitative 
PCR (RT-qPCR) and western blot could be applied to validate the induction of 
TFs of interest at a transcript and protein level. ChIP-qRT-PCR or cross-
referencing with available ChIP-seq data (e.g. ENCODE database), would 
provide confidence in the transcriptional regulation of genes of interest by specific 
TFs. Furthermore, silencing of the most highly ranked conserved TFs by siRNA-
mediated gene silencing could be performed to validate their role upon 
decidualization. Time limitations prevented me of persuing this line of 
investigation even further, although a graduate student subsequently 
demonstrated that siRNA-mediated knockdown of ARNTL, NFE2L1 and TFC3 
perturbated the induction of PRL and IGFBP1 in decidualizing cultures.  
 
Furthermore, my analysis provided proof of principle that ATAC-seq is a powerful 
toll to screen rapidly for dynamic chromatin changes in human endometrial 
stromal cells. I envisage that applying this assay to various reproductive disorders 
associated with aberrant endometrial function, such as endometriosis, 
endometrial cancer, infertility and recurrent miscarriage, will yield important 
mechanistic insights into the underlying pathological pathways.  
 
As part of my Warwick-Monash alliance studentship, I then joined the laboratory 
of Professor Caroline Gargett in Melbourne, Australia, where I applied RNA-seq 
and ATAC-seq analyses to study the impact of TGF--R signalling inhibition on 
eMSCs maintained in prolonged culture. Amongst others, a consistent and 
prominent gene signature in the RNA-seq data involves down-regulation of genes 
involved in ECM deposition and metabolism. Furthermoe, my analysis indicated, 
amongst others, the induction of Nur77 that may be an important TF that mediate 
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the repression of ECM genes in response to A83-01 treatment. Hence, it would 
be interesting to focus on these results and validate the induction of Nur77 at 
mRNA and protein level through RT-qPCR and westeren blot, respectively. As 
next step, it would be then interesting to test if the selective Nur77 agoinist 
cytosporone B, alone or in synergy with A83-01 promotes in vitro expansion and 
clonogenicity.  
 
Time limitations prevented me of persuing this line of investigations, although 
these experiments are ongoing in our laboratory. 
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Appendix 1. Opening Motifs coupled to high affinity TFs 
 
 
Opening 
Motifs 
P Matches to Known Motifs 
Motif1 1E-
140 
CEBPE/CEBPB/CEBPD/CEBPG/CEBPA/HLF/DBP/TEF 
Motif2 1E-83 AP-1/BATF/JDP2/FOS-JUN/FOSL2/Jun-
AP1/Atf3/Fos/Junb/ 
Motif3 1E-64 Isgf3g/Foxj3/Foxo1/Foxd2/Foxp2/Foxp1/Foxp3/Foxl1/Fox
o4 
Motif4 1E-45 Pgr/Gre/PR/ARE/NR3C2/NR3C1/AR/Sox13 
Motif5 1E-28 Bcl6/Stat5a/Stat4/Stat1/Stat3/Stat5/Stat6 
Motif6 1E-28 CREB/Atf1/Crem/Atf3/Creb1Creb3/Xbp1 
Motif7 1E-25 Egr2/Egr1/Panc1-Rbpj1/Egr4/Egr3/E2F6/Znf263 
Motif8 1E-25 CEBP-
Ap1/Chop/Atf4/Foxk1/Foxj1/Zbtb12/Rhox11/Runx2 
Motif9 1E-25 Foxj1/Cdx1/Mafg-
NFE2L1/Foxj3/Cdx2/Rxra/RORA/Hoxc10 
Motif10 1E-24 Irx5/Forkhead/Irx4/Foxg1/Foxa1/Foxo3/Foxd2/Foxd1/Fox
j2 
Motif11 1E-24 NF1/NFIA/NFIX/NFIC/Nkx3.1/Stat5a-
Stat5b/Hic1/Stat3/Rfx5 
Motif12 1E-23 Hmbox1/Hoxc9/Foxl2/Hoxa9/FoxL1/Foxq1/Foxk1 
Motif13 1E-18 Nanog?/Zic1/DCE/Zic3/Ap4/Zic2/MyoG 
Motif14 1E-16 TFEB/TFEC/TFE3/MITF/USF1/Arntl/BHLHE41/USF2/bH
LH/Nkx2.3 
Motif15 1E-15 Znf322/Spdef/Smad3/Zfx/Zfp691/Runx1/PR/DCE/Klf1 
Motif16 1E-14 Tgif2/Pax3-Fkhr/Jund/Meis1/nr1f2/Tgif1/Esrra 
Motif17 1E-12 Myc/NeuroD1/NPAS2/Max-
myc/Usf2/Olig2/Bhlhe23/TFEC/NeuroD2/Atoh1 
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Appendix 2. Closing Motifs coupled to high affinity TFs 
 
Closing 
Motifs 
P Matches to Known Motifs 
Motif1 1E-
32 
Tead1/Tead3/Tead4/Tead2/Spib/Nfatc1/Sox17/Nfatc3 
Motif2 1E-
26 
Runx1/Runx2/Runx3/Znf354c/Foxk1/foxh1 
Motif3 1E-
18 
Sox8/Sox17/Tead2/Tead4/Tead3/Stat6/Sox5 
Motif4 1E-
15 
Sox5/Sry/Sox18/Sox30/Sox9/Sox12/HMG/Sox5/Sox13/Sox8 
Motif5 1E-
14 
Zbtb18/Tcfe2a/Tal1-Tcf3/Ascl1/Scl/Ascl2/Atoh1/Scl/Tcf3 
Motif6 1E-
12 
Pu.1/Sfpi1/Ets1/SpiB/Etv6/EHF/Etv2/Erg/Elf5 
Motif7 1E-
12 
Hand1-Tcf3/Tead3/Tead4/Zbtb3/Tead2/Smad3/Tead1/Zfp410 
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Appendix 3. Up-regulated genes upon decidualization: Log2-
fold change ≥ 1 
 
Gene Symbol log2-fold change q 
SST 10.47197586 1.96E-126 
IGFBP1 10.04965709 5.32E-98 
LRRC15 7.385318639 7.45E-63 
PRL 7.248956321 2.6E-93 
PROK1 7.113095846 1.15E-61 
PTPN5 7.065324986 2.51E-39 
RP11-480G7.1 6.849292565 2.78E-38 
CGA 6.83131967 1.57E-30 
NTRK1 6.787199825 2.4E-46 
TMEM132C 6.435175832 1.32E-48 
WNT4 6.31380214 1.26E-53 
SH2D2A 6.267299957 1.17E-55 
MYLK3 6.13304507 1.16E-39 
TREM1 6.079634179 2.96E-37 
RP11-162I7.1 6.028422193 2.4E-21 
SORCS1 5.983804669 2.72E-48 
ALOX15B 5.981615407 1.09E-24 
ZBTB16 5.94979952 5.95E-32 
GPBAR1 5.895475533 1.39E-27 
RP11-
1260E13.4 
5.833965583 2.31E-25 
PRIMA1 5.814874592 3.33E-33 
LEFTY2 5.780800776 5.28E-28 
ACTBP8 5.722620317 3E-17 
TRABD2B 5.69109739 1.46E-35 
SLC46A2 5.640934147 1.13E-16 
ADORA2BP 5.529117037 6.96E-16 
CXCL14 5.527608904 1.36E-26 
  
184 
 
IL1RL1 5.387245456 9.52E-15 
EDNRB 5.246106726 1.04E-25 
CHI3L2 5.207649519 2.61E-25 
OMD 5.192877801 1.27E-30 
SIGLEC7 5.180944105 1.95E-15 
RP11-362F19.1 5.120734832 8.85E-38 
PCDH20 5.08386358 5.62E-13 
IGHV3-74 5.081227525 6.92E-14 
DKK1 5.077616084 2.51E-29 
LINC00473 5.067759137 4.52E-34 
LGI2 5.059443021 3.64E-32 
TRIM67 5.057619226 1.32E-19 
MAOA 5.00976758 6.86E-35 
SLC7A8 4.977745742 2.57E-61 
TH 4.973070729 5.46E-19 
KLK4 4.963728367 1.18E-20 
KCNA4 4.909844379 2.26E-15 
EREG 4.806409039 4.43E-17 
ENHO 4.802584573 1.85E-24 
AADAC 4.746973747 8.61E-12 
FST 4.68077209 7.1E-17 
MAOB 4.649769044 8.78E-28 
CHST7 4.623372379 5.4E-45 
P2RY14 4.593757874 1.9E-18 
HSD17B13 4.55893132 5.61E-15 
BRINP2 4.479677862 4.8E-12 
RAMP3 4.459563596 3.88E-15 
SERPINA6 4.452100099 3.61E-10 
WNT10B 4.437798811 9.96E-12 
C11orf86 4.419743714 1.85E-09 
ABLIM2 4.416528841 9.3E-31 
HSD11B1 4.384625956 5.92E-09 
ENPP1 4.338704044 1.42E-19 
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RP11-342I1.2 4.336124752 5.26E-14 
GSG1L 4.291571606 4.37E-10 
CNR1 4.264000519 2.96E-08 
SDIM1 4.214860169 4.26E-11 
RP11-269G24.6 4.206309114 4.17E-09 
NKAIN1 4.194596227 5.71E-43 
GAL 4.188934357 3.03E-11 
PLXNA4 4.168853569 6.87E-16 
ACE2 4.167646567 1.44E-10 
CDKN1C 4.146119667 6.3E-46 
WNT1 4.120520939 4.02E-08 
LINC00924 4.11595963 1.36E-17 
RP11-752D24.2 4.106050485 3.31E-16 
TUBA3D 4.096919147 4.42E-08 
RP11-81H14.2 4.059016933 7.55E-10 
FKBP5 4.046394029 4.76E-23 
THSD7A 4.04610117 1.27E-18 
ABI3BP 4.033320059 2.95E-62 
GADD45G 4.027072616 7.19E-18 
MLC1 4.025057181 4.17E-16 
INSRR 4.022887424 3.54E-13 
GALNT15 4.012815118 4E-18 
CD38 4.003343934 1.94E-16 
RP11-7F17.3 3.990978778 2.26E-12 
SV2C 3.986096842 3.55E-09 
PENK 3.965407511 1.36E-65 
SAT1 3.937351564 1.29E-71 
P4HA3 3.934212991 2.81E-41 
RP11-466P24.7 3.927154372 3.96E-09 
RHOU 3.893028986 1.48E-22 
IL15 3.875560637 8.26E-25 
PODNL1 3.863771751 8.48E-26 
IL1R2 3.852387638 1.13E-10 
  
186 
 
GLB1L2 3.845927613 6.61E-31 
CRLF1 3.843238288 1.78E-08 
GAPT 3.806082812 0.000000525 
RBP4 3.796940024 1.41E-17 
CD226 3.796832247 3.88E-22 
RP11-138H11.1 3.791000196 0.000000207 
GPX3 3.780658286 9.52E-08 
RP11-443C10.1 3.763515959 0.000000267 
APOO 3.752184168 7.76E-32 
MACC1-AS1 3.730832627 0.000000029 
MYOCD 3.717760099 9.39E-30 
CSF3R 3.7149218 2.25E-11 
WNT3A 3.69559305 0.000000365 
MGST1 3.675309148 1.09E-24 
EML6 3.673224722 3.12E-16 
ADAMTSL4 3.641957335 2.12E-23 
SYNDIG1 3.636533583 1.06E-08 
RAB3C 3.630927248 0.00000106 
ENPEP 3.618983138 2.75E-13 
KLF15 3.617987956 1.64E-27 
STAR 3.612420463 1.09E-10 
RP11-161D15.3 3.606012286 0.00000036 
REM1 3.600479027 2.86E-08 
FAM89A 3.592188823 2.1E-37 
FAM167A 3.590414973 5.8E-13 
ATOH8 3.552550157 2.67E-28 
Z98256.1 3.545890643 3.89E-16 
CPB1 3.544468175 0.000000789 
SLC7A2 3.544204907 2.72E-41 
PPAP2B 3.533435906 1.63E-59 
COL23A1 3.532051246 4.2E-09 
RP11-459O1.2 3.527095274 0.00000484 
ELOVL3 3.525162464 3.77E-19 
  
187 
 
RP11-820L6.1 3.519510796 2.09E-09 
EFEMP1 3.519048676 8.71E-18 
ELMOD1 3.517731118 7.07E-14 
SLC10A6 3.514596188 0.00000027 
ACSM5 3.50622087 5.21E-09 
KAL1 3.47408889 7.87E-11 
IL1B 3.461104128 0.00000578 
HAND2 3.444476979 7.08E-67 
PLCL1 3.444370106 1.3E-11 
TREML3P 3.441577235 0.00000198 
INHA 3.439702925 5.96E-17 
SEC14L4 3.425292886 1.64E-08 
C5AR2 3.415752326 9.68E-14 
RORB 3.41035228 8.64E-32 
ENPP2 3.402811339 1.14E-12 
LPAR1 3.389651636 1.59E-25 
ST8SIA4 3.37203793 6.03E-15 
ADRA2C 3.371863689 1.19E-16 
SRGN 3.367673477 2.76E-18 
RP11-454P21.1 3.361843853 0.00000863 
ATP8A2 3.360169117 1.04E-17 
CACNB2 3.358547479 6.61E-14 
ABCA8 3.345991159 1.62E-24 
DNAAF1 3.339761375 1.05E-09 
PC 3.338982996 7.53E-14 
WNT16 3.332264686 1.65E-09 
INSC 3.320834882 0.00000994 
RBKS 3.316594539 6.57E-24 
TM4SF1 3.315899528 5.7E-12 
RP11-486P11.1 3.308412128 2.06E-09 
C1QTNF1-AS1 3.305754084 2.34E-11 
TMEM132B 3.30338227 2.63E-24 
LINC00707 3.280406585 5.29E-09 
  
188 
 
CHRDL1 3.26318667 0.000033 
IL1R1 3.241932375 1.22E-19 
RASL10B 3.205076262 2.82E-18 
LMO3 3.202778655 0.00000301 
PYGM 3.198443738 9.95E-10 
LINC00890 3.193117675 1.59E-09 
CRISPLD2 3.165844721 7.12E-34 
ANGPTL1 3.16250368 0.0000488 
ADAMTS15 3.153578985 0.0000241 
MFSD2A 3.153369393 1.51E-10 
C2orf72 3.146692749 6.48E-10 
TLE6 3.142154285 7.37E-21 
CRYAB 3.110478952 2.1E-21 
PRRG4 3.110099954 7.89E-11 
AKR1C1 3.108742974 3.72E-23 
MUM1L1 3.102059793 1.51E-21 
SIPA1L2 3.101856044 1.65E-09 
SPARCL1 3.096592976 1.95E-11 
IRS2 3.094442587 4.65E-31 
AGXT2 3.080450666 0.000000124 
TMEM37 3.075127651 2.47E-20 
SYN3 3.06806329 7.85E-09 
CFD 3.065334389 0.000000734 
CAB39L 3.059760683 3.69E-27 
LGR4 3.044146457 3.44E-15 
AADACL4 3.01738113 1.68E-11 
PRR15 3.01124917 8.02E-11 
AC010132.11 3.006613955 0.0000526 
ADAMTS8 3.003929252 0.000000222 
ADAMTS3 2.978378146 2.02E-09 
INSR 2.977190024 5.88E-22 
ING1 2.976650207 8.75E-29 
KDR 2.965615013 2.89E-09 
  
189 
 
NDP 2.963382526 0.000130516 
IGFBP4 2.940146489 2.03E-38 
PILRA 2.936989746 0.000000566 
CST11 2.935149754 0.0001852 
KCNB1 2.928654945 1.31E-08 
HTR2A 2.92617072 0.00000013 
NELL2 2.926070602 0.0000687 
CXXC4 2.924649199 1.97E-08 
PRKG1-AS1 2.91779531 8.38E-08 
RASL11B 2.914775361 1.17E-11 
FAM134B 2.896450418 4.66E-21 
SERPINB10 2.893105567 0.000231385 
IL18R1 2.890806163 0.00000025 
AOC3 2.889639667 5.68E-10 
APOA1 2.885217443 0.000178052 
STAC2 2.879099091 0.000000811 
PTPRN 2.872427964 0.000000507 
ALDH1L1 2.869849601 0.000000044 
TVP23A 2.865081508 0.00000448 
RP11-43F13.3 2.863221451 0.000000478 
C11orf96 2.859237683 1.21E-18 
RSPO3 2.858672778 3.53E-10 
RP3-525N10.2 2.856645664 0.000000508 
IGFBP2 2.856103162 5.1E-30 
GRM7 2.854978585 0.00000614 
TEX26-AS1 2.852671601 0.00000549 
DNER 2.848200953 0.00000124 
PRLR 2.845442089 3.34E-10 
RP11-158M2.3 2.845380187 0.00000828 
IL2RA 2.844781241 0.000237571 
CLEC2D 2.839847872 3.96E-18 
APOD 2.838841917 3.39E-13 
PHEX 2.821222499 7.29E-10 
  
190 
 
RHOB 2.814733046 1.97E-44 
MRAP2 2.80267586 0.00000249 
RP11-475B2.1 2.798291701 2.74E-13 
KCNK3 2.795808362 0.000322205 
PAEP 2.794514812 0.000000011 
RNF182 2.792860966 8.13E-21 
C3 2.790729345 6.54E-23 
STON2 2.789767743 0.0000668 
PRG2 2.773214417 0.000319426 
PPAPDC1A 2.769183665 2.48E-10 
COMP 2.768723069 0.0000123 
NPR1 2.762976252 2.98E-22 
C7 2.76245137 0.00011759 
RP11-
184M15.1 
2.750717579 0.000325432 
RP11-38P22.2 2.75052607 0.000335178 
LSAMP 2.748235961 1.2E-15 
KCTD12 2.737422484 0.000093 
SLC25A19 2.735331871 1.29E-11 
RP11-563P16.1 2.727282533 0.000206247 
CRYGN 2.726571973 0.000000836 
SPP1 2.716754871 4.27E-17 
TNFRSF1B 2.715807943 2.83E-15 
GCOM1 2.715404443 0.00019947 
SAMD11 2.710910451 0.000000173 
RYR2 2.710310834 0.000156131 
AC005083.1 2.708454535 0.000139211 
TPPP 2.696915146 0.000104982 
ADCY1 2.694803009 1.53E-27 
FLVCR2 2.69338035 3.01E-10 
PLA2G7 2.690407858 1.67E-24 
40238 2.688579507 0.000000162 
CD83 2.686105539 1.07E-11 
  
191 
 
GGT5 2.684981133 3.28E-10 
COL15A1 2.684593456 4.86E-18 
RP1-78O14.1 2.679184464 8.48E-21 
CELF2 2.676156704 1.66E-08 
DPEP2 2.6748813 0.000440448 
CILP 2.672173371 0.000698901 
CSF3 2.669556077 0.000645905 
RAI2 2.662377305 3.29E-37 
RP11-356I2.4 2.662027825 6.64E-08 
IGHG1 2.652351567 0.000769645 
RP11-148L24.1 2.649836952 0.000000609 
FERMT2 2.648561372 2.12E-16 
DEPTOR 2.647989253 1.4E-33 
EVA1C 2.644197411 2.06E-23 
HAND2-AS1 2.642678371 4.18E-30 
ESYT3 2.642156739 2.38E-08 
DRP2 2.641028267 0.00000434 
SLC31A2 2.637895279 3.54E-10 
RASGRP2 2.635932977 9.19E-32 
MAPK10 2.631828365 1.03E-20 
LYPD3 2.62605081 0.000000817 
RGCC 2.62132235 1.08E-24 
WDR86-AS1 2.620810486 1.18E-10 
PARM1 2.620266216 0.000413056 
BTC 2.617570287 0.0000013 
RP11-
284M14.1 
2.613587544 0.000163051 
RP11-75L1.2 2.610696583 1.53E-09 
LTBP1 2.607729433 1.96E-15 
DEFB124 2.606719017 0.000883572 
SIX2 2.604723908 0.000000556 
HSPB6 2.600882898 3.58E-43 
COLEC11 2.595650866 0.000000307 
  
192 
 
PLAGL1 2.59564667 1.87E-21 
ARC 2.593991507 0.000000027 
NEBL 2.589869208 0.00000131 
CD14 2.582180472 0.000000126 
PCBP3 2.579244858 9.55E-15 
ANXA13 2.570330787 0.00078588 
ADAMTS4 2.569027716 4.72E-11 
CEBPD 2.563077238 9.36E-12 
RP11-54O7.3 2.554464595 0.00000106 
SERPINB2 2.548866248 0.000000807 
ABCC8 2.545736678 0.000104418 
TSC22D3 2.535616042 2.72E-17 
LRPAP1 2.526904008 2.2E-27 
ABTB2 2.525198788 2.58E-11 
FRMD3 2.522767179 0.00000141 
CA8 2.513865233 0.0000149 
TIE1 2.512235185 0.00011046 
XCR1 2.509119598 0.001357846 
DCN 2.499266014 1.58E-16 
TIMP4 2.495714827 0.0000136 
PPP1R14C 2.495483138 6.67E-09 
SLC39A2 2.495180019 0.001439967 
HOMER2 2.494956053 0.0000204 
CORO2A 2.494323166 0.00000166 
CD1D 2.493559325 0.0000142 
AKR1C2 2.490894824 8.21E-08 
AC034110.1 2.490438497 0.00080321 
GNG4 2.484601337 4.17E-27 
HPD 2.482700042 0.001288565 
OR7E36P 2.480785938 0.000829077 
CTSL 2.479685275 8.3E-24 
DUSP1 2.462416802 2.95E-16 
SIGLEC9 2.462303779 0.0000001 
  
193 
 
TNFAIP8L3 2.458394417 0.000127388 
TMEM150C 2.457997935 1.24E-24 
PRKAG2-AS1 2.456612888 0.000120325 
AC040977.1 2.454376245 0.000100875 
CCDC73 2.448777583 0.000234999 
IL1RL2 2.442517108 0.00000201 
AC003984.1 2.439700733 0.000542473 
CTB-167B5.2 2.439122346 0.001846684 
RP11-390N6.1 2.438909681 0.000979772 
OSBPL10 2.438501607 6.11E-10 
RP11-130L8.2 2.43741056 0.000253823 
PCK1 2.433837924 0.002036516 
TAGAP 2.427664836 0.000570617 
MEDAG 2.425650406 3.07E-10 
AVPI1 2.4252814 7.65E-15 
U82695.10 2.425079441 1.01E-13 
GLUL 2.421411466 2E-16 
RP11-680A11.5 2.420874788 1.16E-09 
RASD1 2.420521067 3.73E-08 
LONRF2 2.418382933 7.19E-14 
ENPP3 2.417256681 0.002047524 
PI15 2.414129026 0.001075189 
TNS4 2.410350541 0.00000114 
JPH1 2.402800382 7.82E-16 
G0S2 2.400494118 1.96E-14 
TLE2 2.400376262 1.81E-34 
RGL3 2.398752517 6.29E-08 
MDM1 2.392601339 8.77E-09 
TMC1 2.391852491 0.000148206 
HSD17B6 2.388527772 0.000000487 
CTD-2210P24.4 2.377240419 0.000340802 
RP11-215H22.1 2.373707017 0.00259798 
RPH3AL 2.370824395 3.04E-08 
  
194 
 
GABRG3 2.370145799 0.002580067 
ATP2B3 2.369738076 0.00052022 
HIST1H1C 2.366281484 2.48E-19 
RP11-61L23.2 2.364445583 1.33E-10 
RP11-697N18.3 2.361958674 0.0000126 
SNAP91 2.355707318 3.27E-09 
RGS2 2.354410205 5.35E-20 
AC007255.8 2.353412025 0.001155953 
CRB2 2.347608039 0.00049717 
HS1BP3-IT1 2.342234466 0.000268151 
CTB-138E5.1 2.335562954 0.002362833 
GPR155 2.33281371 1.15E-08 
FAM153B 2.331627823 0.001907821 
FAM19A4 2.331457076 0.002832473 
UBE2QL1 2.331382166 0.0000197 
FAM124B 2.330030574 0.003056648 
COLEC10 2.328770807 0.000329714 
RP11-705C15.2 2.321890003 0.000000019 
KALRN 2.318371634 0.00000332 
TMEM108 2.318105619 2.66E-11 
RP11-362F19.3 2.31421067 0.003328399 
PID1 2.312728893 6.37E-27 
KCNS2 2.298862356 0.000516423 
ITPR1 2.297806922 3.79E-09 
RP11-4F5.2 2.295799972 0.000218614 
FAM49A 2.292906065 0.00000869 
SPTSSA 2.292202464 8.74E-13 
AGTR1 2.290032473 0.001302367 
RP11-43F13.4 2.289750124 0.000879877 
NNMT 2.288165237 6.46E-13 
SIK1 2.286956222 1.24E-13 
PKP2 2.280055316 0.0000102 
ACVR1C 2.279449767 0.000476169 
  
195 
 
JAKMIP2 2.277582668 0.0000106 
ELN 2.273805159 3.62E-08 
GREB1 2.272390023 1.24E-19 
UPK1B 2.266062608 0.00000207 
LCN1 2.265784964 0.001734054 
ALOX15 2.264961647 0.003175063 
POM121L9P 2.264273284 0.00132285 
UNC5C 2.26426601 0.0000427 
SMIM5 2.252498077 0.0000939 
ITIH1 2.250628731 0.003338434 
CHSY1 2.250285829 0.00000373 
GAB3 2.247477377 1.39E-08 
CD68 2.245477199 0.000000206 
ANO7P1 2.243657194 0.000000252 
REN 2.237425659 0.002234535 
SCUBE1 2.236842716 0.000666088 
KERA 2.236254819 0.001365505 
NKD1 2.234971396 0.0000429 
RP11-535A5.1 2.228661376 0.004733873 
CHN2 2.227420853 0.000634549 
EPB41L3 2.225909541 5.1E-15 
SDK1 2.219434722 0.000000318 
AL133318.1 2.219204853 0.000110788 
SYT12 2.217747168 0.001504721 
HTRA3 2.21761786 0.00000195 
PTPRZ1 2.215653588 0.004984428 
TUBA3E 2.214177314 0.004665039 
LUM 2.209702707 5.61E-24 
PRR24 2.208212708 6.21E-25 
RP1-124C6.1 2.208053259 0.002597368 
SFMBT2 2.204194415 3.01E-14 
C1orf21 2.200876433 1.81E-20 
NFIL3 2.198490269 2.09E-16 
  
196 
 
HIST1H3D 2.194272965 0.000899822 
RP11-401P9.4 2.188285263 0.0000629 
RP11-13K12.1 2.188218935 0.00000352 
RET 2.187829337 0.000000303 
CLMN 2.183000541 0.0000919 
RP11-65J21.3 2.180237304 0.000564445 
MYO16 2.180044816 7.66E-08 
NRCAM 2.178276846 0.00000232 
EFHC2 2.176542188 0.00000322 
C13orf45 2.172724027 0.005845543 
COL4A3 2.172668376 0.0000263 
TNFRSF8 2.172233323 1.53E-13 
RP11-760H22.2 2.168167014 5.21E-11 
KIAA1210 2.168049027 0.005790341 
XYLT1 2.166358022 2.28E-08 
PPARGC1A 2.165189242 0.00029744 
RAET1G 2.164096611 0.000245 
CYP11A1 2.159513621 0.00000672 
KIAA1217 2.157664837 0.00000249 
PAK3 2.155893909 2.14E-10 
CHST2 2.154306465 9.38E-15 
RP11-505E24.3 2.142569561 0.005656615 
TAC1 2.139274229 0.004920471 
P2RY1 2.136230043 0.00675812 
AC002398.12 2.136029005 0.000398873 
SPHK1 2.135284513 1.11E-23 
SPATA41 2.131942923 0.000293665 
CCL8 2.131914903 0.006339395 
BAIAP2L2 2.13033707 0.00001 
MAPT 2.129695095 0.000001 
CCDC151 2.124020051 0.000149908 
CCR7 2.122817938 0.006578185 
MAATS1 2.120692129 0.002638941 
  
197 
 
ADAMTS2 2.11871963 1.6E-15 
LY6K 2.117537003 0.0000177 
RP11-705C15.3 2.116297986 2.41E-08 
FXYD1 2.116193253 0.0000646 
COL4A5 2.110105923 0.0000181 
SBSN 2.109422264 0.000824308 
CHGA 2.103326957 0.005978988 
MT2A 2.103281735 7.14E-12 
C1orf132 2.102418278 0.00000665 
CORIN 2.09938667 0.0000264 
SYTL4 2.097476589 3.49E-13 
AC023469.2 2.091220996 0.00803818 
IGF1 2.090521567 0.00000923 
PPM1H 2.090144719 0.0000295 
LL22NC03-
104C7.1 
2.087453779 0.007810831 
CCDC68 2.0842616 6.94E-11 
HIST1H2BJ 2.083320525 0.00000108 
GAS1 2.082295339 1.12E-12 
RBP1 2.081228961 1.02E-24 
RP11-259O2.1 2.074070945 0.004680329 
SLC1A1 2.074045157 0.000000102 
AOX1 2.073108244 0.008424756 
MMP8 2.068261756 0.001212226 
C2orf50 2.067329017 0.008570288 
KLK2 2.065638443 0.005862767 
WNT9A 2.062857151 0.00000864 
IGSF10 2.061919325 0.008710527 
KRT5 2.060907211 0.00000459 
RP11-1096D5.1 2.059360494 0.008518375 
ADAMTS1 2.056140475 1.98E-08 
AGFG2 2.056113598 2.16E-12 
SERPINE1 2.053751819 4.04E-11 
  
198 
 
AC021016.6 2.052891805 0.002761976 
PTGS1 2.052170591 1.59E-20 
SLC22A31 2.051427789 0.005500795 
PRODH 2.044665118 0.00920311 
BTBD3 2.035726596 0.0000041 
CTD-3064M3.3 2.031334734 0.004084508 
COL4A6 2.030235736 0.009343875 
COL5A3 2.029621976 5.94E-08 
SOAT2 2.027392275 0.000248683 
KCNC4 2.02668866 0.000000156 
CREG1 2.022620709 1.37E-20 
CCDC69 2.022407114 0.0000462 
MFSD2B 2.021896922 0.001906507 
ERBB3 2.020747714 0.000000356 
OGN 2.01958994 0.0000175 
AC104695.3 2.019102385 0.000182034 
CTD-2263F21.1 2.014421207 0.002644507 
TGM2 2.00792395 4.23E-15 
CISH 2.005385314 0.000000103 
RAMP1 2.003008678 8.32E-21 
VIT 1.999971405 0.010723755 
RP11-403A21.1 1.999659057 0.010586459 
MAFB 1.997339799 8.21E-08 
GATA3 1.99698369 0.009645591 
RP11-318G21.4 1.993980894 0.011504047 
TSHZ2 1.990682737 0.0000102 
MYPN 1.987516609 0.002779504 
HPGD 1.987356041 0.010165714 
LARGE 1.986554184 0.00000248 
PDE7B 1.986513789 0.000000502 
KCNK12 1.983299149 0.003518403 
ROCK2 1.981263416 1.23E-12 
SLC37A3 1.978529431 3.81E-23 
  
199 
 
NFASC 1.975384731 0.0000384 
PTGIR 1.972686301 0.000000551 
GALNT13 1.972123613 0.001246076 
COL4A4 1.970745129 0.00000455 
CCL26 1.969888091 0.005154014 
CAMKK1 1.968219824 1.29E-11 
TNFSF14 1.966836794 0.009623982 
CCL20 1.959350787 0.000140337 
RP11-492E3.2 1.957865964 0.000000241 
PISD 1.957106281 1.56E-17 
RBM20 1.954980734 0.003829148 
RP11-95H3.1 1.953969952 0.012635101 
KIAA0040 1.949622444 0.000231995 
FAM9B 1.948850389 0.013512975 
C20orf141 1.942305568 0.012955415 
STEAP4 1.940362848 0.004162187 
SLC40A1 1.939938727 0.0000146 
TIMP3 1.939849224 0.013136 
KRT23 1.939149223 0.0000351 
IRAK3 1.936990101 1.48E-13 
AC002456.2 1.936343361 0.00104619 
AC023115.2 1.933376326 0.006371318 
LINC00856 1.932641266 0.008792996 
TRIM29 1.927215802 0.000000862 
STON1-
GTF2A1L 
1.927197856 0.000998425 
ACTN2 1.927076728 0.005455629 
SH3BP5 1.925701435 5.01E-17 
KCNJ8 1.925143998 2.02E-14 
F12 1.924108811 0.000226775 
AC073316.2 1.922991348 0.013395198 
MATN2 1.921985407 0.000000216 
RP11-254F19.2 1.921483868 0.012502595 
  
200 
 
TPRG1 1.92136212 0.001407885 
PCDP1 1.91982718 0.001454165 
AOX3P 1.919674922 0.013603004 
NR4A3 1.917690487 0.0000013 
MEI1 1.915401143 0.0000639 
C1QTNF1 1.913636436 6.98E-14 
TPBGL 1.910544645 0.000884532 
MTR 1.906553989 2.83E-10 
SLC47A1 1.905851936 1.04E-09 
KLF4 1.904560124 0.000000134 
NKAIN3 1.902323233 0.001257516 
RP11-172E9.2 1.902068442 0.015588671 
IL1A 1.899164372 0.012537653 
PER1 1.898010231 0.000000136 
HLX 1.895989367 2.64E-19 
RP13-514E23.1 1.894852892 0.009881734 
MERTK 1.89313357 0.00010487 
WNT6 1.892755782 0.0000383 
ZFP92 1.891622936 0.002812272 
CALN1 1.891562619 0.016236978 
METTL7A 1.886246963 5.43E-10 
TSKU 1.885993751 5.31E-21 
SMOC2 1.878740166 8.28E-08 
C6orf57 1.878546301 1E-10 
LGI4 1.876874199 0.003255434 
RADIL 1.875149293 0.0000284 
APCDD1 1.873749193 0.017034396 
ZNF189 1.873721399 7.67E-12 
RGS11 1.873253138 0.000713082 
RP11-589N15.2 1.870856561 0.00000211 
VCAN-AS1 1.867604186 0.007415789 
CPEB1 1.862006049 0.000000882 
WNT9B 1.858748798 0.015433069 
  
201 
 
PEMT 1.854793196 2.49E-13 
STX11 1.854551223 0.000238949 
ALOX5AP 1.851394435 0.000666266 
ABHD5 1.849316202 2.35E-18 
IL11 1.843390865 0.013007385 
EPYC 1.840906121 0.0000142 
RGS22 1.840527825 6.21E-08 
FAM213A 1.839803701 3.56E-10 
LINC00570 1.837915645 0.017650363 
ACPL2 1.835315234 2.74E-08 
ANKFN1 1.834611466 0.01183427 
RP11-98L5.2 1.834519099 0.012934036 
C20orf27 1.834273441 0.00000392 
PDLIM1 1.833971231 0.000000597 
PPP2R1B 1.833026894 1.62E-21 
CD248 1.824289986 0.0000797 
RGS16 1.820778907 0.00160499 
ST6GALNAC2 1.818607774 6.54E-12 
TMEM151A 1.81822051 0.016750963 
MFI2 1.817968231 0.000273208 
CTD-2201G3.1 1.813813525 0.008704196 
ZNF804A 1.810780044 1.49E-08 
AJAP1 1.799153204 0.0000303 
RP11-384O8.1 1.798691159 0.011446084 
NAP1L5 1.797648526 0.00000019 
COL26A1 1.797353634 0.0000112 
ADHFE1 1.796066604 0.000000155 
CXCR2 1.794334901 0.020731383 
CHEK2 1.789958181 4.56E-09 
CXCR4 1.789755917 0.001670891 
CD82 1.785162508 0.000111714 
AL844165.1 1.783815882 0.021682345 
ITPKC 1.783487945 2.34E-12 
  
202 
 
AC010987.6 1.78311582 0.02192402 
OR1H1P 1.782993215 0.018584907 
NLGN4X 1.782387072 8.71E-10 
RHCG 1.781995295 0.022834498 
FBXO32 1.780183556 0.00000014 
RP11-64P14.7 1.776846853 0.024332074 
WBSCR27 1.776565994 0.00006 
IL1RN 1.774281653 0.002173131 
ZC2HC1B 1.772896981 0.024320223 
GLP2R 1.772077833 0.019740582 
NKX6-1 1.768071386 0.0000702 
RP3-428L16.1 1.767523648 0.015726924 
ASIP 1.765477802 0.025123389 
SNAP25 1.760054563 7.81E-08 
ELMO1 1.756964765 0.002760171 
MCOLN1 1.756296259 1.28E-19 
RP11-466P24.2 1.756043789 2.2E-11 
WIPF1 1.753366802 2.75E-11 
LEPREL1-AS1 1.750027705 0.008100875 
RNF144A-AS1 1.74832355 0.0000162 
POM121L10P 1.747269944 0.017806299 
HSPB1 1.747140722 1.84E-10 
ADA 1.744586526 0.00000124 
DANCR 1.742322963 5.45E-12 
FGD5 1.740369034 0.0000127 
RP11-124N19.3 1.740274582 0.003454559 
NID2 1.738702228 1.67E-08 
APBB1IP 1.736386863 0.000530101 
DNM1P46 1.73613965 0.002540208 
COL24A1 1.735862504 0.0000395 
NYAP1 1.73429676 0.00000255 
TNMD 1.733655175 0.024283951 
RP11-75L1.1 1.732850603 0.024374358 
  
203 
 
PLAC9 1.72953624 0.008836331 
RP1-117B12.4 1.728497752 0.014902217 
SLC2A8 1.726320172 1.69E-09 
LDLR 1.72622817 0.00000218 
GCG 1.723711344 0.028784311 
TMEM66 1.721824023 5.58E-16 
WT1 1.72049256 5.83E-19 
NCCRP1 1.720305891 0.010505177 
38961 1.719607231 0.00000742 
OSTF1 1.717724792 3.88E-09 
ABLIM3 1.717264558 0.020766155 
TPST1 1.713417372 1.02E-19 
SYT13 1.713398126 0.000255464 
POPDC3 1.712196651 5.77E-08 
PCSK5 1.711378409 0.0000023 
RP11-767I20.1 1.709168416 0.026049032 
LINC01140 1.70856529 0.018680581 
CYP26B1 1.708023792 0.00000178 
SERPING1 1.707873409 2.63E-15 
RNU6-813P 1.704833427 0.02681177 
RP11-505E24.2 1.703192519 0.0307661 
HIST1H2BD 1.700164415 8.41E-10 
RP11-488C13.1 1.699200951 0.028593049 
C11orf70 1.698889993 0.00000347 
RGS17 1.697438316 0.000784159 
HIST1H2BG 1.696512206 0.009016291 
BASP1 1.69620046 7.06E-19 
RP11-736N17.4 1.695575058 0.002659976 
TYMP 1.693888538 3.81E-09 
KLKP1 1.692543439 0.02460159 
LONRF3 1.689769019 0.003489262 
ZNF330 1.688357006 7.29E-14 
HIST1H2BC 1.687774239 0.0000569 
  
204 
 
USP46 1.687347195 4.38E-13 
OACYLP 1.686805448 0.027035782 
RP4-625H18.2 1.686773694 0.010259982 
SNX10 1.686037378 0.00000188 
ANG 1.685816479 3.51E-08 
RPL21P13 1.684696804 0.031863424 
AC141928.1 1.676633419 0.00034053 
BMPER 1.675722565 0.0000084 
RP13-39P12.3 1.674333915 0.027045492 
UBE2Q2L 1.672800102 0.030681582 
KLHL13 1.672596827 0.00000174 
ABCC9 1.671842525 4.69E-13 
PIR 1.670779854 0.0000099 
ENTPD3 1.669963206 0.005952935 
KREMEN1 1.669576469 0.0000187 
TNFRSF11B 1.669087811 5.04E-10 
SOCS3 1.666623686 5.22E-10 
ROR2 1.665399798 6.38E-10 
IGDCC3 1.664417176 0.00311271 
DLG5 1.664370397 0.000000435 
RP3-368B9.2 1.664116756 0.02325028 
AC091878.1 1.663586543 0.001139514 
snoU13 1.663328265 0.021162639 
SLC22A3 1.662044393 0.002322128 
CA12 1.660847596 0.00000295 
RP1-86C11.7 1.660828799 0.00541163 
HHIPL2 1.659767391 0.028485885 
SGSH 1.658077114 1.05E-15 
RP11-524F11.2 1.654601666 0.034211082 
RP3-428L16.2 1.653925646 0.002114019 
AC068610.3 1.653865983 0.034798177 
MTHFS 1.653573936 0.0000153 
RP1-27K12.4 1.651833478 0.03489139 
  
205 
 
CACNA2D3 1.650800325 7.63E-08 
COL28A1 1.65051731 0.000492613 
SLC24A2 1.64819369 0.001424714 
CLEC4E 1.646774198 0.011191716 
TMEM27 1.646544729 0.015264134 
RP11-65J21.4 1.645604782 0.036865029 
CDC20P1 1.645287576 0.003656146 
CAMK1G 1.642954507 0.000000491 
DNAI1 1.642363529 0.03729037 
CLU 1.641978526 0.000186221 
SEC14L6 1.640842312 0.012982143 
COX7A1 1.640274229 1.72E-09 
ZSCAN1 1.63694011 0.003418033 
RAP1B 1.636197865 1.1E-12 
SRD5A3 1.635740359 0.00000044 
TFPI 1.635194284 4.11E-09 
RP11-342M1.3 1.634220063 0.00398794 
C19orf10 1.633841339 1.01E-08 
PNKD 1.633838961 1.52E-10 
RP11-248N22.1 1.63298903 0.037490823 
EXOC3L4 1.632363523 0.010325967 
RP11-384F7.2 1.631701599 0.038485189 
IGHV3-72 1.630171214 0.032691356 
EOGT 1.6295511 2.45E-08 
ARMC12 1.627348028 0.039184315 
TBC1D2B 1.625926927 0.000000041 
ST3GAL5 1.625897913 0.000000017 
ADAMTS9 1.625787113 0.0002449 
TNNC2 1.625090415 0.019506203 
RDH12 1.622732926 0.038568852 
STON1 1.616073961 1.06E-10 
MAMLD1 1.614312048 2.1E-15 
LEPREL1 1.614124441 0.0000024 
  
206 
 
RP11-710C12.1 1.613666115 0.023506195 
ADAMTS7P4 1.612778158 0.000014 
KANK3 1.612630342 0.016232277 
HIST1H2AE 1.611269219 0.023532348 
RBBP6 1.60876236 1.17E-12 
SLC11A1 1.608284831 0.010478563 
RP11-281O15.7 1.608019876 0.040832526 
SCNN1A 1.60754268 0.0000135 
CKMT2 1.607521118 0.014536029 
RNF13 1.606093863 3.79E-12 
IGFBPL1 1.604253103 0.015963401 
RLTPR 1.60362865 0.017066229 
BCO2 1.603121085 0.006769537 
PLCD4 1.600238354 0.0191573 
LINC-PINT 1.599573226 5.72E-09 
LINC00957 1.599358467 0.000616252 
GTF2A1L 1.598458585 0.024285248 
ANGPTL4 1.59731217 0.0000629 
DFNB31 1.597018101 0.000896154 
MOB3B 1.596380282 0.000240263 
LRRC3DN 1.596173696 0.0000155 
ARHGEF19 1.596127579 3.61E-13 
AP3B2 1.595354852 0.001627958 
OXCT2 1.594057127 0.018644895 
FSTL3 1.593781986 5.44E-10 
RPGRIP1 1.592865683 0.03327251 
RP5-888M10.2 1.592687536 0.041885066 
GAREM 1.592587623 0.000000986 
MCC 1.591880799 0.000000236 
LMTK3 1.590443351 0.013137435 
LRFN4 1.589321593 0.00000403 
RP11-196O16.1 1.588302246 0.002904708 
RP11-363E7.4 1.586750388 0.000172838 
  
207 
 
FIGF 1.58525248 0.039413035 
SLAIN1 1.583717188 0.001888544 
CHPT1 1.583200479 7.05E-14 
PRUNE2 1.582732391 0.000245256 
MAP7 1.579863615 0.00000107 
CCDC114 1.579862528 0.009497506 
RP11-64C1.1 1.579200313 0.005526407 
MT1M 1.578739236 0.009431561 
RP1-137D17.2 1.574821354 0.045364381 
PTPN13 1.574816901 0.000123539 
RP11-582J16.4 1.574799524 0.023554159 
GATA6-AS1 1.574098702 0.013731044 
NR4A2 1.573138579 0.005924375 
GP5 1.572238002 0.037532608 
C10orf10 1.572166039 0.001085919 
DIRAS2 1.571677416 0.0000572 
SIL1 1.571586585 0.000000142 
AC079776.2 1.570458348 0.002371618 
RAB11FIP1 1.568670572 0.002107324 
ZCCHC6 1.566955241 0.0000015 
FAM115C 1.566952217 0.0000679 
ARHGEF26 1.563564522 0.00000798 
C1QL1 1.561827045 0.012838042 
C5orf49 1.56146304 0.025887626 
SLC24A3 1.561041983 0.000000323 
AC073109.2 1.559576645 0.047673981 
ASL 1.558861005 8.75E-08 
RP11-115D19.1 1.558407574 0.0414802 
SLC2A1 1.557620333 8.16E-15 
SPAG4 1.557050513 0.000136086 
KYNU 1.556276415 0.006397526 
MT1G 1.555203894 0.045381796 
CEP44 1.552662608 0.000000776 
  
208 
 
SULF2 1.552028489 1.05E-09 
ATP6V0E1 1.550412077 2.06E-16 
ELTD1 1.54968019 0.0000467 
GPR20 1.54863589 0.030300081 
KCNE3 1.544742485 0.000980098 
SPON1 1.544152812 0.0000886 
LRRC8A 1.543991023 2.23E-12 
PLAUR 1.543870838 3.03E-08 
CPM 1.543241518 6E-11 
TAF7L 1.542923194 0.004583988 
ADARB1 1.541344467 4.28E-12 
TNNT3 1.54132338 0.042359958 
MIR1282 1.539102129 0.019627946 
RP11-
439M11.1 
1.539074351 0.016950237 
USP15 1.536410307 0.0000264 
RP11-
314M24.1 
1.534050221 0.034746251 
PSD 1.52902121 5.89E-10 
MAGI3 1.528545516 0.001024342 
PKDCC 1.528247274 0.001690803 
SLC9A9 1.526601414 0.0000126 
AC003090.1 1.526189808 0.0399755 
C3AR1 1.526117698 0.04987714 
KRT6A 1.524559881 0.021305023 
SOAT1 1.522022355 0.0000646 
LINC01134 1.521115425 0.01609066 
CYP7B1 1.520247808 0.001005873 
AC078941.1 1.51983426 0.015792855 
PNP 1.516108577 0.0000218 
DACT2 1.514763275 0.023362928 
SIGLEC17P 1.512311602 0.04914162 
FYN 1.511574626 4.44E-08 
  
209 
 
NRXN1 1.50989091 0.020737872 
C20orf24 1.508467653 8.6E-11 
TMEM45A 1.508108084 0.0000205 
H6PD 1.505643192 0.000207274 
ISPD 1.505548604 0.000390502 
CXorf57 1.505513872 0.008164725 
TBXA2R 1.50004816 0.0000062 
CEACAM1 1.499161192 0.002135964 
USP46-AS1 1.497633219 0.0000398 
SSR4P1 1.496857921 0.01509914 
RP11-21L23.2 1.496215125 0.000000645 
RP11-529E10.6 1.49479655 0.000354197 
TGFBR3 1.494637718 0.0000717 
KCND3 1.493084562 0.000307979 
FAM105A 1.492336751 0.000000056 
PKD1L2 1.491889325 0.001083178 
RNF219-AS1 1.491583365 0.048429215 
RP11-
544M22.8 
1.49150246 0.048369196 
TNFAIP3 1.490937278 1.69E-12 
RNF39 1.488020406 0.038550035 
DBI 1.485287975 2.37E-08 
LINC00035 1.483278542 0.016091548 
ALDOC 1.479917132 0.001599301 
ZEB1 1.479761554 0.0000384 
LIX1 1.478230106 0.042768273 
VSIG1 1.474631676 0.026666768 
HIST2H2BE 1.474322655 2.89E-09 
TRPM3 1.473365361 0.017972519 
ALDH3B1 1.47297686 1.82E-12 
CEND1 1.470511117 0.016121718 
IL13RA2 1.469481579 0.0000506 
C5orf27 1.469106373 0.034572032 
  
210 
 
SLCO2B1 1.468948414 0.011963602 
SMAD6 1.468230888 0.0000179 
NEAT1 1.467005994 7.57E-08 
MCTP2 1.466771906 0.014329288 
MANF 1.46663456 5.47E-10 
VCAN 1.466100429 0.04511107 
HTRA4 1.465842465 0.029091124 
SQRDL 1.461878155 2.91E-08 
LCP2 1.461629571 0.034354988 
CD59 1.460756118 0.000000704 
HYAL1 1.459088453 0.021557352 
FOSL2 1.458755469 2.29E-14 
ASPA 1.458483612 0.027939425 
CDA 1.458277475 0.001678315 
DLG5-AS1 1.457393131 0.016290274 
BAI3 1.455138585 0.012653458 
GATA6 1.454197069 0.000465182 
SLCO2A1 1.453544417 0.005358179 
ID4 1.452831194 0.003692418 
MT1X 1.451121118 0.0000838 
KIAA0408 1.450783709 0.047788576 
TMEM35 1.446889048 7.17E-08 
RP11-327F22.2 1.446574396 0.018073007 
LYNX1 1.445602485 0.0000007 
HAP1 1.443033689 0.006199729 
AC013271.3 1.442320568 0.001928964 
LINC00632 1.440860512 0.009511506 
ADIRF 1.439550752 0.009264352 
EPOR 1.439285116 0.000106005 
SAMD13 1.438726946 0.021623122 
FZD10 1.436688703 0.003435848 
BEAN1 1.436675839 0.005832434 
COX6C 1.436021586 2.07E-08 
  
211 
 
FBXO10 1.435682872 0.000000259 
GPRIN3 1.434384641 0.000765065 
IRF6 1.433724422 0.004734422 
TCTA 1.430327145 0.00000505 
GPR150 1.428831498 0.041682211 
RP11-421L10.1 1.423575454 0.049827201 
LPCAT3 1.423422388 0.000207204 
ULBP2 1.421868856 0.000168362 
SUMF2 1.421258984 0.000000988 
TYW1B 1.420644504 0.001393554 
METRN 1.418983303 1.91E-10 
RBPMS-AS1 1.416660203 0.010841539 
CERS6 1.416448818 0.0000161 
CMC1 1.415341835 8.92E-09 
RP11-438B23.2 1.415024648 0.029928611 
DNASE1L1 1.412293872 0.00000579 
FBXO8 1.411753372 2.82E-08 
ANKRD37 1.410710427 0.000986198 
HIST1H2AC 1.410230783 6.54E-12 
HIST1H3E 1.409730536 0.002508901 
SLC10A3 1.40882265 0.0000604 
SPTBN4 1.40808218 0.001729987 
APOC1 1.407565958 0.002643187 
FAM207A 1.407539558 0.000000208 
SMCO3 1.406063313 0.020874443 
FAM155A 1.405522768 0.000002 
ZNF331 1.402020257 0.0000244 
EMC7 1.402004748 2.78E-10 
FAM86HP 1.401575643 0.001584282 
LINC01006 1.401196189 0.020120663 
PPM1L 1.39991773 0.001222086 
COQ2 1.399719062 3.27E-08 
LGALS3 1.399174101 0.000000419 
  
212 
 
IL8 1.398747448 0.000590745 
PAQR7 1.398646515 0.000503643 
C1QTNF6 1.397303553 0.0000108 
DIRC2 1.39428555 8.75E-09 
LHFP 1.394162847 1.19E-08 
OLFM1 1.392928998 0.000000235 
GAB2 1.391926782 5.28E-12 
CPAMD8 1.391475682 0.002240131 
USP35 1.391421686 0.00000285 
CHSY3 1.391273656 0.001819096 
TMBIM1 1.390735086 3.05E-12 
TMEM150A 1.390392103 0.000000279 
WDR86 1.38967353 0.0000011 
TMEM120A 1.388859928 0.00000304 
TRMT44 1.386992255 5.29E-10 
CASC10 1.384272681 0.003761494 
RAB31 1.382513674 5.39E-12 
RND2 1.379724864 0.000630811 
SFTPB 1.378650159 0.030301595 
CHRD 1.375684447 1.73E-09 
TMTC2 1.372589383 0.003510207 
MGAT3 1.371716582 0.000351618 
CYP1B1 1.371400515 0.001045482 
CDH20 1.37102203 0.030526128 
EMILIN2 1.368081944 3.52E-10 
TRPM6 1.367518421 0.019820343 
FAM46C 1.3674966 0.002103078 
FKBP1B 1.366564116 0.000496295 
HIST1H2BK 1.366012737 0.00000104 
FASN 1.364699132 0.004083817 
RP11-137H2.6 1.362079998 0.000000616 
RILP 1.361963089 0.000555303 
TCEAL3 1.360373706 0.000000605 
  
213 
 
AC002467.7 1.359700497 0.013158584 
PDK4 1.358889257 0.003350472 
CTTNBP2 1.35843633 0.000126656 
C11orf53 1.356336166 0.018004508 
ECHDC3 1.354543531 0.004479087 
IMPA2 1.35400468 0.000000183 
MAF 1.353907966 0.000273758 
TTPAL 1.353380987 0.000318663 
MAP3K5 1.352009231 0.000000591 
ATP8A1 1.351691881 0.001169042 
ELFN1 1.350464908 0.002316701 
RP13-884E18.4 1.35037637 0.022862038 
FAM198A 1.348377853 0.002174158 
TCF21 1.346746771 0.025763122 
S100A4 1.346744457 0.001228556 
WIPI1 1.344698084 6.94E-11 
KIAA1377 1.342698955 0.000000373 
KIAA1045 1.34171414 0.020950697 
RCBTB1 1.339667844 0.0000298 
ZMYM6NB 1.339617642 0.0000259 
CTD-3065J16.9 1.337747697 0.00693657 
NINJ2 1.335897348 0.036048508 
RP11-800A3.7 1.334510219 0.00245172 
DNAJC12 1.33424849 0.000125904 
FADS1 1.333672002 0.0002311 
RPRM 1.332483764 0.010019141 
MAP3K14-AS1 1.331983179 0.045630792 
EPHB6 1.331793856 0.00000158 
IP6K3 1.328476968 0.0000188 
KLHL26 1.328137764 0.000105201 
NPTX2 1.32775582 0.007794316 
SEC11C 1.323893725 1.59E-09 
DPM3 1.322717179 0.00000159 
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ATG9B 1.319763776 0.00608322 
CTB-92J24.3 1.31795796 0.000000146 
SNX22 1.317803828 0.00615265 
EPDR1 1.314627754 0.00000131 
SMPD1 1.314419474 3.82E-09 
JOSD2 1.310415416 0.00000209 
SMOX 1.308640382 0.000000283 
IFI35 1.308251454 0.000000158 
RELT 1.306211133 0.0000484 
CYB5R1 1.305883499 1.47E-11 
C6orf211 1.30571037 0.00000388 
SHBG 1.303051858 0.017237628 
CLDN23 1.302384729 0.013292533 
SLC3A2 1.299915147 2.6E-10 
NR4A1 1.299631832 3.8E-09 
FAH 1.29847521 0.000000617 
GHR 1.296999405 0.0000221 
CD151 1.29678032 5.32E-08 
KLF9 1.295996019 2.23E-11 
CCDC102B 1.295810211 0.004830063 
C9orf72 1.295808257 0.000000036 
TGFBR1 1.293281366 0.000000705 
HLA-E 1.292392162 0.000000019 
HPSE 1.292324872 0.0000395 
SNX21 1.290839163 0.000024 
TNFAIP2 1.290202033 3.78E-08 
GCKR 1.289470995 0.031424088 
CNTN3 1.28855765 0.000026 
PYGL 1.288448149 2.89E-11 
GNG2 1.2884176 0.000357985 
MAPK14 1.288316698 0.000000531 
TMED8 1.287783342 0.00000196 
DERL1 1.287308042 0.0000209 
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A1BG-AS1 1.287277746 0.0000102 
NOL3 1.285863101 5.32E-09 
FOXO1 1.285107969 1.15E-08 
TMEM179B 1.285095955 2.88E-08 
GPR115 1.284627328 0.007461423 
NUDT16 1.28294248 0.000288912 
BRE 1.282485258 3.5E-10 
FAM46A 1.282418667 0.0000841 
MFSD12 1.281400275 0.00000497 
NPC2 1.281239099 7.42E-10 
CCDC170 1.279231176 0.00000558 
ABHD14A 1.277011673 0.000355965 
RAB6C-AS1 1.276021885 0.008766651 
IDI1 1.274859033 0.0000853 
ZC3H12A 1.274687054 0.000881729 
STYK1 1.272989573 0.037332184 
WT1-AS 1.271103024 0.000000147 
B3GAT3 1.268622331 2.22E-09 
NMNAT2 1.268451853 0.001568904 
FKBP2 1.267970084 5.27E-09 
PLCD1 1.267306988 0.000242223 
DOK6 1.265312429 0.000816392 
RMDN2 1.26521307 0.000000939 
LINC01160 1.264672265 0.018029252 
B4GALT3 1.263924166 7.83E-08 
MXRA7 1.263780533 2.48E-11 
GPRC5B 1.263221078 0.0000235 
UBAC2-AS1 1.263076139 0.037019624 
MAP1B 1.263056365 0.002011341 
SOD2 1.262059337 0.0000103 
HSD17B14 1.261929502 9.83E-08 
GPD1L 1.261911037 0.002706501 
STRBP 1.261279705 0.000539641 
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ZDHHC12 1.259602536 0.0000173 
RP11-175K6.1 1.259537873 0.016555734 
HDAC4 1.258952843 1.54E-08 
DNAJC1 1.258678785 0.00000117 
DCTN6 1.256819127 3.61E-08 
LRRC3 1.255557677 0.001962805 
STOM 1.25469557 0.00000115 
CTD-2127H9.1 1.254528088 0.042689981 
SORBS1 1.254525583 0.001645484 
NR1D1 1.254266487 0.0000159 
SAA1 1.25338875 0.000542707 
CCDC85A 1.252674254 0.013916287 
ALDH1A3 1.24982956 0.000578113 
SCD5 1.249791289 2.14E-08 
DIAPH2 1.24888199 0.002277153 
AHCY 1.248670538 0.000412846 
CXCL1 1.247635794 0.004064576 
RP11-712B9.2 1.247343978 0.018917079 
SESTD1 1.247321262 4.66E-09 
RP1-239B22.5 1.246964135 0.000226932 
ST20 1.246879908 0.007907312 
GLB1 1.245698287 0.0000152 
SLC19A2 1.245342785 0.00000423 
PCDH9 1.245329204 0.017244738 
FXYD5 1.244872787 0.001609889 
TAP1 1.244827201 0.000240871 
SLC6A8 1.243453477 1.3E-09 
ST6GALNAC1 1.243087397 0.03429316 
STARD8 1.243003102 0.018229593 
IL15RA 1.242412492 0.00151752 
CDH11 1.241379801 0.00000827 
NDRG1 1.238357806 3.47E-08 
ZNF860 1.235799005 0.022143863 
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CD302 1.235618669 2.42E-09 
DLEC1 1.235075075 0.037560565 
FZD4 1.23490267 0.002761287 
CERK 1.233889305 0.00000421 
ROM1 1.232505182 0.001030049 
HEXIM2 1.232219654 0.000497571 
AQP8 1.231886586 0.042964808 
RP11-395B7.4 1.23171644 0.00257345 
XG 1.228759824 0.00247024 
LYN 1.227065704 0.000285928 
GCNT1 1.226682078 0.0000384 
SH3RF3-AS1 1.224889304 0.004522612 
RORA 1.22485908 0.00000172 
OSTM1 1.224069459 1.11E-09 
CTU1 1.22269609 0.000696148 
TGFBR3L 1.222214776 0.033970237 
FAM174A 1.221909323 0.0000155 
USP38 1.221693262 2.91E-08 
HSD17B7 1.219710188 0.000550366 
GLA 1.218623478 0.0000048 
LYSMD1 1.218352878 0.00000288 
GALNT18 1.218334521 0.000000437 
SNX24 1.218037675 4.67E-08 
ITGBL1 1.217328556 0.01226742 
IFNGR1 1.217122247 0.000000721 
ATP13A3 1.216529843 0.000210655 
PRADC1 1.216449479 0.0000397 
TMEM208 1.215824357 0.000000112 
SLC39A11 1.21563409 0.000172798 
PDE10A 1.214474895 0.00000159 
ARNTL 1.2133024 0.000086 
SEMA3A 1.211066047 2.98E-10 
SLC2A1-AS1 1.210349071 0.004628834 
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HIST1H2BN 1.210343217 0.006716039 
H2AFJ 1.20993956 0.00000212 
EMR2 1.208429212 0.000510335 
ENPP4 1.20729261 0.0000542 
FAM199X 1.205435892 0.001030161 
PPIB 1.203821728 0.00000661 
AIM1L 1.20300416 0.031512518 
CRADD 1.20218002 0.000327568 
MBNL1-AS1 1.200289053 0.0000179 
TSPAN7 1.200002248 0.019546689 
IFITM10 1.198074205 0.0000858 
ACER3 1.197363472 0.000155574 
IZUMO4 1.196846022 0.010854237 
ADORA2B 1.196364629 0.006427161 
NCK1 1.195343596 0.00000319 
RCAN1 1.195233177 0.000488797 
PTRH1 1.194113953 0.000434252 
NOG 1.193321521 0.025116592 
LGMN 1.192056583 4.46E-08 
CDH26 1.191933177 0.037468574 
PON2 1.190572726 8.79E-10 
POLE4 1.189544017 0.000000217 
LAYN 1.188554042 3.05E-09 
MICA 1.187727177 0.000000487 
CLIC2 1.187028864 0.004015933 
BEST1 1.186467376 0.000000472 
PNCK 1.186379202 0.032430098 
SRPX 1.183474638 0.00000421 
ACAT1 1.183019365 0.0000745 
GPR157 1.182808523 0.00000994 
HS1BP3 1.182768399 0.0000718 
MAPRE3 1.182657498 0.0000326 
38596 1.181907447 0.000484278 
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IFI27L1 1.178090648 0.00000339 
RRAS 1.177197916 0.000107884 
AC112229.4 1.176825588 0.0000212 
CMIP 1.175257753 4.44E-08 
SCML1 1.174274018 0.001463986 
AGTRAP 1.17386477 0.000000806 
RP11-434C1.1 1.173791422 0.029360349 
LMAN2 1.172597157 0.00000268 
DHRS3 1.172355047 0.004174565 
WBSCR17 1.171885818 0.033031134 
SPOCK2 1.171220013 0.022798557 
ARL4D 1.170340526 0.000857494 
MRPL33 1.170297073 3.98E-08 
ACTC1 1.169702054 0.039587383 
GNA15 1.169174741 0.045421767 
ERGIC1 1.168125626 0.0000528 
SEMA3B 1.166835892 0.00000827 
LSS 1.163226847 0.0000447 
PNPLA2 1.162722023 0.00000127 
CTC-786C10.1 1.162665543 0.005085051 
TMCC3 1.161419458 0.001242724 
KLK10 1.161365029 0.000241134 
ITGB8 1.159011565 0.000180976 
CTA-217C2.1 1.158754747 0.0000329 
AC011242.6 1.158571335 0.00203434 
FTL 1.157893814 6.79E-08 
FBLN5 1.157737789 5.62E-08 
CTD-3184A7.4 1.157106714 0.005691721 
SLC2A12 1.155757066 0.011829383 
SUSD2 1.154675518 0.0000139 
ATG4A 1.154148901 0.000168345 
RP11-112L6.4 1.153956918 0.044218449 
NUS1P2 1.153687326 0.021613466 
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RPGR 1.152777611 0.0000447 
LINC00467 1.151137456 0.011178493 
TMEM38B 1.150365957 0.0000149 
CPEB4 1.150134818 0.0000585 
ARSG 1.149769753 0.003486197 
EMP3 1.149069292 0.000366223 
HLA-DMA 1.148560465 0.0288779 
CLDND1 1.148239127 0.00000116 
OSMR 1.147305836 0.001019215 
LAMA2 1.147294857 0.007928491 
SASH1 1.145390577 0.002081366 
ALDH2 1.143446789 0.005064371 
TSPAN12 1.142079552 0.0000269 
AKAP13 1.141915461 0.000105697 
ADCY2 1.140664286 0.000307863 
ERVMER34-1 1.140009351 0.000806253 
RAB4B 1.139526825 0.0000119 
HSD17B1 1.138711158 0.000504733 
LAMC3 1.135712506 0.008801155 
RP11-498C9.2 1.134756112 0.017917543 
MFAP3L 1.133653452 0.003814681 
RP11-218E20.3 1.133452662 0.013084946 
STC1 1.130187335 0.006859142 
PTPRN2 1.130121597 0.000551775 
CLTB 1.12990164 0.000000352 
CRELD2 1.129622723 0.0000123 
UNG 1.128873806 0.00000026 
BRF2 1.12881169 0.0000033 
REXO2 1.128109716 0.000000113 
NCOA4 1.128104318 2.52E-08 
EML2 1.127891242 0.000896832 
CSPG4P12 1.127719537 0.000323929 
ABCA3 1.12601281 0.004207433 
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CFH 1.125513997 0.023063893 
DPP6 1.12512603 0.022958441 
SGCB 1.125100737 0.0000357 
HYAL3 1.124332532 0.001510463 
SLC35D1 1.12409496 0.00188802 
CCDC86 1.123854357 0.000000667 
GLRX 1.122144237 0.00000182 
TEX2 1.121391505 0.0000838 
EIF2AK3 1.120640933 0.000196224 
FGGY 1.120616967 0.008607184 
C20orf195 1.120132272 0.043057855 
RNASEK-
C17orf49 
1.119505385 0.047665906 
CTSB 1.119490921 4.21E-08 
TSC22D4 1.117333849 0.00000288 
C1R 1.116118394 0.000000253 
METAP2 1.115278155 2.27E-09 
ACYP2 1.11510513 0.0000072 
VWA1 1.114449057 0.006665227 
CYSTM1 1.111146641 0.00000146 
RAB18 1.109395178 0.000000311 
AIFM2 1.109168787 0.000000505 
ANKRD2 1.109100566 0.047686368 
HIST1H4H 1.108581316 0.002599349 
RNASEL 1.108375965 0.0000147 
FZD10-AS1 1.107655936 0.018088072 
SRCRB4D 1.107554489 0.02815255 
WNT5B 1.105209566 0.001966888 
BAMBI 1.10448095 0.000429173 
RABAC1 1.103687875 0.00000571 
RP11-54A9.1 1.101367812 0.019773213 
ZNF438 1.101027807 0.001593901 
MMP19 1.100638915 4.34E-08 
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PRDX4 1.100284028 0.000262322 
ERO1L 1.09986748 4.45E-09 
UGT2B7 1.09955948 0.003858595 
HDAC9 1.097980161 0.028944414 
TPGS1 1.097876466 0.000496634 
TMED3 1.097415666 0.0000927 
LINC00598 1.096882326 0.021424385 
LINC00968 1.096546168 0.009986394 
CES1 1.096413808 0.0000925 
SLC44A1 1.094877748 0.0000226 
TLR4 1.094767652 0.000458681 
LITAF 1.094359256 0.000000107 
LINC00683 1.093369924 0.035135295 
POLD4 1.093267027 0.0000151 
KCNK1 1.090654211 0.00000588 
IL18 1.087905837 0.002964625 
CTD-
2013N24.2 
1.08524189 0.043466414 
NEU1 1.084860955 0.000000274 
KL 1.084734946 0.013388252 
TXN 1.084233524 0.000637565 
SIK2 1.083300841 0.000000849 
GLUD2 1.082624907 0.006571167 
MFAP5 1.082565062 0.004334919 
LNX1 1.081700054 0.012808709 
CITED4 1.081315899 0.00042852 
TMEM154 1.081304161 0.000413826 
SLC1A2 1.080374367 0.011505658 
RP11-67L2.2 1.080280522 0.000895536 
CA5BP1 1.080052759 0.00249785 
WDFY3-AS2 1.080039528 0.003623417 
AIM1 1.07831128 0.026465849 
RP5-1065J22.8 1.076864223 0.034352436 
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TRPC4 1.075830934 0.000280234 
C3orf58 1.075553155 0.0000772 
COPZ2 1.075328977 0.000491879 
RP11-395A13.2 1.075151917 0.007246924 
TMEM147 1.074745146 2.46E-08 
SGK1 1.073660651 0.001509197 
MZT2B 1.073244429 0.000492024 
MXRA8 1.07318014 0.000000104 
CCDC53 1.071789047 0.00000298 
PROSER2 1.071060963 0.000102915 
RBMS1 1.070952322 2.11E-08 
TXNDC15 1.070442219 0.00000038 
TSPO 1.070130726 0.0000994 
GCNT3 1.069924285 0.022182992 
ZBTB11-AS1 1.069815225 0.001269856 
LRP8 1.068148352 0.010331958 
ATRAID 1.067975336 0.0000143 
DCXR 1.066736824 0.000136486 
VKORC1 1.066147276 0.000331091 
ABHD17B 1.065401919 0.000000662 
PHYH 1.064819543 0.000000407 
PGD 1.06426437 0.001787192 
TSPAN13 1.06421385 0.001140606 
GPR108 1.06366209 0.000000379 
FAM53B 1.063583415 0.0000125 
RNF152 1.063388689 0.000446698 
BLVRB 1.062577827 0.00000779 
RP11-295K3.1 1.059631591 0.046623711 
STAT3 1.058100669 0.000732367 
ALDH1A2 1.057537351 0.000177704 
RIOK3 1.056642824 0.000000374 
SLC30A1 1.055558017 0.0000162 
PGM2 1.053528289 0.000483417 
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SSC5D 1.053368668 0.000293832 
QPRT 1.052884567 0.00000552 
MDFIC 1.052005221 0.000000345 
RP11-465B22.3 1.051661615 0.038711172 
C19orf24 1.05054259 0.000013 
ADAP1 1.05048429 0.024833042 
TMEM53 1.050082701 0.002478145 
GREB1L 1.049227112 0.000000236 
SLC35E3 1.049176373 0.0000837 
SLC35G2 1.048578471 0.0000498 
EDN2 1.048532984 0.01820462 
ABCA1 1.048038249 0.00209095 
OLFML2B 1.047582624 0.010152895 
NUDT16P1 1.047532401 0.046368792 
ITPK1 1.046675966 0.000000176 
EDEM2 1.045872576 0.000184636 
SDF4 1.044939581 0.0000149 
CCDC159 1.044571961 0.0000765 
GBA 1.043412178 4.64E-08 
C9orf89 1.043302115 0.000000669 
DOCK8 1.041661138 0.009860664 
CA2 1.041220254 0.047874404 
MCTP1 1.041116503 0.000805821 
B3GNT2 1.040310437 0.000253715 
ABAT 1.039645799 0.006275146 
HLA-F 1.038637278 0.003970509 
C1orf85 1.038408754 0.00000661 
NAP1L3 1.037426698 0.00040181 
DDRGK1 1.037251581 0.00000206 
ADCY3 1.036446955 0.01131106 
AP1S2 1.036411698 0.003273882 
ITFG3 1.036073912 0.0000103 
ADD3 1.03509132 0.0000191 
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ABCB8 1.032737998 0.000832048 
SLC7A11 1.031990316 0.002992049 
TM7SF2 1.031621121 0.000254867 
C4orf48 1.031587345 0.000824828 
SERPINB9 1.031164729 0.004860422 
RCN3 1.030229938 0.000243447 
SELM 1.02887497 0.00000632 
OAT 1.026786509 0.00000689 
LINC01003 1.026754129 0.01870097 
PDIA5 1.026426732 0.002507018 
CTD-2536I1.1 1.026226694 0.030369919 
CLYBL 1.026125059 0.006889708 
SCPEP1 1.023603378 0.000000126 
MCUR1 1.023052194 0.000000693 
RP11-295G20.2 1.022734904 0.012459688 
PBLD 1.021956036 0.000477084 
PLXND1 1.021697621 0.015850715 
KCNMB4 1.021311641 0.008571318 
AIMP2 1.020502087 0.0000388 
PIGP 1.020279812 0.0000367 
PDCD5 1.020179948 0.000024 
MASP1 1.019252126 0.006980522 
DHCR7 1.019192468 0.009869387 
RNF14 1.018986653 0.000000758 
UNC79 1.01895397 0.047009399 
EMP2 1.018911752 0.00000251 
TBC1D1 1.01847604 0.005795156 
ATP6V0B 1.016839267 0.000000122 
ARL4A 1.015746742 0.000219986 
KIAA1549 1.015659147 0.0000788 
EPHX1 1.015589478 0.0000965 
CD63 1.014066646 0.00000684 
RN7SL3 1.014007665 0.028904959 
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GPX7 1.013373015 0.000231373 
TAF13 1.01314447 0.00000085 
CASP9 1.012774883 0.000106155 
MIEN1 1.012570652 0.00011376 
SELPLG 1.012549218 0.006583901 
RP11-355B11.2 1.011113976 0.021816117 
RP11-334C17.5 1.010745856 0.008119996 
IL10RB 1.01021324 0.0000429 
FBLN1 1.010003497 0.0000108 
SPRYD4 1.009926545 0.000520667 
MOV10L1 1.00957762 0.0000115 
C19orf70 1.009104463 0.0000114 
SUSD3 1.00889758 0.0031879 
BNIP3P1 1.008148531 0.000943918 
HMGN3 1.007320653 0.0000904 
SERF2 1.006651206 0.0000427 
ACE 1.006264416 0.029982176 
SNX25 1.005917218 0.000000648 
MVD 1.005663721 0.000700055 
FKBP11 1.005568114 0.001894719 
LIMS3 1.005411808 0.000306247 
TIMP1 1.004995052 0.000281971 
SMAP1 1.003187967 0.0000773 
RP11-135L13.4 1.002763049 0.011294848 
UCP2 1.002259488 0.025851129 
UBE2D1 1.001839468 0.000000447 
C5AR1 1.001532007 0.023904805 
LINC00116 1.000665521 0.000792991 
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Appendix 4. Down-regulated genes upon decidualization: 
Log2-fold change ≤ -1 
 
 
Gene Symbol log2-fold change q 
TNFSF18 -6.478964402 3.23E-32 
INHBE -5.884321704 1.04E-18 
EGR2 -5.274229596 2.66E-17 
SERTAD4 -4.999475267 3.27E-26 
TNFRSF19 -4.891775017 7.89E-76 
SSTR1 -4.890083317 6.37E-43 
MXRA5 -4.489495577 6.63E-33 
PHGDH -4.430202293 1.18E-36 
SYTL5 -4.419102984 5.6E-41 
DKK2 -4.32675239 7.69E-10 
CALB2 -4.12458001 1.54E-15 
TNFSF4 -3.960684243 2.01E-20 
SLC6A9 -3.93819276 1.72E-19 
TNNT2 -3.937206526 1.03E-14 
COL12A1 -3.882128111 4.95E-59 
ADRA1D -3.876341209 4.89E-13 
TMEM130 -3.693861991 5.32E-11 
FAM196B -3.676870569 5.26E-15 
GLI1 -3.665220372 2.01E-12 
SBF2-AS1 -3.665135925 4.97E-41 
HTR1D -3.645204857 4.07E-09 
MYBL2 -3.633644884 2.51E-33 
LRP2 -3.62009864 0.000000285 
PSAT1 -3.607758077 3.74E-13 
SULT1C4 -3.604581401 2.17E-11 
CNTN5 -3.602621883 6.06E-09 
ADM2 -3.594698793 4.29E-14 
  
228 
 
ITIH3 -3.558075628 2.49E-16 
38047 -3.501007808 9.45E-15 
MXRA5P1 -3.484783246 0.000000478 
NCKAP5 -3.480388334 3.33E-15 
OLFML2A -3.478998768 1.26E-16 
MKI67 -3.462861154 3.93E-27 
FAM111B -3.399998921 1.94E-14 
MEOX1 -3.39852901 9.06E-11 
SORCS3 -3.386384818 0.0000109 
DOCK2 -3.354057658 2.13E-08 
BUB1B -3.341101433 3.11E-28 
CACNG4 -3.334648774 0.00000049 
NEIL3 -3.332498259 1.01E-13 
GBP4 -3.319460316 9.71E-26 
RASGRP3 -3.317088224 6.91E-11 
LINC00643 -3.309890415 0.00000919 
CHRM2 -3.304274792 1.37E-12 
RP11-
284N8.3 
-3.281040135 0.000000128 
FMN2 -3.259599217 2.21E-24 
DTL -3.249761598 1.04E-15 
TNFSF15 -3.235616735 1.3E-10 
WNT2 -3.233514586 3.2E-12 
KCNA3 -3.230462217 0.000000201 
ZNF365 -3.221292117 4.35E-15 
MIR143HG -3.219573115 1.2E-22 
DPY19L2P1 -3.184966903 2.09E-11 
BRIP1 -3.182414237 9.4E-22 
NCAPG -3.175300379 1.49E-24 
CCNE2 -3.15732126 1.15E-12 
RP11-
709B3.2 
-3.149127291 7.58E-09 
IQGAP3 -3.143042706 2.84E-27 
  
229 
 
RIBC2 -3.139096696 0.0000338 
AL121578.2 -3.108761843 0.0000427 
SKA3 -3.103322449 1.55E-14 
RP11-
554D15.1 
-3.102458777 0.0000226 
HJURP -3.088061719 1.18E-18 
NES -3.087777528 1.05E-16 
DIO2 -3.054472453 1.66E-18 
SYT1 -3.043178477 8.65E-11 
E2F7 -3.036895256 4.6E-12 
C1QTNF7 -3.033298963 7.4E-12 
TYMS -3.030154902 3.81E-20 
HUNK -3.027191731 4.3E-22 
PDE5A -3.02220806 2.22E-13 
RASGRP1 -2.983978379 3.88E-10 
LINC00617 -2.983070033 0.000000274 
ASF1B -2.981733991 1.83E-15 
MIR145 -2.979353524 4.42E-20 
FJX1 -2.969208172 1.91E-08 
ZNF469 -2.959950264 1.2E-12 
CPA4 -2.949856419 3.22E-14 
KIF20A -2.942080275 2.07E-17 
ADAMTS16 -2.933999798 1.93E-11 
LRRC17 -2.922721978 4.15E-08 
CAND2 -2.921606653 7.74E-15 
IGFBP5 -2.915642343 0.000121201 
CAMK1D -2.910196942 6.16E-13 
GINS2 -2.901039018 1.94E-10 
AC131025.8 -2.894287997 0.00000318 
CENPU -2.883437441 8.25E-15 
RP11-
426C22.4 
-2.882712369 0.000000176 
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RP11-
588K22.2 
-2.880159074 0.0000338 
FAM64A -2.87355014 1.29E-16 
KIT -2.866737402 4.62E-10 
BUB1 -2.865749724 1.88E-18 
RAD54L -2.865290807 1.75E-10 
ANLN -2.86244239 4.2E-24 
MAP3K7CL -2.862418319 5.03E-14 
TENM4 -2.856956301 2.64E-08 
MRVI1 -2.85019438 1.65E-18 
RRM2 -2.848489188 9.54E-30 
DPY19L2 -2.84835008 2.48E-10 
NUF2 -2.845470417 1.19E-14 
EGR1 -2.844014529 7.5E-38 
RAB3B -2.837069233 1.61E-10 
UHRF1 -2.832300717 1.39E-23 
NRP2 -2.828769535 8.91E-10 
E2F8 -2.825564432 0.000000236 
FOXM1 -2.8222335 6.49E-23 
POSTN -2.818605362 3.66E-16 
CNTN1 -2.815799532 0.000000013 
VASH2 -2.812041267 3.44E-08 
NREP -2.808165496 2.52E-14 
CDC25C -2.8075364 1.52E-10 
COL8A1 -2.799157262 3.44E-17 
DPYSL3 -2.79466439 0.0000738 
E2F2 -2.787418993 0.000000584 
CASC5 -2.784711854 7.48E-23 
EXO1 -2.767062159 3.62E-08 
TROAP -2.766756916 1.67E-14 
PLCB1 -2.763230911 3.95E-09 
NCAPH -2.762443973 1.44E-14 
ERCC6L -2.761729534 0.000000849 
  
231 
 
GTSE1 -2.760317869 1.27E-18 
GUCY1A3 -2.755576835 0.00000929 
FAM83D -2.749806384 2.23E-15 
CEP55 -2.744744396 7.72E-24 
CAMK2A -2.741106867 0.0000221 
TICRR -2.737970191 4.97E-10 
CLSPN -2.725606992 7.14E-12 
PKNOX2 -2.723249265 0.00000012 
MCM10 -2.71105548 1.48E-10 
LINC00327 -2.70742165 8.32E-09 
PRELP -2.695510256 4.41E-11 
NTF3 -2.692058007 0.00000034 
HRK -2.69176817 0.000405801 
RP1-140K8.5 -2.687139142 0.000055 
CDK1 -2.686430719 2.02E-20 
TNXB -2.684158515 4.75E-13 
TMPO-AS1 -2.683801139 0.000000782 
RASSF2 -2.680154098 1.55E-19 
PRRG3 -2.667713698 0.0000693 
KIF18B -2.66690852 1.22E-11 
HEPACAM -2.6613203 0.000604723 
LBH -2.660207214 4.02E-13 
FNDC1 -2.658126877 4.24E-10 
LANCL3 -2.658075168 0.00000202 
SGCD -2.655198295 1.47E-08 
ITM2A -2.655176184 0.0000152 
ATP8B1 -2.651453703 8.94E-12 
FRMD4A -2.648969956 9.57E-08 
SPAG5 -2.647535803 4.59E-19 
C6orf141 -2.646631398 0.000157089 
KB-1410C5.2 -2.645960662 0.000784577 
DLGAP5 -2.641384938 2.29E-18 
MYLK -2.641246354 4.84E-16 
  
232 
 
SHCBP1 -2.63963268 8.77E-21 
MBOAT1 -2.63852621 1.92E-14 
ZNF367 -2.634271598 1.77E-12 
CBLN2 -2.632933831 0.000382016 
CDT1 -2.623787024 3.06E-11 
ESCO2 -2.621971973 4.9E-11 
SAPCD2 -2.620799777 0.000000066 
TTK -2.615696129 1.34E-15 
PLEKHA4 -2.607120201 2.27E-13 
RGS4 -2.605585551 1.75E-11 
DUSP6 -2.604070472 3.73E-10 
FBXL22 -2.598403388 0.00028374 
AURKB -2.590395231 9.71E-09 
AFF3 -2.589586994 1.19E-34 
TOP2A -2.586289371 1.68E-33 
NCAM1 -2.584530914 7.2E-10 
RNF165 -2.582138394 0.00000829 
COL16A1 -2.58096138 1.19E-09 
TCF19 -2.580803063 7.8E-15 
FAT3 -2.578357579 0.0000308 
SLC7A3 -2.577730974 0.00000297 
C17orf107 -2.575776026 8.91E-08 
ZNF711 -2.573121138 2.81E-13 
ATP8B4 -2.570764748 0.00000244 
KCNA6 -2.57030129 0.000222132 
SLC4A4 -2.56674004 0.000111146 
RCOR2 -2.559210209 6.46E-08 
BIRC5 -2.557153182 2.94E-23 
GRIN2A -2.556971109 0.0000493 
SH3BP1 -2.556666562 1.13E-11 
CLDN11 -2.555386995 0.00000469 
PLK1 -2.555312528 2.04E-23 
KIAA0101 -2.552340448 3.08E-14 
  
233 
 
CNGA1 -2.545374806 0.0000828 
FIBIN -2.545311685 0.00000125 
ARHGDIB -2.544881595 1.54E-17 
CTD-
2297D10.2 
-2.540334518 0.001277033 
PGM5 -2.537295676 0.000000001 
KIF11 -2.52217967 2.29E-22 
RCAN2 -2.52103494 0.00000024 
SETBP1 -2.518417714 8.06E-08 
PREX2 -2.518168046 0.00000114 
FLRT1 -2.513214045 0.001269368 
CDC20 -2.513119746 3E-13 
JPH4 -2.511447318 3.61E-11 
LGR5 -2.51028343 0.00000695 
LPAR4 -2.506172281 0.000628627 
KIF18A -2.50579416 2.86E-09 
B3GALT2 -2.504062616 0.000022 
CDC6 -2.503426398 7.23E-15 
SCHIP1 -2.500726907 0.0000562 
MIR143 -2.497194546 0.001384495 
ROBO3 -2.494197514 0.00000238 
PKMYT1 -2.493300237 1.07E-08 
FHOD3 -2.49218599 0.000584822 
PTCHD4 -2.492171895 7.97E-08 
INPP5J -2.490575513 0.0000725 
PLK4 -2.490068687 2.03E-12 
CTD-
2269F5.1 
-2.488974041 0.000692397 
PTHLH -2.488465151 0.00000259 
LMNB1 -2.487120932 2.53E-12 
CDCA5 -2.484806913 2.04E-17 
DEPDC1 -2.482434201 2.36E-18 
CDCA2 -2.480510691 1.02E-10 
  
234 
 
POLQ -2.478629246 9.35E-11 
IGDCC4 -2.477579509 7.25E-11 
FGF9 -2.475103095 0.00000694 
RHOJ -2.473712537 7.16E-12 
AC010890.1 -2.464496393 0.000437394 
RPS6KA6 -2.460063483 1.55E-08 
SYPL2 -2.458308889 1.96E-22 
SULF1 -2.456466359 2.53E-15 
ASPM -2.453593354 2.4E-11 
KIAA0754 -2.451906867 1.16E-09 
ARMC4 -2.449780727 0.000063 
PALM2 -2.44869371 1.66E-08 
PAPPA2 -2.44733788 0.001173298 
KIF2C -2.44468025 1.04E-15 
CENPF -2.444601607 1.91E-22 
CDCA3 -2.438101079 1.03E-14 
RP11-
344E13.3 
-2.434641194 1.42E-08 
PALM2-
AKAP2 
-2.422229159 0.000516258 
PLXDC1 -2.419288127 3.01E-10 
NUSAP1 -2.418966479 5.58E-23 
NTM -2.40698604 0.00000339 
BAI2 -2.40556779 1.16E-09 
KIF14 -2.405385085 1.61E-12 
AC007362.1 -2.404446376 0.000022 
CR1 -2.404385258 0.000609959 
CSRP2 -2.396168646 0.000000398 
CENPA -2.395279822 1.08E-10 
PRC1 -2.393201969 9.64E-27 
EBF3 -2.385871027 0.00010583 
USP53 -2.375775592 1.33E-14 
SFRP1 -2.373884818 2.48E-10 
  
235 
 
FMNL3 -2.36835175 1.11E-13 
ADCY4 -2.365269932 9.32E-12 
WEE1 -2.363762306 4.54E-09 
MIR503HG -2.361276121 4.77E-10 
GREM2 -2.360653989 0.000021 
C11orf82 -2.356432581 1.12E-08 
NBEAP1 -2.352763347 0.0000966 
ZFHX4 -2.346937544 0.00000142 
RP11-
354P17.15 
-2.344879178 0.002773462 
AKAP5 -2.343047438 0.00000581 
LOXL1-AS1 -2.342058003 9.76E-08 
IL17RB -2.34034 0.00011532 
LINC01085 -2.34002086 0.00049182 
BLM -2.339699519 5.76E-08 
SMAD3 -2.334169554 0.000000077 
FMO2 -2.333362191 0.00176912 
RP11-
693N9.2 
-2.332496978 0.002923398 
NPM2 -2.3252047 0.000108454 
HOXD-AS1 -2.324000374 0.000784553 
SHROOM3 -2.322535646 2.03E-11 
CLEC14A -2.321131034 0.002076507 
FOXS1 -2.315029325 0.001130009 
ERP27 -2.313765088 0.00088978 
CDCA8 -2.312390941 1.77E-15 
KIFC1 -2.309665067 1.12E-14 
DIAPH3 -2.309176469 4.44E-15 
TPX2 -2.308886563 1.14E-13 
HTR7P1 -2.307756798 0.00000197 
GRIP2 -2.307248529 0.000037 
TOX -2.307052786 0.000490731 
KIF4A -2.30619643 3.81E-15 
  
236 
 
TGM1 -2.305425486 0.0000488 
RP11-
554A11.4 
-2.300902559 0.000226492 
ATP2B1 -2.29889117 7.23E-18 
ANK2 -2.296192964 4.98E-10 
PAG1 -2.288607519 5.24E-10 
TLL1 -2.287836422 0.001528438 
PLCE1-AS1 -2.282682834 0.001052457 
SPC25 -2.28171544 1.37E-08 
HMCN1 -2.276924021 5.22E-11 
MYH11 -2.274267171 2.89E-09 
MBNL3 -2.27078741 0.0000401 
PTGES3P1 -2.268376082 0.001190105 
GUCY1B3 -2.264289242 0.00000402 
RP11-
548O1.3 
-2.262507875 8.85E-17 
ATAD5 -2.262433242 0.000000182 
ZBTB12 -2.262034795 4.73E-08 
NUP210 -2.261351567 0.00000243 
SYT16 -2.261269077 0.003037695 
LRRC4B -2.258836845 5.62E-12 
TK1 -2.258657083 4.01E-14 
AC092667.2 -2.257244242 0.003425463 
BMF -2.249544411 0.00000549 
OIP5 -2.245650261 0.00000897 
PTX3 -2.242238557 0.00083907 
C2CD4C -2.241011406 0.004468727 
CCDC81 -2.238508096 1.07E-14 
B4GALNT4 -2.23530012 0.0000855 
UBE2C -2.231986792 4.89E-11 
ITGA4 -2.229440966 1.25E-15 
TSPAN18 -2.227738862 0.0000136 
MCM5 -2.224744937 8.52E-19 
  
237 
 
PCDH10 -2.223533616 2.07E-08 
CCNB2 -2.223365716 2.11E-13 
DNM1 -2.221740562 2.87E-08 
CCDC15 -2.221575275 0.00000555 
GABRA5 -2.220025516 0.000000793 
ARHGAP11A -2.213086477 5.31E-16 
CDKN3 -2.212165792 8.25E-11 
RAD51AP1 -2.211759963 5.06E-10 
RASGRF1 -2.208316027 0.000215123 
WNK4 -2.20704619 0.0000174 
SYT7 -2.199943493 0.000017 
TRHDE -2.199250495 0.0000365 
PBK -2.198957613 2.16E-13 
RP11-
297M9.2 
-2.197234193 0.000877263 
DOCK10 -2.196527424 0.00000403 
COLGALT2 -2.196303717 0.005259501 
ADAM12 -2.19588053 2.74E-11 
RHOBTB1 -2.191464427 9.24E-09 
LZTS1 -2.186449047 0.000148225 
ITGA11 -2.182456477 0.000000341 
PPP1R12B -2.180127579 2.25E-11 
CENPH -2.179755794 2.02E-09 
CSDC2 -2.179361742 2.45E-09 
OSR1 -2.179180435 0.001112401 
OBSCN -2.176311888 6.09E-19 
MELK -2.168342884 5.24E-09 
GPSM2 -2.166053494 1.03E-08 
ZNF521 -2.164815144 0.000000164 
TRERF1 -2.164382967 1.28E-16 
STC2 -2.1608153 0.0000266 
SAMD3 -2.159316299 0.000165789 
PRRT2 -2.158451148 0.00000353 
  
238 
 
NDUFA4L2 -2.156744044 0.000713615 
LINC00312 -2.155708559 0.0000223 
ISM1 -2.153585758 0.00000129 
ADCYAP1R1 -2.151627836 0.006264154 
ZNF488 -2.149789834 0.0000227 
CD200 -2.144906872 0.001651094 
ROBO2 -2.144216146 9.29E-12 
F2RL1 -2.143275499 0.00000698 
OSBPL7 -2.143185956 6.21E-11 
HOXA2 -2.14255104 0.000412025 
NXPH4 -2.142039282 0.002332883 
FAM69B -2.140775781 0.001713747 
KIF23 -2.140582139 7.71E-20 
B3GALNT1 -2.139120409 0.0000287 
KIF15 -2.138303801 5.13E-08 
RASSF5 -2.131736287 0.002741549 
C1orf198 -2.129769249 2.66E-12 
DNMT3B -2.12767501 0.000000222 
CMAHP -2.124354981 4.92E-08 
IL34 -2.122671452 0.000666157 
DNAH10OS -2.122568844 0.0000143 
NEK2 -2.118321753 1.11E-08 
FLI1 -2.115576482 0.000559807 
EZH2 -2.112994951 0.000000043 
ITGA8 -2.11227624 0.0000365 
PCP4 -2.107991382 0.007378635 
BRCA2 -2.107489482 0.00000021 
CDH4 -2.10742278 0.000241856 
PRR11 -2.106322877 9.22E-13 
ABCA10 -2.105732423 0.000426767 
RP11-9G1.3 -2.103722901 0.007149446 
PDGFC -2.101487497 2.57E-10 
ANO1 -2.098828435 9.93E-08 
  
239 
 
SDPR -2.09717574 6.85E-09 
CTD-
2267D19.6 
-2.096782618 0.007809255 
IQCA1 -2.096128559 0.000150256 
NPAS4 -2.094531787 0.006848542 
37865 -2.093158918 0.000132505 
DIRC3 -2.093027873 0.001195316 
MYH10 -2.092442709 9.72E-19 
PRR5L -2.086056771 0.00000301 
TSPAN8 -2.082310376 0.00016909 
ETV4 -2.080386428 0.0000317 
SLC35F3 -2.079776176 0.0000322 
CRABP2 -2.078102979 0.000116978 
KCNMA1 -2.076545277 0.000403127 
AC109642.1 -2.076026426 0.006765439 
ATCAY -2.075964004 0.000000517 
SGOL1 -2.074550197 0.000000774 
FBXO43 -2.072747461 0.006625009 
TMEM119 -2.072428559 2.37E-08 
RP11-
686D22.3 
-2.07237848 0.000616602 
NFIX -2.071397297 1.35E-17 
MRGPRF -2.071241264 0.00000345 
LOXL4 -2.069725536 2.22E-08 
CREB5 -2.067509004 0.000000489 
CIT -2.066646783 0.00000578 
RP11-
597D13.7 
-2.065650849 0.001883486 
MIAT -2.059690778 0.000617955 
MCM7 -2.058242981 2.88E-10 
PLCH1 -2.055381194 0.00000456 
NUAK1 -2.054327639 1.33E-11 
CADPS -2.05376396 0.000255413 
  
240 
 
GINS4 -2.053727295 2.19E-09 
IL17RD -2.051129968 0.00000859 
ACBD7 -2.047215239 0.002613015 
SSPN -2.046301304 9.86E-08 
APOL3 -2.042176051 0.000000533 
HELLS -2.041555355 8.21E-14 
NFE2L3 -2.037530469 1.31E-09 
C8orf34 -2.034864051 0.00135787 
CDC45 -2.033516062 0.000000179 
RECQL4 -2.03291442 3.65E-08 
SYNPO2 -2.030453525 4.65E-15 
FGF17 -2.021140331 0.003960524 
TRIP13 -2.017705266 1.16E-12 
MPPED2 -2.014741891 0.005830251 
RP11-
567M16.1 
-2.001347621 0.002749451 
PREX1 -2.001048423 3.69E-12 
LIG1 -2.000529633 0.00000242 
WFDC1 -2.000035491 4E-10 
RP11-
355I22.7 
-1.996607518 0.006327423 
SLC7A4 -1.995333838 0.000742676 
CASS4 -1.995056326 0.011440371 
GRIA1 -1.991944274 3.42E-10 
HYDIN -1.991895351 0.000000325 
MEX3A -1.990570326 0.0000426 
DPY19L2P4 -1.988655744 0.011700205 
MMP11 -1.988604124 0.008111229 
CCNA2 -1.987248522 3.72E-16 
ADAMTS6 -1.982030154 1.76E-12 
LINC00865 -1.978518562 1.74E-08 
ACTG2 -1.977661141 1.87E-10 
FAT1 -1.976684522 7.1E-10 
  
241 
 
JPH2 -1.97536599 1.53E-11 
DIRAS1 -1.97253106 0.0000004 
ZNF853 -1.970571751 0.000000255 
PMAIP1 -1.968399362 0.0000352 
MARK1 -1.967200641 9.12E-08 
TRAC -1.964563894 0.011549905 
LINC00920 -1.961645081 0.009086035 
RP11-
253E3.3 
-1.961549871 0.0000268 
BBC3 -1.96118209 0.000136263 
RP11-
268J15.5 
-1.960057795 0.000000696 
WTAPP1 -1.959000805 0.008175978 
KIF20B -1.956395893 3.97E-13 
KIAA1524 -1.954749061 8.52E-12 
RP11-
617D20.1 
-1.953872057 0.003194924 
PABPC4L -1.951433807 0.000000993 
ARL4C -1.950777366 0.000219631 
MSC -1.950485075 0.000000603 
MKX -1.949885089 0.001232259 
VANGL2 -1.946924773 0.00000282 
FZD7 -1.946408213 0.0000182 
RUNX2 -1.943965268 0.0000449 
PDZD4 -1.938897662 0.0000647 
HMMR -1.937881597 1.23E-10 
ZSWIM4 -1.93670169 0.00000027 
DYRK2 -1.936550813 3.31E-14 
RAC2 -1.935924562 0.001116274 
CAV1 -1.933403705 1.3E-11 
SPEG -1.929911132 0.000000015 
XRCC2 -1.929316382 0.0000064 
E2F1 -1.927780115 0.000000683 
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CENPM -1.927533499 0.0000194 
GBP2 -1.926595108 2.98E-09 
VEGFC -1.923791131 7.53E-16 
TRAIP -1.923010562 0.0000257 
HCAR1 -1.922036067 0.010227421 
FANCA -1.920729548 6.66E-09 
SCN5A -1.919804766 0.0000123 
GAL3ST4 -1.917511439 0.000139598 
SERTAD4-
AS1 
-1.916954057 0.014866845 
FAR2 -1.916097097 1.47E-11 
EPB41 -1.915412376 0.000350185 
PSG1 -1.914284258 0.007666882 
AC096677.1 -1.913395871 0.009081171 
RP11-60L3.1 -1.912369603 0.004841773 
CTC-301O7.4 -1.91190995 0.000913528 
LIN7A -1.911016772 8.54E-09 
KIAA1683 -1.910892544 1.75E-09 
THSD1 -1.91031867 0.005677119 
TGFB3 -1.899001275 0.00024946 
FMO3 -1.897878764 0.013304985 
RP11-
141M1.3 
-1.897824076 0.013176646 
ACKR4 -1.892517339 0.003298757 
AC112721.2 -1.892371892 0.014249004 
GREM1 -1.891026865 0.012176514 
NEFL -1.890870589 0.004033896 
FAM211A -1.887511971 0.000000643 
SLC9A7 -1.88685015 0.00000236 
FRMD6 -1.885244063 1.25E-10 
GINS1 -1.883473084 0.000000022 
CCDC14 -1.883381565 5.6E-10 
FGL2 -1.882812898 0.006620856 
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RNU2-52P -1.881230061 0.017129922 
F2RL2 -1.881214195 8.97E-14 
LRRC8C -1.880597303 0.0000472 
DAPK2 -1.878658283 0.0000672 
DCAF12L2 -1.878595921 0.005014279 
NXPH3 -1.878055992 0.000115543 
SCN9A -1.876730197 0.001504701 
CCDC144CP -1.876193306 0.002903279 
HMGA2 -1.875666932 0.000366307 
C10orf105 -1.873162701 0.010336008 
SCN8A -1.872845873 4.08E-08 
PSRC1 -1.869171472 0.000000739 
SLC26A10 -1.868488027 0.0000221 
CENPK -1.868265253 0.00000107 
PCK2 -1.867643111 0.00000247 
PPARGC1B -1.867139173 0.0000738 
GPR137C -1.866199668 0.000761738 
LYPD6B -1.866192927 0.018022636 
ROR1 -1.864768542 4.54E-11 
CCDC3 -1.863388399 0.0000358 
DES -1.863220615 0.000000801 
OLR1 -1.862006401 5.07E-08 
CEACAM19 -1.859660433 5.15E-14 
ARHGAP11B -1.857594156 0.000000084 
RP11-
286H15.1 
-1.856248991 0.010777556 
RP11-
247C2.2 
-1.851388426 0.005193945 
CHAF1B -1.849703914 0.000000285 
TMEM179 -1.848532038 0.001975116 
MPZ -1.848497285 0.000572506 
CCNB1 -1.846246557 1.05E-11 
TUBB8P4 -1.846232372 0.0192896 
  
244 
 
XKR5 -1.845863187 0.007856124 
NEURL1B -1.845803546 0.0000355 
USP32P1 -1.842980926 0.00253844 
PLN -1.841838937 0.004614065 
SFRP4 -1.83788442 0.00000304 
IFNA6 -1.837880757 0.014739652 
GBP3 -1.836634573 2.07E-10 
PALLD -1.83603568 5.02E-16 
SEMA3D -1.835610768 0.000045 
PPFIA4 -1.832693756 0.000129416 
WDR62 -1.832325732 0.00000234 
AMOT -1.830689368 0.0000063 
PKD1L1 -1.829997864 0.000204581 
LOXL1 -1.829891462 9.89E-18 
C21orf58 -1.828221021 0.000000459 
DOCK11 -1.828123864 1.57E-16 
APOBEC3B -1.828029048 0.0000472 
MAD2L1 -1.827297765 3.99E-10 
ARSI -1.826719383 0.0000179 
MMP9 -1.825552403 0.006680274 
KIF26A -1.82432201 4.2E-14 
RP11-
181G12.2 
-1.823513942 0.000814228 
GOLGA2P7 -1.822313694 7.79E-08 
C18orf54 -1.821578505 0.000000036 
AP000349.1 -1.820473363 0.011836815 
DMC1 -1.817454667 0.00955226 
MCM2 -1.817325909 2.87E-14 
FAM198B -1.812823038 0.0000663 
CTD-
2231H16.1 
-1.811141353 0.01817454 
TMSB15A -1.810943725 0.000245525 
CCL7 -1.808403526 0.017448233 
  
245 
 
MTMR9LP -1.807722446 0.00000544 
GRIK5 -1.807200573 0.0000954 
MYOM1 -1.807114506 0.004974024 
TMPO -1.80215813 3.75E-10 
FLNC -1.800326892 3.69E-09 
KLK6 -1.800322448 0.005601325 
USP44 -1.800303636 0.000218816 
CCDC74A -1.800080301 0.0000435 
MDGA1 -1.799728979 3.33E-09 
SRPK3 -1.798510852 0.019341211 
FGF1 -1.798010233 0.000127062 
AK5 -1.795712273 0.022826358 
C11orf87 -1.792200284 0.00245873 
POLE2 -1.78977476 0.000611249 
PTPLAD2 -1.789772284 3.11E-10 
RP11-
685N10.1 
-1.789116808 0.017994533 
RP11-32B5.1 -1.788454011 0.003113509 
CPE -1.788442486 0.0000931 
ANGPTL2 -1.788043611 0.0000544 
SKA1 -1.787536914 0.00000324 
RP11-
527D7.1 
-1.786571949 0.011006191 
KLF2 -1.786497626 0.008051672 
NRIP2 -1.785762169 0.017728445 
SLA -1.78573073 0.000963978 
VSTM5 -1.78295722 0.012060274 
GAS2L3 -1.780834517 1.99E-08 
RP11-
222A11.1 
-1.77961457 0.004799796 
AC073046.25 -1.775118993 0.022348384 
RNU6-26P -1.770551692 0.023113799 
PCDH7 -1.769437795 2.91E-10 
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APLN -1.76830577 0.011371444 
RP11-
448G15.3 
-1.765052435 0.00000581 
CASKIN1 -1.763247907 0.01465852 
FANCI -1.762243699 3.3E-14 
HS3ST5 -1.759193538 0.007741988 
SNORD116-
20 
-1.758500296 0.001794279 
TRIM22 -1.758085411 0.000000388 
PSD2 -1.7580503 0.003981133 
RP1-
122P22.2 
-1.755253269 0.004110115 
DRAXIN -1.750505849 0.017223147 
MOXD1 -1.749189103 0.0000388 
TSPAN11 -1.749101725 0.000292461 
RTKN2 -1.745749387 4.32E-09 
RMI2 -1.742682343 0.00000566 
PRICKLE1 -1.741837149 5.62E-13 
ARHGAP29 -1.74020055 0.000856342 
PEAK1 -1.73650316 5.91E-11 
SHF -1.73510917 0.000565903 
NIPAL1 -1.733802347 0.000360891 
ADORA1 -1.7330717 0.001408875 
ANK1 -1.732827685 0.0000497 
NPBWR1 -1.732286575 0.017906909 
GJC2 -1.731255805 0.005167043 
EPHB3 -1.729023239 0.000000112 
C7orf57 -1.727852627 0.02798049 
TMEM132E -1.724620555 0.027000018 
TRIM59 -1.723766706 0.00000592 
ACTA2-AS1 -1.723561158 0.000576473 
TRIB2 -1.720899286 0.000000473 
ZWINT -1.720865007 4.32E-08 
  
247 
 
LRFN5 -1.72045189 0.0000335 
RAB39B -1.718522805 0.019316687 
C9orf106 -1.715869013 0.02573332 
GRIP1 -1.715550214 0.000021 
NHSL2 -1.715119581 0.005966732 
SH2B3 -1.713784046 1.1E-12 
CADM4 -1.712784048 0.00000455 
DCHS1 -1.712332019 1.82E-09 
MCM4 -1.712241941 9.61E-12 
CAMK2B -1.711896429 0.029812243 
PTTG1 -1.711786302 9.11E-10 
FLNB -1.70698703 1.48E-08 
CAMK4 -1.706056633 0.003752318 
CHDH -1.705938677 0.006003894 
MICAL3 -1.705415896 6.98E-11 
GSG2 -1.704088815 0.000358196 
ARHGAP25 -1.703116022 0.001647108 
XK -1.700723436 0.004310226 
ITGA7 -1.699735264 0.000225809 
ADRA2A -1.697015859 0.03129121 
NEDD4L -1.696593454 0.0000699 
CTD-
2078B5.2 
-1.695415144 0.03020842 
RP11-20I23.8 -1.695195966 0.000132832 
DLEU2 -1.695185218 0.003959935 
ISLR2 -1.694964387 0.0000102 
AP001476.2 -1.692425771 0.023398745 
SH2D5 -1.692328473 0.003513456 
PCDH18 -1.687480488 1.31E-14 
MIR181A2HG -1.68612028 0.002150866 
GPC2 -1.685960472 0.000176234 
TMEM215 -1.68435687 0.015310482 
NAV1 -1.682993442 2.47E-08 
  
248 
 
NMT2 -1.682722095 1.43E-13 
RP1-
170O19.14 
-1.681957207 0.011076567 
CST1 -1.680962328 0.000000707 
ADAM19 -1.679805175 1.46E-14 
RFC3 -1.677535287 6.56E-10 
ADAMTS10 -1.676892793 0.000077 
AGAP2 -1.676820528 0.015685399 
AC004893.11 -1.676005119 0.001306439 
HSD17B2 -1.673541288 0.001598932 
KRT34 -1.672966874 0.00000264 
FZD8 -1.672653261 0.000288208 
RP11-87H9.3 -1.669927259 0.033915922 
PTGFRN -1.66891837 8.25E-10 
MIR503 -1.667480753 0.034518011 
SGCG -1.6671746 0.008964827 
CHRNA1 -1.664578872 0.034382718 
ALDH1L2 -1.6640022 5E-10 
PPP2R2B -1.663594296 0.030800635 
ETV5 -1.662293651 7.94E-08 
GXYLT2 -1.661920008 0.0000332 
MB21D2 -1.661652215 0.00000785 
BMP6 -1.661616821 0.019514548 
GPC4 -1.659712398 0.001158888 
TMEM173 -1.659445151 0.0000017 
ZNF385D -1.659345827 0.030099417 
SPTBN2 -1.657973416 0.000246614 
PDE6G -1.657513675 0.029238427 
SYNJ2 -1.657025058 0.0000401 
MTHFD2 -1.657005597 0.00000154 
MND1 -1.654556269 0.012990893 
PGM5P2 -1.654345356 0.032709851 
HBEGF -1.652849402 0.000326046 
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CEP78 -1.651638587 2.45E-08 
MGARP -1.651068213 0.000490408 
SBK1 -1.650711437 0.01443076 
RGMA -1.650670414 0.000233774 
NUDT10 -1.650532493 0.000555501 
RP11-
597D13.9 
-1.649734998 0.0000145 
POC1A -1.649302087 0.0000042 
ZFP69B -1.647691096 0.000165893 
WNT2B -1.643244118 0.003507653 
DLG3 -1.642546546 0.000000472 
DCLK2 -1.64215165 0.00000578 
EPPK1 -1.640091166 0.008732266 
UNC5B -1.639755011 3.81E-13 
SOX8 -1.639634415 0.027135821 
PHC1P1 -1.639267514 0.002762733 
TCF7 -1.638917029 0.0000158 
ATP10A -1.638372307 0.000669216 
CNIH2 -1.633551762 0.01485785 
ETV1 -1.629130871 0.034298246 
SYDE2 -1.628796786 0.000000843 
TANC1 -1.628720787 1.22E-11 
AC006115.3 -1.628635998 0.030546688 
ENAH -1.628162787 7.57E-16 
EDA2R -1.628104984 0.00000153 
LINC00862 -1.627814807 0.020210732 
LINC00993 -1.62771216 0.032728566 
KLHL4 -1.624113303 0.034556089 
DRAM1 -1.623083633 7.95E-12 
LEF1 -1.622431864 0.002807537 
FAIM3 -1.621839898 0.010769048 
FILIP1L -1.621673448 3.62E-17 
SOX6 -1.621643913 1.04E-08 
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TNFRSF10C -1.620792639 0.00046929 
FAM19A2 -1.620424387 0.0000537 
RP11-
445H22.4 
-1.620026123 0.039458475 
TCF7L1 -1.61946676 4.43E-09 
KCNG1 -1.618699124 0.0000123 
SH3D21 -1.617139599 0.0000585 
FAXC -1.615432034 0.004641804 
IQCJ-SCHIP1 -1.614815648 0.00052 
RP11-
383H13.1 
-1.613844065 7.24E-09 
GLYATL2 -1.613412372 0.035711589 
RP4-
791M13.3 
-1.613360452 0.017968122 
CDC42EP3 -1.612880145 7.11E-17 
RP11-
283G6.3 
-1.610943626 0.035752558 
NRGN -1.608963903 0.012337824 
AF186192.5 -1.608240507 0.041270455 
CDH10 -1.607421759 0.026555053 
ASB2 -1.606319826 0.008580819 
LINC00900 -1.603852562 0.036317376 
SACS -1.603313133 6.4E-13 
PRSS12 -1.601901593 0.0000158 
RP11-
381E24.1 
-1.601390758 0.036337694 
HPSE2 -1.601310901 0.000560421 
KIF24 -1.599637473 0.0000323 
RP11-
1109F11.3 
-1.598207404 0.023406044 
GLIS3 -1.597753021 0.000488311 
BMP7 -1.595226462 0.020270206 
CACNA2D2 -1.593408508 0.016975389 
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RP11-
424C20.2 
-1.593126561 0.016866107 
FABP4 -1.591296184 0.000334233 
STOX1 -1.589855479 0.01674256 
RP11-
404P21.5 
-1.589551131 0.042512851 
MCOLN3 -1.589424601 0.000323894 
TRHDE-AS1 -1.586109168 0.031898047 
ELOVL2 -1.584624849 0.04365474 
TACC1P1 -1.583128231 0.038693541 
GALNT16 -1.581054592 0.038396279 
LINGO1 -1.577672542 0.018662404 
HMGA1 -1.577583927 0.000118675 
THBS1 -1.574846823 0.029258293 
FHL3 -1.574142333 9.21E-08 
TGIF2 -1.57305238 0.0000247 
OSBPL6 -1.572264764 0.00072271 
DHRS11 -1.571941918 0.00025779 
OLFML1 -1.571686967 0.0000211 
ZNF93 -1.569930194 0.00000462 
NPAS3 -1.569767814 0.002551559 
AJUBA -1.569338449 0.000489331 
COL11A1 -1.5690582 0.04657872 
PPME1 -1.568702433 4.95E-11 
RP1-
170O19.20 
-1.568621785 0.011669399 
AHRR -1.566767297 2.98E-10 
ACVRL1 -1.566358766 0.0000223 
RP11-
540A21.2 
-1.566175208 0.001503159 
ARHGAP28 -1.566013388 0.002403906 
PTGIS -1.565773143 0.044445264 
LRRC2 -1.565291004 0.000187532 
  
252 
 
RP11-
366L5.1 
-1.565010378 0.041578717 
BACH2 -1.56464702 0.003266105 
PTCH2 -1.562532006 0.001493651 
RSPO2 -1.562079473 0.037414751 
DBF4B -1.559554259 0.00000539 
IFNA2 -1.557574195 0.041383462 
SLC25A37 -1.557547739 3.48E-11 
CELSR2 -1.557132312 0.002582317 
RP5-858B6.3 -1.555412204 0.045521957 
ARHGEF39 -1.555198987 0.000835335 
CENPO -1.554432965 0.000000026 
RHEBL1 -1.554310536 0.003494227 
RAPGEFL1 -1.551184821 0.0000733 
LINC00908 -1.547372287 0.000518881 
CDHR3 -1.54708137 0.002321191 
SLC1A4 -1.544842525 0.00000172 
PTN -1.543314208 0.0000777 
CDH2 -1.542189852 0.000000891 
PYROXD2 -1.541948398 3.32E-10 
ESPL1 -1.53843873 0.000000927 
CDC25A -1.538318341 0.000268729 
DOK3 -1.538023688 0.004585771 
SGK223 -1.536944578 0.00000141 
AKNA -1.536347406 7.27E-11 
PKN3 -1.535201427 0.000142514 
EVA1A -1.535121079 0.001162841 
GPR63 -1.531917986 0.033571953 
HOXA13 -1.531695757 0.0000459 
LPHN2 -1.530283137 0.0000163 
RAD51 -1.529349107 0.00000752 
CPEB2 -1.52866417 8.21E-12 
ST5 -1.527230275 9.08E-11 
  
253 
 
CCDC144A -1.525566948 0.013772522 
RP11-
695J4.2 
-1.525560188 0.001883518 
NOTCH1 -1.524473055 6.7E-12 
CALML4 -1.523222336 0.00036323 
CEP128 -1.521449918 0.000279471 
TCEA1P2 -1.521375356 0.004219699 
TCL6 -1.521346383 0.001589244 
CTD-
2015H6.3 
-1.520943546 0.002244243 
RP11-
177H13.2 
-1.520113457 0.007780136 
AURKA -1.516774841 2.49E-09 
SGIP1 -1.514044604 0.0000532 
IRF2BPL -1.513709401 0.000000496 
EDIL3 -1.511913965 0.000000447 
RP11-
713M15.2 
-1.511847203 0.033965571 
FLT1 -1.511017259 0.001144879 
HDAC5 -1.509721703 5.29E-08 
DSCC1 -1.509211651 0.0000372 
MEX3B -1.508899987 0.000585966 
NBPF3 -1.50874211 0.0000195 
CLIC3 -1.508697785 0.008345039 
CRNDE -1.508655047 0.006539222 
PDGFB -1.508436245 0.002761168 
FZD2 -1.507952885 4.02E-11 
PTOV1-AS1 -1.507338916 0.004084377 
RP11-
757G1.6 
-1.505462904 0.008346365 
CSMD2 -1.505175463 0.000121291 
C1RL-AS1 -1.504551821 0.0000493 
N4BP2L1 -1.504444466 0.003234086 
  
254 
 
AMOTL1 -1.504166592 0.00000541 
PARD3B -1.501648786 0.0000151 
ABCA9 -1.501594696 0.047124647 
ZNF33B -1.501374816 0.000857743 
CDKL5 -1.50120498 0.002536277 
FBXO5 -1.501190079 9.37E-08 
CTD-
2033D15.1 
-1.500321745 0.026432252 
GDPD3 -1.50011567 0.005445737 
UHRF1BP1 -1.499366112 1.29E-08 
STRIP2 -1.498181069 0.002095304 
KLHL29 -1.49683536 0.0000136 
DENND2A -1.493973043 0.000000295 
PELI2 -1.491003595 3.37E-08 
EME1 -1.490200542 0.004004551 
ANKRD34A -1.489963569 0.001567841 
B4GALT6 -1.489196358 0.000002 
NACAD -1.488933234 0.000000052 
WI2-
3658N16.1 
-1.487581685 0.000469256 
HS6ST2 -1.486934847 0.039265471 
RP11-
863P13.3 
-1.486474033 0.037961376 
GCNT4 -1.486113463 3.51E-09 
KLF12 -1.485180198 0.0000334 
ASXL3 -1.484982554 0.042502922 
RAB15 -1.48420716 0.0000291 
TNFRSF4 -1.482660614 0.023299639 
GNB3 -1.478152688 0.000556614 
MEST -1.478132602 1.67E-10 
USP32P3 -1.477547429 0.001497884 
TAGLN -1.476697993 9.79E-16 
GRM4 -1.476624635 0.039242738 
  
255 
 
PHLPP1 -1.472823683 0.0000137 
CENPE -1.471859128 8.45E-08 
RP11-
125B21.2 
-1.469309114 0.041027316 
GABRQ -1.468021248 0.018465657 
LINC00622 -1.467128794 0.032413276 
RP11-
309G3.3 
-1.46624281 0.00519144 
ICA1L -1.465032203 0.0000092 
FIGNL1 -1.463965944 0.00000692 
PLEKHG4B -1.463618555 0.013027632 
UBA7 -1.463494723 0.000000808 
APOL2 -1.463335989 0.0000591 
FANCB -1.462948376 0.001861117 
DNM3OS -1.459711421 3.6E-09 
ZNF496 -1.4596419 0.000000187 
SPRED2 -1.459300317 6.11E-10 
SMAGP -1.458484637 0.004253701 
SLC8A1 -1.457421675 0.000806803 
KIRREL -1.455398426 0.000000038 
MMS22L -1.454439087 0.000000986 
IKBKE -1.454407118 0.000000139 
KCND1 -1.453802555 0.000585458 
RP11-2E11.9 -1.451197904 0.021900292 
GOLGA2P5 -1.449698402 0.026338865 
MYH9 -1.44952182 5.03E-14 
LPPR3 -1.449283547 0.036930063 
RIMS1 -1.449156673 0.004452538 
SLC4A8 -1.447910891 0.001883194 
C1QTNF9B-
AS1 
-1.44761888 0.000245651 
MSH2 -1.446372951 0.00000156 
SPDL1 -1.446133877 6.44E-09 
  
256 
 
HEG1 -1.445109492 3.96E-08 
RGS10 -1.442616314 0.000000709 
ARHGEF6 -1.441579487 0.000000472 
KAZN -1.440779098 0.0000752 
C18orf56 -1.440184479 0.0357386 
SLC9A7P1 -1.438320261 0.026467991 
HAS2 -1.437163925 0.001614362 
BMP4 -1.43679476 0.0020705 
CASP12 -1.434917743 0.038100334 
LRRC37A4P -1.434687205 0.010096788 
IFIT2 -1.433534172 0.001930176 
CKAP2L -1.432096109 0.00108021 
TNC -1.431099019 0.005179574 
THBS2 -1.430939208 0.000846517 
DGKI -1.429954503 0.00000151 
SLC23A3 -1.429947864 0.011215685 
CTGF -1.428736105 0.0000218 
ARHGAP18 -1.428434511 0.000000153 
PDCD1LG2 -1.42840129 0.0000194 
NR2F1 -1.427948689 2.07E-10 
LOXL2 -1.425555377 4.31E-15 
RP11-
395P17.3 
-1.425157991 0.001939848 
FABP3 -1.423115615 0.001106293 
AF001548.5 -1.422515756 0.003754984 
TACC3 -1.421840234 0.00001 
ICOSLG -1.421497291 0.004166209 
CMKLR1 -1.421460554 0.037647857 
TENM3 -1.420721855 0.000000552 
MIR4442 -1.420698902 0.030211827 
MAP3K14 -1.420159166 0.000328164 
GSDMB -1.419359195 0.0000061 
TMEM144 -1.418295588 0.00047431 
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ABCB4 -1.418088052 0.029839818 
RFX2 -1.41724588 0.0000607 
ZNF300 -1.416859975 0.0000289 
KRT15 -1.416079386 0.019112937 
RUNX1 -1.415714938 1.72E-08 
CECR2 -1.415476101 0.038795867 
RP11-
474B16.1 
-1.415295468 0.026658804 
PHC1 -1.414574124 1.58E-08 
SLFN13 -1.410978498 0.00365457 
TCEA3 -1.410908569 0.00117969 
IL18BP -1.41076464 0.000893833 
PABPC1L -1.408430963 0.000000276 
MTL5 -1.408308299 0.041261491 
MCF2L2 -1.404201856 0.007681263 
PPFIBP2 -1.403062534 0.000966173 
RP5-
1043L13.1 
-1.402221832 0.002468038 
ST8SIA1 -1.401944478 0.00379539 
DACH1 -1.401449425 0.003641002 
PDLIM7 -1.400273022 0.00000007 
LINC01116 -1.398624739 0.004634583 
RP11-
134G8.8 
-1.398412559 0.00946113 
C9orf47 -1.39788861 0.00175172 
TRANK1 -1.396248833 0.00000262 
ARHGAP26 -1.39601779 0.005866679 
UGCG -1.395370101 0.000151035 
AC144831.1 -1.391720847 0.032485191 
ORC1 -1.391151079 0.005251692 
SLC27A6 -1.389706612 0.025406767 
WARS -1.3890727 1.79E-08 
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RP11-
999E24.3 
-1.388110775 0.006519942 
AMH -1.387829199 0.035640527 
CACNA1H -1.387353784 0.00000485 
CEBPG -1.385313748 0.0000341 
NEU3 -1.385192963 0.002907857 
WHSC1 -1.383451572 2.84E-12 
AC093642.5 -1.383274301 0.0324671 
PFKP -1.382357607 0.000132586 
NBPF11 -1.382007525 0.045654275 
AIF1L -1.381769163 0.000000379 
SIX4 -1.381323772 0.00000063 
KRT18 -1.380679015 0.005576733 
CCNF -1.378582938 0.0000113 
GPR124 -1.377223148 0.000190463 
CCND1 -1.37716183 6.45E-08 
FAM13A-AS1 -1.376423268 0.006727188 
RP11-
748H22.1 
-1.37609713 0.045883769 
FAM169A -1.374336434 0.000483395 
RP11-
696N14.1 
-1.37424795 0.0000449 
IER5 -1.372717668 0.000275909 
KLF5 -1.372644618 0.000193684 
MAP6D1 -1.372566507 0.003773796 
HMGB3 -1.372565209 0.000670635 
NEXN -1.37244988 0.000210982 
BCL7A -1.371382297 0.003200792 
RP1-152L7.5 -1.369927388 0.00000747 
SPRY2 -1.368542649 8.61E-08 
EGR3 -1.367644087 0.003896868 
DEPDC1B -1.367602077 0.020088487 
INCA1 -1.365761935 0.008794831 
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KLRAP1 -1.363849765 0.003203857 
ACVR2B-AS1 -1.362625786 0.028123354 
FOXF1 -1.361150196 0.012797529 
WDR76 -1.360826551 0.00000107 
CCDC85C -1.360488229 0.001147627 
C19orf57 -1.358467595 0.03643936 
RP11-
686D22.7 
-1.357858612 0.000137443 
ANKRD53 -1.35718578 0.037592942 
ATXN7L2 -1.357013386 0.0000316 
HIC1 -1.356934547 0.00000133 
C5 -1.356634098 0.001018251 
MYBL1 -1.354916666 0.0000453 
ST7-AS1 -1.354765876 0.008404221 
RPLP0P2 -1.354762699 0.045941518 
TIMELESS -1.354621517 2.26E-08 
RARB -1.354122753 0.000812739 
BDNF -1.353318959 0.027321426 
AC005943.5 -1.352821697 0.001470724 
RPL29P19 -1.351839076 0.023303643 
CNNM1 -1.351611465 0.000319195 
IFFO2 -1.350890869 0.0000019 
RP11-
259N19.1 
-1.350836638 0.03810824 
CYFIP2 -1.35040911 0.001206655 
ZNF286B -1.350212494 0.00726741 
PRIM1 -1.350204058 0.003679031 
AC092835.2 -1.350146741 0.044676665 
LINC00672 -1.349764696 0.002540465 
RP1-257A7.4 -1.347023943 0.03668313 
KIAA1211 -1.346071862 8.38E-08 
STK33 -1.343589083 0.003483176 
FANCD2 -1.343104279 0.0000463 
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BFSP1 -1.342897594 0.003460643 
LYPD1 -1.342252746 0.041775836 
USP49 -1.341580539 0.0000168 
HECW2 -1.341348177 0.000175352 
CADPS2 -1.340707699 0.0000705 
ZNF827 -1.340037943 0.000000105 
FAM71F2 -1.339806201 0.045628603 
MACF1 -1.339753711 6.76E-09 
TMEM71 -1.338834002 0.034175419 
FAM65B -1.336256072 0.000000145 
SPRY1 -1.33584203 0.0000138 
SMO -1.333723159 0.00000352 
CKAP2 -1.332369307 1.27E-09 
ISYNA1 -1.332040107 0.000258123 
PITX1 -1.331338935 0.007692095 
RP11-
1008C21.2 
-1.330357666 0.014045892 
TET3 -1.329941703 6.18E-09 
CCDC64 -1.329586714 0.013825691 
FOXN3 -1.327862597 0.000000346 
CHML -1.324585194 0.000246822 
SCN2A -1.324165815 0.017296074 
TET1 -1.322807534 0.000427172 
RIMS3 -1.322523985 0.00361921 
ZNF608 -1.321452426 0.000736313 
KIAA1432 -1.319601877 5.84E-11 
ZCCHC18 -1.318769341 0.030482525 
SGMS2 -1.317147487 0.000000204 
HHAT -1.314926443 0.000603718 
APOBEC3G -1.314633808 0.0000449 
NTRK3 -1.314235669 0.008806112 
GAB1 -1.313106911 0.000000884 
DDC8 -1.312874091 0.01960377 
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RGS5 -1.311276071 0.039685962 
VAT1L -1.310036148 0.000873878 
LRRC61 -1.309825088 0.018511246 
BNC2 -1.309372636 0.00000004 
EPHA2 -1.308849479 0.001233901 
GBP5 -1.308549383 0.024648043 
CADM1 -1.307999772 0.00000787 
PMEL -1.307930346 0.023560355 
RP1-
151F17.2 
-1.307181309 0.003705242 
MMP16 -1.30675356 0.000000776 
ASGR1 -1.305923369 0.046656859 
SALL2 -1.301874564 0.000097 
MAST4 -1.300613225 0.0000123 
BZRAP1 -1.299439401 0.000172928 
DTX4 -1.29941053 4.37E-09 
RP11-
582J16.5 
-1.296898943 0.00165944 
RP11-
1055B8.7 
-1.2955117 6.66E-08 
NXNL2 -1.295055803 0.031650643 
VPS9D1-AS1 -1.293581345 0.04504517 
RASL12 -1.29341841 0.015329661 
ICAM1 -1.293004511 0.003339837 
RP11-
1002K11.1 
-1.292929214 0.018167233 
CDK18 -1.292276068 0.001210027 
KLHL30 -1.289754203 0.034954266 
PARP8 -1.288721083 0.000346266 
TRIB3 -1.288698562 5.07E-08 
AQP1 -1.288168612 0.011936472 
BCL9 -1.288133048 0.000000673 
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JMJD7-
PLA2G4B 
-1.285279094 0.004440277 
GUCY1A2 -1.284711172 0.004677331 
NYNRIN -1.28281794 1.24E-09 
MSI1 -1.282314558 0.038941442 
ZNF775 -1.282186599 7.49E-09 
CCDC150 -1.282052888 0.006883051 
ARNT2 -1.282029008 0.001209619 
MMP12 -1.281947583 0.014790328 
MIR27B -1.281717895 0.017963223 
PAFAH1B3 -1.280966127 0.008133925 
ATP1B1 -1.279398008 0.01087965 
ASPHD2 -1.279136494 0.004020732 
PELI1 -1.27838413 0.000316336 
NRG1 -1.278381265 0.022806281 
MCM3 -1.275950981 0.000000022 
CCDC136 -1.274472965 0.000332754 
RP11-
20I23.13 
-1.272799847 0.002492598 
RP11-
46C24.7 
-1.272744149 0.008852312 
ZSWIM5 -1.272448361 0.00000648 
IL27RA -1.272439903 0.000412407 
COLQ -1.272304382 0.001688806 
MMP24 -1.271650554 0.013837135 
POPDC2 -1.268847442 0.030102315 
ITGA6 -1.26742873 0.00000624 
CYYR1 -1.267062719 0.008161676 
CST4 -1.266736469 0.041667649 
RNF125 -1.265724986 0.041162094 
BRCA1 -1.265580225 0.000342491 
TRO -1.264666369 0.000000298 
KHDC1 -1.264064983 0.004452443 
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AC005003.1 -1.263231569 0.041498759 
HIVEP1 -1.263218425 6.02E-08 
ZNF724P -1.262153826 0.035350892 
RUNX1T1 -1.261671785 0.00000433 
ARHGAP31 -1.261247783 8.28E-08 
DNMBP -1.260468962 0.000000071 
PSIP1 -1.259244255 1.16E-08 
CHAF1A -1.259175501 0.00000789 
DSP -1.258532061 0.01521903 
RP11-
617F23.1 
-1.257323171 0.021249836 
COL13A1 -1.257164646 0.001820769 
TP53I11 -1.256929021 1.71E-10 
SH3BP2 -1.256763985 0.0000303 
PRPH2 -1.256359897 0.000208766 
ANKRD36B -1.256006666 0.04171958 
BATF3 -1.255831028 0.032629743 
PDE8B -1.255361587 0.0000868 
BGN -1.254766465 0.000000143 
ULBP1 -1.254751994 0.000703645 
TBKBP1 -1.254476186 0.000362882 
EPHA7 -1.254305005 0.007281265 
USP13 -1.254159866 0.00000131 
PXN -1.252664994 5.61E-09 
RP11-
161M6.2 
-1.251649977 0.039368971 
DCSTAMP -1.251072992 0.044230629 
ACTA2 -1.250267253 9.69E-10 
BAIAP2L1 -1.25026024 0.010162158 
ASNS -1.250156095 0.000396643 
N4BP2 -1.249501652 0.00000165 
TRIO -1.248223273 9.72E-09 
SHMT2 -1.244973596 0.000000256 
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ZBED6CL -1.243997819 0.007270446 
SMC4 -1.243749591 0.000000059 
BCOR -1.243461553 0.000132493 
HSPA12A -1.243247109 0.000000014 
POLD1 -1.241167874 0.0000041 
CTD-
2619J13.9 
-1.240320373 0.026825674 
ZNF215 -1.240159927 0.000543632 
ZNF852 -1.240128069 0.007244884 
SRGAP1 -1.239092114 1.26E-08 
ARHGEF2 -1.238822621 0.00000421 
GBP1 -1.238549292 0.000000995 
CYR61 -1.236688785 0.0000641 
RAPGEF3 -1.234718363 0.027599553 
USP54 -1.233596006 0.0000159 
PKD1P6 -1.232384788 0.002691457 
JAG1 -1.231969043 0.002603744 
FBXL19-AS1 -1.230754245 0.002392063 
ABCG4 -1.230717413 0.049710396 
LINC00936 -1.230712171 0.009335723 
KIF17 -1.229970623 0.019337875 
KLHL5 -1.228753766 0.00000574 
PASK -1.228655189 0.000822771 
MAMDC4 -1.227735197 0.001482269 
LEPR -1.227457599 0.0014979 
ZNF248 -1.227348411 0.000855433 
PCYT1B -1.226050466 0.001189274 
FAM132B -1.223946207 0.036557682 
GEM -1.223537932 0.002393337 
ANKRD36 -1.222302848 0.000997695 
PER2 -1.221153884 0.0000723 
TRIM6 -1.220915865 0.005346217 
ZNF33A -1.220035558 0.001259881 
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TIFA -1.219918591 0.002271154 
FAM129A -1.219714458 0.020853258 
SATB1 -1.218988401 0.000000442 
RP11-
1114A5.4 
-1.218117599 0.025719132 
PHTF2 -1.217394833 3.6E-09 
A2M-AS1 -1.215887657 0.02475154 
TNS3 -1.215704937 7.16E-08 
SPRY4 -1.214394363 0.000195127 
DLC1 -1.214003512 7.79E-09 
TNFRSF12A -1.213588332 0.010382058 
MXD3 -1.212415208 0.000118109 
TNFRSF10B -1.212130053 0.0000676 
CAMK2N2 -1.212046787 0.034775701 
NNAT -1.211327206 0.020136036 
ZWILCH -1.211298793 0.000000164 
ITPRIP -1.210954843 0.00436897 
GNPTAB -1.208103696 0.0000077 
TMED10P2 -1.207201996 0.031449302 
TMEM25 -1.207070023 0.003699968 
FAM78A -1.20673162 0.00235961 
SVEP1 -1.20609739 0.0000751 
HOXD9 -1.205121715 0.000000837 
NBPF1 -1.202410191 0.00000575 
CTD-
3099C6.9 
-1.202402345 0.042359789 
CDK2 -1.202346531 0.0000232 
C3orf67 -1.201197551 0.04394658 
MFAP2 -1.200760549 0.007426188 
INA -1.200573942 0.005243267 
TRAM2 -1.19988506 0.00000996 
ADCY10P1 -1.199523472 0.004912362 
SLC7A1 -1.198908375 0.000000023 
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ALS2CL -1.198898665 0.000676618 
COL27A1 -1.198196469 0.000117795 
GRIK2 -1.196124247 0.004661553 
FRAS1 -1.196097325 0.007292314 
FRY -1.194695455 8.74E-08 
CCDC18 -1.19319172 0.00136731 
CHRNA5 -1.192585393 0.035349048 
ZNF730 -1.192411318 0.04248736 
RBFOX2 -1.19156249 2.92E-08 
TMEM158 -1.190050638 0.001028084 
RP4-565E6.1 -1.188834088 0.007002391 
HMGB2 -1.188083083 0.0000283 
TMEM26 -1.187967834 0.001608951 
CNN1 -1.187600711 5.46E-08 
FEN1 -1.185363088 0.00000222 
ARNTL2 -1.184756554 0.0000894 
SAMD12 -1.184094847 0.015165964 
GSG1 -1.182493827 0.041906944 
ASTN2 -1.181508543 0.000187494 
KCNT2 -1.181294189 0.026462531 
GPT2 -1.181247427 0.0000239 
FAM227A -1.180568971 0.003229582 
RP1-
228H13.5 
-1.18049339 0.000914576 
LMO2 -1.179274689 0.046212397 
RP11-
958N24.1 
-1.178708581 0.008778984 
FHDC1 -1.176484991 0.004009785 
NFIC -1.176299496 6.68E-10 
NAV2 -1.176141023 0.001325734 
PIK3CD -1.17578646 5.25E-08 
COL11A2 -1.175487692 0.01278411 
CCNJL -1.175304048 0.000937345 
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NBPF12 -1.175210868 0.000106911 
CAP2 -1.173834003 0.0000795 
CACNA1A -1.172747402 0.019831595 
CBX2 -1.172361832 0.001279255 
FAM171B -1.172228479 0.0000892 
NEO1 -1.171679324 0.00000324 
MEGF6 -1.171088032 0.029066928 
TPBG -1.169710891 0.000046 
ACTN4 -1.16933254 7.86E-10 
DUSP5 -1.168872929 0.017884078 
BARD1 -1.168756381 0.000330992 
AC105020.1 -1.168504116 0.011744936 
RBPMS2 -1.167331814 0.005624776 
RNASEH2A -1.167312265 0.0000272 
CAPRIN2 -1.166670893 0.000340705 
RNF207 -1.165624358 0.000101921 
LASP1 -1.164899278 4.83E-09 
LIMD2 -1.164429599 0.001468516 
MIR214 -1.163749117 0.002512846 
RUSC2 -1.162448379 0.00013797 
SLC7A5 -1.161171942 0.007277869 
MURC -1.160791269 0.042593277 
MTURN -1.160462397 0.002683384 
ARHGEF40 -1.160227042 0.00000176 
TRIM46 -1.159917132 0.002186828 
PAK1 -1.159200941 0.000000215 
FSD1 -1.159140883 0.002731373 
PLEKHG2 -1.15833448 0.00000155 
MET -1.158082501 0.000904674 
TRBC2 -1.157901293 0.02421002 
NLGN3 -1.157543335 0.014477848 
DDB2 -1.156902967 0.0000628 
MCM6 -1.15647677 0.000000765 
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LAMA4 -1.156117037 0.0000143 
RP11-88I18.2 -1.155714697 0.004523915 
STK32A -1.154681504 0.017149707 
KCNH2 -1.154462815 0.0000759 
LIMD1 -1.151760338 0.00000107 
MYO18A -1.151596884 0.000216553 
SLFN11 -1.151305948 0.000201634 
DNMT3A -1.151176722 0.000201881 
KCNS3 -1.150539956 0.007992634 
GLIPR2 -1.150053564 0.0000431 
FAM171A1 -1.149574216 0.000187138 
SOX4 -1.149336469 0.004819044 
CDK19 -1.149102806 0.000163662 
FHL2 -1.147455887 0.0000203 
TBC1D30 -1.147334755 0.036874908 
CRIM1 -1.14632882 0.000000996 
BRD3 -1.146323963 0.000217186 
RP4-
756G23.5 
-1.145620627 0.02899806 
AVPR1A -1.14558315 0.042924433 
KDM2B -1.145391141 0.00000984 
EPHB4 -1.145128178 0.0000967 
HLA-F-AS1 -1.144806493 0.026798598 
CDRT4 -1.144411844 0.029473413 
CHTF18 -1.143637249 0.001046377 
C2CD3 -1.143618031 0.00000821 
PACRG -1.14268526 0.04806388 
DPYSL4 -1.142324224 0.001954333 
SOGA2 -1.142110616 0.0005771 
MAP3K1 -1.142056498 0.000131048 
RP11-
566E18.3 
-1.139559136 0.0000132 
SGOL2 -1.13856315 0.0000673 
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FCHSD2 -1.136947724 0.00000256 
RGS3 -1.136728252 0.000691761 
COCH -1.136336287 0.000210805 
DCLRE1B -1.136326494 0.0000753 
TMEM194A -1.135987087 0.00000132 
NDC80 -1.133264214 0.000528023 
TSPY26P -1.132794286 0.00000618 
FKBP9L -1.132598536 0.008770517 
FUT8 -1.131481078 0.000000031 
MTBP -1.130793374 0.004034171 
VAMP5 -1.130348407 0.001671023 
ZFYVE9 -1.130163167 0.000000622 
ZNF782 -1.129429792 0.006484064 
ZCCHC14 -1.129015541 0.000178437 
RGS9 -1.127668401 0.001287474 
SLC35F2 -1.1274915 0.009890064 
FANCG -1.127206437 0.00000925 
CDC42EP1 -1.126939861 0.0000139 
RP11-
1212A22.1 
-1.12637014 0.014428195 
TRAF5 -1.12615709 0.00000122 
TCF3 -1.125987962 0.0000207 
ITPR3 -1.125381357 0.006595103 
PTPRK -1.124575805 0.00010066 
SHROOM4 -1.123698357 0.001523654 
RP11-
296I10.6 
-1.123204973 0.011902392 
SLC16A14 -1.12305411 0.024420571 
RBL1 -1.120857967 0.000223393 
PARD6G -1.119906733 0.001832317 
CCDC30 -1.119838674 0.034166279 
BHLHE40 -1.119562055 0.000509249 
POLA1 -1.119230156 0.000137117 
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HECTD2 -1.118400746 0.0000471 
NETO1 -1.118370929 0.022795101 
FIGN -1.118048206 0.006588892 
NCAM2 -1.117642603 0.013016414 
PIEZO2 -1.117292343 0.021631813 
LCAT -1.116548998 0.000165121 
TRIM45 -1.115564355 0.000691792 
PEAR1 -1.114158279 0.000101171 
GDF15 -1.113507891 0.000956236 
ZFP36L2 -1.113390402 0.000537559 
CCSAP -1.113342087 0.000315921 
ADAM11 -1.113293802 0.018978886 
CORO1A -1.113148222 0.033034266 
MIS18BP1 -1.111946643 0.000108432 
H19 -1.111927919 0.007002939 
CLUHP3 -1.111855306 0.002292928 
PYGO1 -1.111729829 0.000104343 
PDLIM5 -1.1111692 0.000000174 
PLEKHG1 -1.107771827 0.000462877 
FBLIM1 -1.107267039 0.0000315 
ZNF362 -1.106521037 0.0000242 
CYP1A1 -1.105117456 0.036382833 
SLCO5A1 -1.104476093 0.003502238 
RHBDF2 -1.102277061 0.000221406 
PLCG1 -1.100655673 0.00000816 
DDX12P -1.100158962 0.04442761 
FARP1 -1.099517358 0.000000308 
ANKRD36C -1.099027922 0.014551052 
XPOT -1.097821686 0.000000468 
TRIM47 -1.09671528 0.00122602 
LYPD6 -1.095956724 0.013743517 
ACTN1 -1.095724246 0.000000221 
MPV17L -1.095403014 0.033015631 
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OXTR -1.092966776 0.000253825 
TNS1 -1.091593815 0.000104661 
RP11-
686D22.8 
-1.091565644 0.004280014 
ZMYM3 -1.09134313 0.000000266 
ZNF280B -1.090307584 0.006611919 
TRPC6 -1.090008016 0.000170223 
SOGA1 -1.089100901 0.000000604 
FAM131B -1.088371863 0.001147764 
GJC1 -1.086945128 0.0000166 
DNHD1 -1.085850664 0.000999064 
CDH24 -1.085471588 0.00063774 
GDPD5 -1.085316602 0.0000881 
UBE2T -1.083656822 0.00055181 
SMAD1 -1.083448681 0.0000419 
RP3-
510D11.2 
-1.083002007 0.030356321 
YPEL2 -1.082020462 0.000261445 
FAM85A -1.081126968 0.00416424 
GALNT6 -1.079665834 0.02079754 
HOXB3 -1.078524862 0.004159137 
RCC2 -1.078410247 0.000221127 
CIDEB -1.077703057 0.010893043 
KIF22 -1.077530502 0.0000321 
AL591479.1 -1.077245961 0.047467226 
PRDM5 -1.077062464 0.000444282 
PURG -1.076499021 0.019667026 
SPOCD1 -1.07615664 0.000865401 
ARVCF -1.076021018 0.008718021 
PPP1R13L -1.073884195 0.00056412 
ZNF792 -1.07346174 0.009850432 
NFIA -1.073217031 0.000927542 
C2orf27A -1.072596429 0.015164259 
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SYNE2 -1.071817445 0.004954913 
C1orf112 -1.071608884 0.000521399 
POLE -1.071491013 0.0000252 
RP11-
686D22.4 
-1.071088793 0.022300192 
MARS -1.070559287 0.0000106 
PATZ1 -1.070350184 0.00022409 
LAMA5 -1.068415884 0.00000763 
CTD-
2303H24.2 
-1.06825393 0.023749188 
ADSSL1 -1.068134386 0.017556951 
SH3RF1 -1.067707252 0.003837991 
CNN2 -1.067168107 0.000021 
XRCC3 -1.067148837 0.007830883 
LRRC8B -1.066998618 0.026574184 
LMNB2 -1.066982083 0.00000131 
NCAPD2 -1.06564098 0.0000175 
FZD6 -1.064960017 0.006317521 
ZNF70 -1.064625932 0.002823639 
ZNF445 -1.063563221 0.000000843 
PTRF -1.062217321 0.000000208 
RP11-
91J19.4 
-1.061550638 0.001343376 
LMCD1 -1.060824527 0.010656084 
SAMD14 -1.060594928 0.000277312 
CNIH3 -1.059999208 0.00161139 
SPIN4 -1.059910487 0.001089481 
HSPA12B -1.059907076 0.046093692 
KLF11 -1.059002361 0.003192926 
PSMC3IP -1.058918079 0.000876837 
PHLDA3 -1.05884121 0.014958181 
C21orf91 -1.058435687 0.0000126 
EPHA5 -1.058120727 0.049076699 
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MAP4K5 -1.057689861 0.000685563 
PYCARD -1.057394783 0.008368763 
NLRP1 -1.057087943 0.004626271 
PAXIP1-AS2 -1.056366963 0.020182769 
AMER1 -1.056357344 0.003338261 
DPY19L2P2 -1.056285919 0.043705353 
KIF9-AS1 -1.056015301 0.002864436 
ANO4 -1.054962156 0.043909459 
SLC38A1 -1.054542409 0.0000221 
NEFM -1.054399395 0.010933198 
PLGLA -1.054238932 0.031392285 
PCNA -1.053805502 0.0000641 
FLNA -1.052600437 0.000018 
AC159540.1 -1.05248918 0.000946731 
EHD3 -1.052361776 0.00000519 
ZMAT3 -1.051328292 0.000659477 
DBN1 -1.051250456 0.006786884 
ANKRD13A -1.049319429 0.0000119 
TMSB15B -1.048266108 0.017438993 
KIAA1324L -1.045780736 0.005726442 
CYTH3 -1.042887749 0.0000029 
NFKBIE -1.042709036 0.000465455 
ZNF714 -1.042557684 0.00097083 
FN1 -1.042443407 0.00000465 
SWAP70 -1.042209844 0.000218875 
PTPRJ -1.04088043 0.002124488 
C1QTNF2 -1.040029004 0.029836025 
NPTXR -1.039890396 0.0000183 
TMEM237 -1.039523543 0.0000502 
CARS -1.038009484 0.00000751 
ZNF217 -1.037858153 0.000123553 
ABCC4 -1.037046174 0.00000132 
MKL2 -1.036164386 0.000590451 
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CENPI -1.035135797 0.002979761 
RP11-
383J24.6 
-1.033508827 0.022425999 
SPECC1 -1.032669097 0.002102084 
RMI1 -1.032629472 0.000789099 
TCEAL7 -1.030782692 0.001443588 
ORC2 -1.029965812 0.000621963 
AFAP1L1 -1.029704346 0.001150282 
PKD1P5 -1.028832348 0.014916348 
HCP5 -1.028130342 0.004647442 
PAMR1 -1.027187906 0.003150013 
AC125232.1 -1.025722079 0.019999514 
FGD1 -1.02545259 0.00000238 
SASS6 -1.024865472 0.003211091 
NF1 -1.024856454 0.00000063 
INCENP -1.023891448 0.0000346 
NANOS1 -1.023429121 0.018366556 
KMT2A -1.023277883 0.00000403 
ERF -1.02158642 0.00000674 
B3GALTL -1.021576433 0.001747701 
PMEPA1 -1.021213655 0.033085669 
KMT2E -1.020986328 0.000162622 
PIWIL4 -1.019412275 0.023999684 
EHMT2 -1.019251802 0.0000293 
CDKN1A -1.018002509 0.001996708 
PARD3 -1.017132589 0.002210396 
LDB2 -1.01570263 0.000293129 
GOLGA6L20 -1.015062286 0.01785534 
CDKL1 -1.014635336 0.004629265 
RP11-
698N11.4 
-1.014210345 0.03245145 
PCDHGC3 -1.014021254 0.013081356 
GLI3 -1.013396565 0.00000598 
  
275 
 
SLC20A2 -1.012381853 0.002983501 
NR2F1-AS1 -1.011226759 0.0000174 
TMEM200A -1.010061958 0.000609005 
ATXN7L1 -1.008790677 0.00018566 
ANKRD50 -1.008685596 0.000104994 
CNTRL -1.008494808 0.001884598 
EXT1 -1.008457345 0.000000223 
TCF4 -1.00806519 0.00000344 
SV2A -1.007973786 0.0000065 
AEBP1 -1.007722692 0.0000203 
EXTL1 -1.007362086 0.021566498 
C10orf12 -1.00600794 0.015777561 
TFAP4 -1.005799915 0.006620903 
SLC22A15 -1.005227405 0.012762106 
DTWD2 -1.003067569 0.001348091 
ERCC2 -1.00148498 0.0000251 
ZNF436 -1.000559927 0.000662032 
SPEF2 -1.000452891 0.038311373 
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Appendix 5. Up-regulated genes upon A83-01 treatment: 
Log2-fold change ≥ 1 
 
 
Gene Symbol log2-fold 
change 
q 
DMKN 4.523963536 8.27978E-28 
DPP6 4.447884761 1.34849E-19 
CPVL 4.250279449 4.08576E-18 
STAR 3.999001852 7.5428E-28 
WDR86-AS1 3.988012684 6.38718E-13 
INSC 3.972614236 8.65087E-14 
THBD 3.897921319 6.06721E-14 
NPR1 3.863393913 1.1083E-22 
PLA2G7 3.83005198 1.16967E-22 
CEACAM1 3.641867474 2.00749E-12 
GDF7 3.614411536 3.05962E-18 
CDK18 3.60803325 1.2436E-25 
WNK2 3.506100657 1.04066E-13 
KDR 3.494189986 3.48995E-11 
PDE3B 3.456980678 7.73737E-21 
RRAGD 3.346332525 4.66204E-15 
WDR86 3.33783044 2.72936E-09 
STAC 3.32618256 5.3289E-16 
SCARA5 3.265194702 2.71209E-07 
NR0B1 3.254839379 1.25831E-08 
RARB 3.254517463 1.05697E-33 
EPB41L3 3.24712539 8.10396E-08 
SNX10 3.234557287 1.66061E-18 
ASPA 3.206758651 4.74258E-21 
WISP2 3.203273617 1.35691E-11 
NFIB 3.188784186 1.2835E-14 
PTGES 3.175727149 5.01326E-18 
SLC25A18 3.166413619 1.13659E-23 
TLR3 3.126577806 1.616E-20 
AC012065.7 3.110767063 9.18381E-10 
SPTLC3 3.105330742 1.21654E-10 
AK4 3.067240747 3.21233E-16 
COLEC12 3.050666458 5.93249E-17 
RARRES1 3.034939537 1.27095E-08 
IRAK3 3.024529749 1.58869E-15 
ADORA2B 2.991345949 1.12806E-13 
TMEM132D 2.985047005 5.61955E-06 
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MFI2 2.97843671 1.07552E-22 
SUSD3 2.973538383 1.36158E-11 
HEYL 2.965177293 2.2063E-10 
DOCK8 2.939295355 4.26296E-10 
IL18R1 2.897917158 1.14773E-05 
BIRC7 2.859490391 3.05314E-05 
CARD11 2.84867975 4.68215E-09 
TNFRSF1B 2.834311013 1.09547E-11 
ENPP2 2.806957931 5.55734E-14 
LCP1 2.781189271 1.51376E-06 
CYP1B1 2.772837679 6.77781E-10 
KIAA1199 2.767241795 1.41034E-08 
COL4A3 2.753078616 5.95851E-05 
EMILIN2 2.747028523 9.09765E-17 
SHANK2 2.745602509 2.12864E-05 
RP11-
676J15.1 
2.727317276 5.52855E-05 
FCGR2A 2.726253335 1.27801E-08 
SLC6A12 2.709309964 3.83362E-05 
MALL 2.702227732 4.54745E-14 
EYA4 2.701854815 1.92203E-07 
PCBP3 2.690009113 2.49393E-13 
A2M 2.685826988 4.58496E-10 
IGFBP2 2.682062571 4.16842E-21 
FGF12 2.66710222 1.30051E-05 
ANXA9 2.662632645 3.19569E-08 
CLUL1 2.646851668 0.000143838 
PCDH15 2.6378804 0.000146101 
EPB41L4A 2.626440236 9.83805E-07 
GPM6B 2.612022103 8.16355E-09 
HPSE 2.605262634 3.66991E-09 
HAP1 2.600477197 2.27683E-16 
JAG1 2.599824365 6.096E-13 
WWC1 2.589294338 2.2207E-05 
BEAN1 2.58898313 6.74382E-08 
PKDCC 2.586019047 3.90644E-09 
SLC29A2 2.581876316 6.18842E-08 
ITGAX 2.566678816 2.60427E-05 
CD1D 2.565439561 5.83812E-05 
NKX3-1 2.563516505 3.90031E-07 
GALNT14 2.562490981 5.90425E-05 
FAM134B 2.560937864 3.56057E-10 
PHYHIP 2.543511954 5.18379E-13 
MOB3B 2.520525723 2.07946E-08 
TMEM132B 2.51333156 4.03316E-10 
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HS3ST1 2.504067064 0.000430696 
NUP210 2.496907546 4.98953E-05 
SEC14L6 2.495839368 2.98825E-06 
IGSF10 2.493264337 6.50805E-15 
C12orf68 2.491911348 2.07946E-08 
CRISPLD2 2.486811635 4.2032E-16 
GALNT12 2.479525817 4.00894E-09 
WNK4 2.478640235 1.06225E-15 
SLIT2 2.473951358 7.35122E-15 
IRX6 2.469015342 0.00040394 
GPRIN3 2.468411206 2.51111E-09 
FAM53B-AS1 2.461353726 0.000700851 
GRB7 2.456059026 1.15263E-06 
CA12 2.453152357 4.21463E-05 
ALDH1L1 2.452772946 3.65219E-07 
OVCH1 2.442647096 2.84701E-05 
FOXQ1 2.43845721 0.000213923 
ALDH1A1 2.436511865 6.06834E-07 
RASD1 2.430125164 3.52987E-07 
TGFBR3 2.430091326 1.23317E-22 
ST6GALNAC2 2.428743255 1.46198E-12 
TMTC1 2.426034584 5.84608E-13 
LPAR3 2.420949228 2.67461E-05 
RAB37 2.418521654 0.000304863 
EFEMP1 2.414959522 0.000125276 
SPARCL1 2.411961701 0.000188828 
SNAP25 2.402941015 2.22317E-06 
FAM49A 2.397166601 1.00266E-07 
EVA1C 2.394314513 5.06751E-11 
KCNS2 2.393600715 2.28935E-05 
CLIC6 2.392098494 2.0434E-08 
SLC47A1 2.387770364 1.11859E-07 
PPP2R2B 2.387676432 0.000411282 
STX11 2.374666889 5.4405E-05 
LCN1 2.361756013 0.001356513 
VNN2 2.357695437 0.001097313 
TNK1 2.355294234 1.83822E-05 
ACSL5 2.347195501 2.04579E-18 
PTGS2 2.345045543 0.000358164 
MTSS1 2.345028166 0.000229975 
PRUNE2 2.338687402 2.63245E-07 
GSTA3 2.338421156 0.0003586 
CSF1 2.32912662 8.26615E-21 
LINC00173 2.324517303 0.001089943 
PTPRH 2.323339268 7.69833E-13 
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BAALC 2.314032091 1.73447E-07 
HSD11B1 2.299083588 0.000420319 
TACSTD2 2.292031066 6.06834E-07 
WBSCR27 2.290034976 2.11262E-08 
KRT19 2.289988397 9.44957E-08 
IL1R1 2.286786853 1.55004E-18 
MBP 2.281683096 9.11926E-13 
PRRG4 2.280315786 6.06834E-07 
CEBPD 2.279009202 2.65443E-13 
CHRNA7 2.2722242 0.001131056 
ITGA8 2.265306779 7.06923E-06 
KCP 2.263149919 1.4024E-06 
SEMA3E 2.257695697 0.000327788 
KLHL13 2.250326334 3.61727E-07 
BZRAP1 2.247542371 7.96642E-13 
SYT7 2.245343485 1.83595E-05 
FAM131C 2.239988227 0.000970877 
C2 2.239522183 1.40224E-06 
IGSF9B 2.237634849 0.00296644 
IL22RA1 2.22014095 0.003286968 
TMEM179 2.218808786 0.001967934 
RASL11A 2.218642102 1.52336E-06 
SIGLEC9 2.217268398 0.000204675 
WT1 2.205052539 4.94047E-16 
AC003092.1 2.197358563 0.000229894 
SOD3 2.195734142 1.07211E-08 
AC114730.2 2.194370162 0.00353063 
HAAO 2.192090932 2.82808E-06 
MGAT3 2.191976493 2.40669E-08 
DDO 2.19159744 2.17449E-05 
GAS7 2.189862499 6.28562E-18 
RXFP1 2.173700497 1.95337E-13 
ADIRF 2.167450623 0.000125276 
CCDC64 2.165715653 0.002803297 
ENPEP 2.161418536 4.02974E-11 
SLCO2A1 2.149658578 0.003995374 
VWA1 2.148738069 2.7777E-14 
LLGL2 2.143426419 3.18206E-05 
IGFBP6 2.141735288 3.52079E-11 
CX3CL1 2.135027985 7.06923E-06 
EPHX2 2.130591807 2.60273E-05 
C10orf10 2.130463137 3.59575E-15 
FMNL1 2.128784066 4.84454E-07 
SLC27A2 2.126684912 0.003752742 
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RP11-
359E10.1 
2.122916908 0.000301592 
TTC39A 2.116888593 1.41735E-05 
CELF2 2.116112463 9.24492E-07 
RHBDL3 2.114921136 0.00109169 
CCRL2 2.111913494 0.001371502 
TNXB 2.110264254 9.77476E-06 
RP11-720L2.3 2.110186858 0.003408966 
KCNMA1 2.10729627 1.39426E-09 
TMCC3 2.101051662 0.000261671 
CD68 2.097302317 0.000398317 
GGT5 2.093313077 2.16403E-06 
KIAA1644 2.090563642 0.000317106 
BHLHE41 2.076202399 3.8026E-06 
PCSK1 2.075156712 0.005072554 
RASGRP2 2.060568562 1.09781E-08 
NR4A2 2.059908396 4.42847E-06 
TNFSF10 2.055611403 0.000430696 
CNGA1 2.047774018 0.000726675 
ADRA2C 2.039742228 7.11175E-06 
PPARGC1A 2.039072568 4.18599E-07 
CD40 2.03335826 0.000825255 
AQP3 2.032532679 2.34409E-05 
NEFM 2.023641263 2.4806E-06 
RAI2 2.021674816 0.001985238 
ST8SIA4 2.013057439 0.001922268 
FAM81A 2.009167347 8.94335E-05 
CD22 2.007740113 0.002567913 
CCL26 1.990041559 0.004564531 
SFRP1 1.9883606 0.000453217 
MTUS2 1.988131651 0.004882914 
BCAM 1.987940233 2.91416E-07 
RBM11 1.985564415 0.010870819 
RIPPLY3 1.98266121 0.00470003 
SIGLEC17P 1.982431716 0.005998417 
LIFR 1.979845235 2.01342E-10 
STK32B 1.974266625 1.91354E-05 
GPR126 1.973104203 2.60436E-09 
RAB27B 1.971163404 0.001460373 
SCN5A 1.968503563 2.1737E-06 
FGD5 1.96654739 0.01260517 
RP11-
445H22.4 
1.964153348 0.006115711 
KCNK15 1.96241556 0.002204983 
ANK1 1.958808226 1.97632E-05 
KIAA1671 1.957076721 6.90508E-10 
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AIM1 1.95604009 5.60674E-08 
LPPR5 1.954591765 0.01402222 
ARHGAP20 1.954432836 2.82808E-06 
SORL1 1.953170741 4.04745E-06 
COL4A4 1.952375834 0.00333102 
AC073621.2 1.947334368 0.009692452 
FYB 1.945720617 0.01468672 
FAIM2 1.944773608 3.97606E-06 
IL15RA 1.942579999 4.50291E-05 
CLCN1 1.941902813 0.010441548 
DDIT4L 1.93980802 5.93878E-08 
LINC00341 1.931266954 6.32514E-07 
PBX4 1.928398759 0.001506052 
CRYGN 1.924223059 0.013040332 
PPP1R14A 1.919632954 2.91201E-06 
CSF3R 1.91938153 0.007025045 
FAM162B 1.917912872 0.000303997 
FAM65B 1.916883734 0.000144225 
CTD-
2135D7.5 
1.913329928 0.015543126 
CAMK1G 1.910271099 1.26221E-09 
CTD-
2020K17.1 
1.909588466 2.79705E-06 
TMEM150C 1.899790525 4.70718E-05 
CLDN23 1.897888265 6.69316E-05 
RBP7 1.896386936 0.012293622 
SOD2 1.896275782 3.84895E-13 
GPR133 1.883512898 0.000873841 
PRDM6 1.876969623 6.22772E-05 
PRRX2 1.87332607 9.11352E-05 
SDK1 1.868196907 1.27369E-09 
WT1-AS 1.859541701 7.62226E-05 
HTRA3 1.857444656 1.74216E-05 
CLMN 1.855458502 0.021223295 
KRT18 1.84966319 6.84516E-10 
NETO1 1.849658017 0.003031901 
KB-1517D11.4 1.845777402 0.010663211 
L1CAM 1.840736089 8.86643E-07 
RP11-
752D24.2 
1.840493452 0.01611129 
CHRD 1.840030848 1.53076E-08 
C1orf21 1.839820231 1.55285E-05 
RARRES3 1.837329367 0.000231354 
ANKRD33 1.835770256 0.015456307 
CYP26B1 1.835511141 0.002356232 
TNFRSF21 1.834795607 1.25831E-08 
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RP11-598F7.5 1.833651375 0.025151608 
C1orf226 1.826696728 0.00109169 
KRT36 1.823564063 0.026798346 
GIPC3 1.820024903 2.18119E-05 
FAM89A 1.818275949 2.50964E-06 
FAM149A 1.816691743 1.1658E-06 
AQP8 1.813109165 0.000205496 
AGPAT9 1.805893901 0.000432837 
TSHZ2 1.805310743 0.00109169 
NKAIN3 1.801582145 0.025936388 
HOXB-AS3 1.799948725 5.17495E-06 
PLEKHG1 1.793390244 1.26686E-11 
PZP 1.782568147 0.03082676 
STEAP4 1.781518692 0.032899001 
RUNX3 1.777179975 0.033530971 
GUCY1A3 1.776166189 0.000265919 
IL1RL1 1.769501192 0.021118209 
DLL4 1.768041165 0.001883777 
LZTS1 1.764682053 0.015221302 
ACVRL1 1.764650886 3.21036E-06 
AC141928.1 1.762500738 1.01773E-07 
IL6R 1.761348952 1.65336E-06 
AOX1 1.757923896 0.001478439 
TRPC3 1.751912591 0.000202698 
ZC3H12D 1.751761725 0.004257433 
ASS1 1.748304032 2.09204E-07 
TRIM54 1.748233372 0.035384371 
RGL3 1.746918249 6.90517E-05 
SNCA 1.744003674 5.6389E-05 
ADAMTSL4 1.739635622 0.000357704 
ANKRD30A 1.737203339 0.04047545 
TMEM54 1.733808631 2.05321E-06 
ANKRD6 1.733063398 4.95358E-06 
RP4-647C14.2 1.73215444 0.001151843 
TNFSF13B 1.729353708 0.000899094 
NDNF 1.729300438 0.009254167 
LINC00944 1.728920623 0.03332757 
APOC1 1.726457981 0.00561843 
LAG3 1.722711494 1.6558E-05 
MTL5 1.722319621 0.00308804 
GUCY1B3 1.721334515 7.62226E-05 
VWA7 1.716909972 0.004393848 
FAM124A 1.714595229 1.0725E-05 
LY75 1.711691279 0.032146864 
EYA1 1.709760525 0.001624348 
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AGT 1.708283288 0.00586709 
APOBEC3H 1.707550314 0.041563844 
HCAR1 1.702847111 3.93872E-05 
FGF13 1.70217859 0.008135816 
ANKRD29 1.701871102 0.006739214 
LXN 1.697707304 2.39674E-05 
AL512428.1 1.69738468 0.035912336 
ZNF536 1.695833179 0.047067663 
SNCG 1.694735372 0.016040854 
LINC01140 1.693137092 0.01917327 
RP11-
151D14.1 
1.692546093 0.042028167 
WNT2B 1.692447913 0.005746005 
CELSR1 1.688147127 1.19057E-06 
LAPTM5 1.686789244 0.044921489 
KIAA0040 1.68605153 0.025251802 
LINGO2 1.685412258 0.000538878 
KCND3 1.68306562 0.028276098 
GMFG 1.680649595 0.014080865 
RP11-
173M11.2 
1.680326244 0.025251802 
GS1-72M22.1 1.679163915 0.006279484 
OAF 1.674403747 2.47584E-09 
CRABP2 1.669425218 0.00693407 
GPR150 1.665151428 0.012051353 
CGN 1.664064218 0.029499099 
RP11-
432J24.5 
1.660024916 0.044071243 
ADH1C 1.659787099 0.006225331 
APOL1 1.658247568 2.43688E-06 
PSG4 1.657846522 0.003296631 
SCIN 1.655170655 0.036084131 
GRIN2A 1.654360276 0.024309705 
MAN1C1 1.654323616 0.000234311 
TRIM29 1.653541594 0.042028167 
OSR2 1.653345632 9.77476E-06 
RAC2 1.653345399 6.92963E-06 
LAMA3 1.651664455 0.003226389 
ABCC3 1.650547965 0.003138053 
CD14 1.64814649 0.016257208 
BRINP1 1.648118019 0.015375891 
TM4SF1 1.646736937 0.011232018 
RP11-713C5.1 1.646262938 0.017609351 
PARM1 1.645774083 0.005721504 
LAMB3 1.642943186 0.0109364 
TMEM255B 1.64060797 0.015491297 
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GPRC5C 1.640099608 0.001093143 
NOV 1.639269298 3.33823E-05 
EBF3 1.636274319 0.003076395 
CMKLR1 1.634792833 0.035389921 
PLA2G4A 1.626903412 0.000800598 
CFD 1.625732726 0.028343057 
MAP3K5 1.619323813 1.10872E-09 
NR4A3 1.61795794 0.042991452 
MYL3 1.613585655 0.006644119 
ADH1B 1.61186906 0.027826811 
SYNPO 1.610739375 1.59543E-05 
SH3GL2 1.609013909 0.006078516 
IL2RB 1.597459461 0.000661427 
CCBE1 1.595626984 0.009869886 
ADRA2A 1.59513277 0.016211049 
RP4-555D20.2 1.592825663 0.044540924 
ADRA1D 1.585888458 0.001430055 
KCNC4 1.584437737 0.002693654 
ANKEF1 1.582988106 0.006271271 
PRSS21 1.582238863 0.000165226 
UNC13D 1.578590633 0.000166431 
ABCC6P2 1.577734092 0.041605335 
ASPHD1 1.576820627 0.006644119 
ERVMER34-1 1.576663805 0.006111317 
NIPAL1 1.574220669 0.007420398 
MBNL3 1.573338718 1.41432E-05 
IGJ 1.572530241 0.041950636 
NYAP1 1.57093959 0.003840841 
PTER 1.570038425 0.000393474 
TPD52 1.564382943 0.002227432 
AK7 1.560029048 0.014740148 
ZNF204P 1.559283703 0.049542875 
ADAP2 1.555993019 0.012299707 
NAV2 1.553840141 0.000914577 
PTPRU 1.551596041 0.00437233 
RP11-
549B18.1 
1.550805053 0.007004965 
B4GALT6 1.550671888 3.76252E-05 
PYGM 1.54689077 0.002527125 
MAMDC2 1.542290814 0.007347731 
RNF125 1.538223848 0.003212115 
TMEM100 1.536019281 0.048801662 
CFB 1.535984209 0.032906323 
SPIRE2 1.534775469 1.73447E-07 
TIMP4 1.534583902 0.019821074 
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GRTP1 1.529418482 0.001655179 
SDC4 1.529115886 1.34414E-05 
RP11-49I11.1 1.528205636 0.002117165 
DHRS13 1.527301594 8.41752E-05 
AC005481.5 1.526944868 0.038938096 
LINC00939 1.525755982 0.021167122 
TWIST1 1.523062967 6.06834E-07 
PDE10A 1.519513962 0.005683109 
PTH1R 1.519333506 0.008339494 
SBSN 1.513657833 0.047067663 
ACE 1.512927923 4.08035E-05 
HSPB6 1.507190644 7.9336E-09 
BATF2 1.502972086 3.43693E-05 
LIMCH1 1.502886463 0.001486947 
CHST1 1.502046824 0.02172337 
PLXND1 1.501729376 8.06006E-09 
DAPK2 1.501296834 1.54492E-05 
HYAL1 1.499989246 0.001412677 
NOS3 1.493074484 0.009657902 
SYNE3 1.491809312 0.000917734 
RCSD1 1.485676051 0.039891499 
TINAGL1 1.485465059 0.033495137 
APOL3 1.48333261 1.25077E-06 
C11orf96 1.476891495 0.00599711 
NPR3 1.47445021 0.030609329 
IL33 1.474274344 5.4405E-05 
CAMK2A 1.47084691 0.040949429 
BACH2 1.47036775 0.003408966 
NRG1 1.467271357 0.002083118 
RTN4R 1.461587321 0.014050753 
PTX3 1.460529681 8.94335E-05 
NR4A1 1.458169973 0.001726673 
CLDN7 1.457785205 0.000777721 
EGFLAM 1.457025475 0.027320913 
SCN1B 1.454941628 0.001001161 
S100A3 1.453367855 0.005651751 
MRGPRF 1.451845167 0.001600468 
SUSD2 1.451695217 2.71674E-05 
PSG2 1.443829899 0.007602201 
COL4A6 1.44380629 0.000937182 
CDCP1 1.440790459 0.009925089 
IL20RA 1.440441521 0.007121537 
KCNQ3 1.439756561 0.018525025 
MCOLN2 1.437923395 0.003225921 
METRN 1.437009089 2.34409E-05 
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RFX8 1.436750574 0.014652461 
HLA-F 1.436053771 1.07393E-05 
NDRG1 1.435817461 6.66947E-06 
PRKAA2 1.431110912 0.003650729 
NOD1 1.429575348 5.6389E-05 
RP11-
554A11.4 
1.42909879 0.00109169 
BAIAP2 1.429078737 9.29958E-07 
TFAP2C 1.428792702 1.18899E-05 
DUSP5 1.427846146 0.010950435 
CDCA7 1.427786342 0.0007725 
ALDH3B1 1.425976588 0.000124743 
STEAP3 1.418049433 0.004666912 
CARD9 1.414073277 7.63135E-06 
ITPR3 1.408630292 9.01351E-05 
FBLN1 1.408265903 3.25267E-05 
TGFB3 1.407106045 0.000825285 
PTPRN2 1.405428247 0.002747605 
DKK1 1.404919246 0.012761395 
TMC6 1.397746214 0.002986748 
IL17RE 1.396969013 0.029357578 
CDH13 1.392151414 0.001655179 
SYNM 1.391171769 0.001471107 
ERBB3 1.385790779 0.047383084 
SLC40A1 1.384537885 0.006050549 
FCRLB 1.383434547 0.024804674 
EMX2OS 1.382595206 0.000762315 
OLFM1 1.3819068 0.032196461 
CSDC2 1.380703895 0.000229245 
CCDC109B 1.380272393 1.18585E-05 
MLPH 1.380252655 0.000281469 
TGFBR3L 1.372084197 0.044869396 
TPPP3 1.37036954 0.000385163 
DAAM2 1.370317619 8.84796E-06 
PITPNM2 1.370052987 4.6018E-05 
MARK1 1.368896386 0.00394273 
CKB 1.365744984 0.012088881 
RGS16 1.365646483 0.02071941 
CHST15 1.36382792 6.7843E-05 
TIMP3 1.363798957 4.19014E-05 
FAM47E-
STBD1 
1.361033246 0.032906323 
MCOLN3 1.359154944 0.000188828 
PODXL 1.352028996 0.032553511 
MME 1.351383141 0.016663228 
CTSD 1.351377983 7.42898E-05 
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TRIM7 1.350681127 0.03082676 
TJP2 1.349469533 0.001499913 
C10orf54 1.347600265 0.001143401 
GJD3 1.346549024 0.006160294 
SEMA4D 1.344491513 0.001804856 
TNIK 1.343289275 0.001572324 
BZRAP1-AS1 1.342638446 0.029983115 
NANOS1 1.341674036 0.031661553 
RPS6KA1 1.340729147 0.006078516 
THRB 1.336690973 0.003580244 
POU2F3 1.335924891 0.035951111 
ELOVL2 1.331747314 0.020730963 
DSG2 1.326258114 0.008074757 
USP53 1.324271227 0.042613412 
TEC 1.320295003 0.042864515 
GPX3 1.318845405 0.002384039 
PLD1 1.312467124 4.84454E-07 
STXBP2 1.310721317 0.000876848 
IFITM1 1.308812993 0.003237857 
CCDC69 1.308649799 0.001827044 
BAIAP3 1.308331353 0.019005565 
PLIN2 1.306614061 6.71354E-06 
KIAA1456 1.30657947 0.000486965 
ARID5A 1.300386354 0.000813092 
VAMP5 1.298555392 2.66866E-05 
FAM167B 1.295742354 0.005240048 
ISG20 1.292668926 0.003092007 
EFCAB1 1.285779815 0.032637814 
CCDC102B 1.285618971 0.024865899 
PEG10 1.283229825 0.009542099 
GCK 1.280194206 0.028459154 
ALS2CL 1.277219617 0.005679358 
PRELP 1.275467478 0.002554584 
NEURL1B 1.274111575 0.000633865 
RP11-
1002K11.1 
1.273994642 0.01015546 
TENC1 1.271881699 0.001351068 
TCEA3 1.271684069 4.19407E-05 
FBLN7 1.270609949 0.000140301 
C6orf141 1.266773931 0.002060293 
NHS 1.258263736 0.006378622 
ETV7 1.25819009 0.011905589 
HRH1 1.257633362 0.001649238 
SLC35G2 1.254994576 0.012059008 
FCHO1 1.254257562 0.012761395 
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ICAM4 1.252307872 0.032005769 
GGT1 1.251732276 0.011806992 
SH2D4A 1.25051618 0.00125498 
PIM3 1.249157991 0.000281705 
DBNDD2 1.247155985 0.041804588 
LITAF 1.247145832 0.000847011 
FOXP2 1.246752195 0.001048841 
FXYD5 1.24598431 0.014793522 
P2RX4 1.24390261 0.009060811 
HHEX 1.24243162 0.024036631 
NOTCH1 1.241351473 0.000229975 
HLA-DPB1 1.239268154 0.003384651 
HMSD 1.236778624 0.040774626 
APLP2 1.234153469 0.029511801 
RAB3IL1 1.234066073 0.000180262 
DPP4 1.232574345 0.021880853 
GCNT1 1.230093595 0.014626339 
FAM83H 1.228624522 0.030940891 
ITGB8 1.227647718 6.44376E-05 
NR1H3 1.223999107 0.013648987 
TCL6 1.223044046 0.009939553 
DIRAS1 1.220036294 0.047068973 
ABCA6 1.217429856 0.009647418 
MEIS3P2 1.217253701 0.001336329 
MOCOS 1.215936801 0.015369103 
RADIL 1.215884982 0.00696336 
SCARA3 1.214674204 0.004093897 
PSG5 1.213017996 0.033946007 
FLT1 1.2130058 0.038627879 
NAMPTL 1.212624022 0.014793522 
ABHD17C 1.212385815 0.015277797 
BOC 1.206289516 5.17495E-06 
SH2D5 1.203824676 0.045697933 
HOXB3 1.200178066 0.001881039 
GNAL 1.193791036 0.015534194 
ADARB1 1.19346543 0.00071735 
ACOT4 1.191418345 0.041130536 
PSG1 1.189668647 0.037080325 
RIN1 1.189415677 0.001336329 
TMOD1 1.188562866 0.048712928 
LINC00346 1.185953254 0.004856198 
OSMR 1.185644885 0.000158044 
CEBPB 1.185191119 0.000490638 
S100A4 1.18154356 0.035116313 
USP44 1.177821879 0.021123504 
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ZFP36 1.175490795 0.000552164 
KRT8 1.175072805 0.002561479 
ATCAY 1.173446416 0.046574328 
HMGB2 1.172832857 0.003953641 
FAM174B 1.170811811 0.018390492 
LAMA4 1.170238057 0.007146069 
PLA2G16 1.169842557 0.008089805 
SMIM10 1.16734237 0.001001481 
CLGN 1.165518837 0.006437564 
SNED1 1.163689746 0.017609351 
MFSD6 1.157255583 0.009132511 
TPCN1 1.155667732 0.001777491 
AVPI1 1.152689668 0.009060811 
ADCY1 1.149872228 0.012663968 
EPDR1 1.148877891 0.044675384 
MTMR10 1.148295798 0.003408966 
EPAS1 1.147139127 0.002526727 
FRAS1 1.146654177 0.033168116 
THPO 1.14593051 0.041937297 
CYGB 1.142345734 0.029983115 
KCNIP3 1.140362619 0.032213465 
PC 1.132900465 0.001558976 
HSPB8 1.131874496 0.029983115 
VAT1L 1.130569703 0.009789871 
GPRC5A 1.128236542 0.000140947 
ALDOC 1.127243299 0.0066582 
AFAP1L2 1.124755159 0.000700851 
COL18A1 1.119668778 0.000534247 
GLUL 1.118551849 0.002150489 
ROR2 1.115151721 0.000653496 
BDKRB2 1.11124515 0.00014157 
TAPSAR1 1.109356942 0.001641384 
ADCY4 1.10654184 0.007039999 
CORO2B 1.105766585 0.004551005 
MAP7 1.103051669 0.03082676 
MPV17L 1.10009602 0.040563078 
SIGIRR 1.094363208 0.000970877 
TOX2 1.086051217 0.018909858 
CDC42EP4 1.084500411 0.000273656 
HNMT 1.080154102 0.003104592 
HLA-DPA1 1.075685283 0.007979228 
DUSP1 1.07275888 0.021880853 
CHCHD10 1.072486169 0.005046582 
DMTN 1.071717369 0.042402279 
ADPRH 1.070568468 0.041605335 
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FLI1 1.066356976 0.005753723 
ST6GALNAC6 1.060895452 8.08985E-05 
SLC37A1 1.058678612 0.006113425 
AGFG2 1.057885166 0.012232955 
PCK2 1.056623505 0.030609329 
CNTNAP1 1.054960024 0.000315922 
ANXA11 1.054392449 8.94028E-05 
CTSH 1.053912196 0.008971679 
F10 1.053837078 0.000216637 
STOM 1.053687356 0.000928467 
CCR10 1.052157152 0.014538748 
SMAD3 1.050685388 0.014024537 
ECHDC3 1.049695467 0.01839861 
NFIL3 1.046759285 0.008043276 
TBC1D8 1.046047397 0.023201167 
KREMEN1 1.045257026 0.033530971 
MAP3K8 1.042897362 0.015167486 
ECE1 1.037655876 0.009605174 
SLC9A3R1 1.037511759 0.002886058 
CNKSR3 1.034133864 0.000861636 
SFMBT1 1.032669129 0.01084408 
CBX7 1.028514082 0.02995244 
PLCL2 1.027016713 0.00241592 
NAMPT 1.025073603 0.018802824 
BCL3 1.021382376 0.010765852 
EFNB2 1.020425232 0.002204983 
SAV1 1.018245629 0.000586984 
CTNNAL1 1.018163363 0.009254167 
PLA2R1 1.017670146 0.000243211 
ENOSF1 1.013115315 0.000308971 
EFNA5 1.011668295 0.008133989 
TMCO4 1.008810151 0.002342093 
APOE 1.007265735 0.034935787 
C16orf45 1.00642347 0.043682696 
SECTM1 1.002140968 0.01714322 
IL6ST 1.001329341 0.000548785 
PLEKHF1 1.000538546 0.017802588 
 
 
 
Appendix 6. Down-regulated genes upon A83-01 treatment: 
Log2-fold change < -1 
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Gene Symbol Log2-fold 
change 
q 
KCNE4 -
1.003149166 
0.023400333 
CASK -
1.004025572 
0.005004505 
PTPRD -
1.006076373 
0.003879865 
APCDD1 -
1.007142571 
0.030585672 
DOCK9 -
1.007263856 
0.000459728 
TGIF2 -
1.007503321 
0.044798066 
THAP2 -
1.007929303 
0.041605335 
KIAA1217 -1.02636513 0.041950636 
NNAT -
1.027689615 
0.006998066 
ZNF804A -1.03050877 0.00350631 
CLCN4 -
1.035221971 
0.020775617 
FHDC1 -
1.036443976 
0.040638383 
PDCD1LG2 -
1.037729473 
0.039346794 
NR2F1-AS1 -1.03927625 0.006102824 
EPHA5 -1.04291727 0.001794243 
DRP2 -
1.043467631 
0.041499829 
FKBP7 -
1.043502863 
0.000635843 
MMP16 -
1.044806272 
0.001181136 
SH3BGRL2 -
1.045457829 
0.006748617 
ANTXR1 -
1.050840211 
0.000134035 
PDE4B -
1.053041202 
0.005679358 
COL4A2 -1.0537044 0.013599398 
MRAS -
1.056193934 
0.000554393 
PCDHGA4 -
1.056737862 
0.012655969 
SLC9A7 -
1.061226157 
0.037812983 
LINC00936 -
1.067703727 
0.002384039 
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MCAM -1.07241098 0.039707804 
LNX2 -
1.072814049 
0.004246079 
PRDM1 -
1.074108008 
0.031863329 
AGPS -
1.074231581 
0.001309704 
GOLGA2P7 -
1.079265479 
0.010740254 
CAMK1D -
1.080119378 
0.006476974 
MAST4 -
1.080595166 
0.001120906 
TMEM132A -
1.084946743 
0.007557099 
ITGB5 -
1.086350007 
0.000442129 
PTGFR -
1.086879014 
0.021073957 
OPN3 -
1.091174654 
0.000265656 
CCNJL -
1.092917669 
0.009673355 
STK38L -
1.096948485 
9.07075E-05 
ITGA4 -
1.098594161 
0.010849903 
WISP1 -
1.101516718 
0.005787411 
PDGFC -
1.105000744 
0.017427635 
HUS1 -
1.108211886 
0.002943876 
TLN2 -
1.109650392 
0.001437035 
SPRY2 -
1.110911261 
0.015816043 
F2R -
1.113998498 
0.005985014 
SSTR1 -
1.115747394 
0.007261605 
SLC41A2 -
1.119065717 
0.01887024 
COL7A1 -
1.119540585 
0.013738984 
DDHD1 -
1.124079887 
0.0061883 
TGFBI -
1.124128147 
0.00897028 
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COL5A2 -
1.127308874 
0.004459059 
MIR29A -
1.129449339 
0.001122534 
ZNF117 -
1.131753719 
0.003036148 
MMP11 -
1.135015314 
0.006751631 
MEX3B -
1.137225808 
0.023213668 
LANCL3 -
1.137507206 
0.019093473 
OSBPL10 -
1.137865244 
0.000495968 
SEMA3F -
1.138236678 
0.019188062 
ITGA1 -
1.139799575 
0.045531016 
LIMS1 -
1.141557877 
0.011025236 
LAMC1 -
1.141837269 
0.001222061 
TTYH3 -
1.144267757 
4.94212E-05 
C14orf37 -
1.149887062 
0.000229894 
SNHG14 -
1.150003734 
0.016893762 
RBM24 -
1.157266358 
0.001175412 
SPARC -
1.164087614 
0.000842631 
FGFRL1 -
1.164484984 
3.44974E-05 
FAM101B -
1.168483087 
0.001889011 
LAMA2 -
1.169086526 
0.040949429 
C16orf87 -
1.169351706 
0.000180681 
COTL1 -
1.170453619 
0.001804856 
COL1A2 -
1.172149664 
0.001443097 
ANO8 -
1.173091179 
0.007300823 
FOXP4 -
1.174786281 
2.49822E-05 
NR2F1 -1.17673198 0.001857707 
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LOX -
1.178259568 
0.003076992 
PXDN -
1.187066842 
1.72344E-05 
ZFP69B -
1.187253556 
0.0017013 
RP1-228H13.5 -
1.188399244 
0.001991292 
RHOBTB1 -
1.188776082 
0.000796754 
SAT1 -
1.194987128 
0.000497223 
ZNF219 -
1.196247338 
0.009254167 
MMP15 -
1.198106652 
0.000495968 
SMO -
1.198732661 
0.029357578 
ADSSL1 -1.19926368 0.04601717 
SERINC5 -
1.201607473 
0.001160839 
HMGA2 -
1.204896222 
0.020159737 
FBN1 -
1.206465317 
0.000284386 
RP1-152L7.5 -1.21041747 0.001275461 
BNC2 -
1.212704769 
1.11255E-05 
PCDHGA3 -
1.214480147 
0.040949429 
TES -
1.219858226 
0.006578619 
IKZF2 -
1.220414426 
0.017161504 
KLHL4 -
1.225259106 
0.035073566 
PABPC4L -
1.226571518 
0.001244734 
JAM2 -
1.227277766 
0.007854584 
MGAT5 -
1.238116822 
0.000547369 
FRY -
1.241011031 
0.001727492 
ADAM19 -
1.246014971 
0.009516703 
SLC2A1 -
1.248094746 
0.013289106 
KIAA1549 -
1.250277587 
6.164E-06 
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TOX -
1.251902577 
0.048712928 
TET3 -
1.252089565 
0.000805929 
LMBR1 -1.25311301 0.000654643 
PSD3 -
1.257862165 
2.41624E-05 
ABTB2 -1.25796413 0.000359178 
FNBP1L -1.25812032 0.001386618 
C8orf4 -
1.264007616 
0.006768668 
SLC22A23 -
1.264259341 
0.01132718 
FRK -1.26443841 0.006522989 
NRIP2 -
1.267076433 
0.035079594 
RP11-
686D22.8 
-
1.270115707 
0.004654208 
EFNA4 -
1.270949937 
0.000213923 
FANK1 -
1.275628938 
0.02068082 
MAP3K7CL -
1.283530009 
0.018451985 
PCDHB3 -
1.283864339 
0.037786411 
ENC1 -
1.285030612 
6.70829E-06 
CLDN1 -
1.290732138 
0.008421189 
TRPA1 -
1.292388207 
0.00676838 
CREB5 -1.29338688 0.027572656 
L3MBTL3 -
1.297024981 
2.06522E-05 
NTN4 -1.29914414 0.005325635 
GLIS1 -1.30747925 0.027358655 
AP001062.7 -1.30900451 0.004523561 
CCDC144A -
1.309756847 
0.028644374 
CASP12 -
1.311001491 
0.037432615 
CDK5R1 -
1.314336233 
0.000100564 
IGFBP7 -
1.319145465 
0.000621772 
TSPAN6 -
1.319288866 
1.77497E-05 
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ABCC9 -
1.322317937 
0.03082676 
SLC38A5 -1.32285975 0.001842652 
DCHS1 -
1.325317729 
0.000849285 
PYCR1 -
1.330892276 
6.12745E-06 
RNF182 -
1.341012926 
0.002763086 
AMPD3 -
1.346627957 
0.000265397 
PCDHGB1 -
1.349929566 
0.015393363 
MFAP2 -
1.355247718 
3.33823E-05 
ALDH1B1 -
1.356180747 
0.001246048 
KIAA1324 -
1.357008409 
0.028797227 
GAD1 -
1.358593458 
0.01973426 
TMEM206 -
1.362198323 
1.56787E-05 
FAM227A -
1.370965522 
0.005850622 
THBS1 -
1.371079975 
0.032672691 
ADAMTS7 -
1.372188293 
7.7583E-05 
PHEX -
1.372874097 
0.0149599 
C1orf51 -
1.374624865 
4.6018E-05 
FAM26E -
1.377731044 
0.029115663 
CD163L1 -
1.378619683 
0.003172064 
AF131217.1 -
1.382223554 
0.023213668 
ZSWIM4 -
1.383558111 
1.40224E-06 
ENAH -
1.386617794 
1.4965E-06 
RP11-119F7.5 -
1.387767464 
0.024141061 
ATP2B1 -
1.388464409 
1.55267E-05 
LOXL2 -
1.389164896 
0.000380555 
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SLC2A11 -
1.391924448 
0.000159286 
GPT2 -
1.392727847 
2.08771E-05 
ADCY10P1 -
1.396532475 
0.017237376 
IL16 -
1.398390325 
0.025258388 
GDPD1 -
1.401964189 
0.001135726 
TNFSF4 -
1.402163045 
0.001267358 
TMEM2 -
1.403966675 
0.000155569 
PNMAL1 -
1.408520236 
0.005634212 
PDGFD -
1.410703296 
0.00339235 
ESYT3 -
1.411181232 
0.043750738 
PLCB4 -
1.411219979 
0.026820317 
BAMBI -
1.411853181 
1.85693E-05 
CACNG8 -
1.412146447 
0.024309705 
NCKAP5 -
1.413899184 
2.59287E-05 
H2BFM -
1.414542706 
0.033701805 
MARCKS -
1.416283968 
1.14773E-05 
DOK6 -
1.419033544 
3.33823E-05 
SHANK1 -
1.421431465 
0.000400802 
SORBS1 -
1.422419026 
0.005544643 
RASGRP3 -
1.428881558 
0.022005216 
RNF122 -
1.429753738 
0.000660983 
SPECC1 -1.4366618 8.23588E-07 
HECW1 -
1.440795498 
1.68787E-06 
HIST1H2BG -
1.443212222 
0.041866862 
ADAMTS17 -
1.446770911 
0.027826811 
TTC3P1 -1.4477692 0.010617819 
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BCAT1 -
1.447927052 
9.98812E-06 
HK2 -
1.450353498 
0.008830174 
PDE3A -
1.458311355 
0.000825255 
INPP5F -
1.460886265 
4.12816E-05 
COL12A1 -
1.469260357 
0.000166257 
SHROOM2 -
1.474328076 
0.000213923 
SEMA5A -
1.474500872 
0.000381306 
PURG -
1.475279704 
0.043377258 
SOX6 -
1.477099608 
1.08454E-05 
RP11-395N3.1 -
1.483508707 
0.02306876 
ARVCF -1.4837121 4.57545E-06 
PPP1R3C -
1.484019939 
0.002731269 
TFAP2A-AS1 -
1.485280498 
0.040125482 
PWAR6 -
1.485836086 
0.011781972 
SRPX2 -
1.488479386 
0.000136313 
RP11-
686D22.4 
-
1.489184837 
0.019869472 
MB21D2 -
1.490246593 
3.33823E-05 
COL16A1 -
1.497024556 
5.07311E-06 
COL24A1 -
1.498617123 
0.000125842 
OSR1 -
1.500672423 
3.18028E-05 
COL5A1 -
1.503160529 
2.34409E-05 
TSC22D3 -
1.507345225 
4.99372E-05 
HIST1H4E -
1.511785965 
0.026988238 
FBLN5 -
1.515640932 
4.69642E-06 
TRO -1.51692688 0.002281829 
ACTR3C -
1.517474916 
0.00566621 
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PCDH19 -
1.518343602 
0.006953228 
PODXL2 -
1.518730208 
0.016864566 
TENM3 -
1.524353939 
0.000308121 
SH3D19 -
1.528917744 
1.02405E-05 
KBTBD11 -
1.529607402 
0.002336982 
ANGPT2 -
1.531015922 
0.037080325 
WNT7B -
1.533691952 
0.047454216 
PGM5 -
1.534794535 
0.005980265 
NTF3 -
1.535110115 
1.15377E-05 
PARD6G -
1.535480587 
0.000498801 
PRLR -
1.539551628 
0.013508143 
GPR155 -
1.539953129 
5.46935E-06 
PCDHA4 -
1.540860516 
0.027630666 
RHOJ -
1.544526966 
1.00154E-07 
LMO3 -
1.545548621 
0.004551005 
CSRNP3 -
1.548603444 
0.003584309 
SBF2-AS1 -
1.549928484 
7.91267E-05 
BPGM -
1.561932566 
4.77212E-06 
FMNL2 -
1.571927714 
1.27904E-05 
LPPR3 -
1.574643815 
0.040949429 
GNA14 -
1.579398062 
0.005157507 
GALNT5 -
1.584237721 
0.003552645 
UPP1 -
1.593358504 
4.19014E-05 
NANOS3 -
1.594091298 
0.037665144 
HIST1H4H -
1.599534715 
0.000824108 
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PDPN -
1.600446433 
9.9702E-08 
SPSB1 -
1.605025244 
2.6791E-07 
RP1-193H18.2 -
1.609181398 
0.035190579 
ST6GALNAC3 -1.61226093 1.09888E-05 
MYH11 -1.61349125 0.044305347 
NAP1L2 -
1.614649932 
0.011755049 
RP11-87H9.3 -
1.615292441 
0.01956656 
SEMA3C -1.61577532 7.31795E-09 
SLCO5A1 -
1.619284633 
0.026284186 
XIRP2 -
1.621276141 
0.037295553 
COL4A1 -
1.621504462 
4.87212E-05 
ANGPTL1 -
1.622425104 
0.043661089 
SCUBE3 -
1.622757257 
2.12396E-05 
MIR199A2 -
1.625092927 
0.008069264 
ADAMTSL2 -
1.628121765 
0.011483887 
SHF -
1.631137764 
0.002317168 
HAS2-AS1 -
1.631192461 
0.02975416 
ACTG2 -
1.634381075 
0.011025236 
LMCD1 -
1.639124472 
0.000552164 
EPYC -
1.644425141 
0.001335308 
IRS1 -
1.646936353 
2.46447E-06 
ECM2 -
1.653077895 
0.006815095 
SLC4A4 -
1.659243729 
0.025041723 
SEMA6D -
1.659755959 
0.002851451 
LEF1 -
1.660127734 
0.000747302 
AC004538.3 -
1.660866504 
0.04729791 
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P4HA3 -
1.663550791 
9.45778E-05 
LRRC61 -
1.663691362 
0.000653496 
PIK3R3 -
1.671560077 
2.74875E-05 
PXDNL -
1.680036286 
0.044451674 
PCDHB2 -
1.683913875 
0.006717169 
LINC00519 -
1.684341972 
0.012761395 
SOBP -
1.684519558 
0.000255061 
RP11-
524D16__A.3 
-
1.685089113 
2.4806E-06 
AJ006998.2 -
1.693964008 
0.008938635 
FBXL22 -
1.699466273 
0.012223654 
PADI1 -
1.700826383 
0.017098404 
CSF2RB -
1.706529007 
1.17292E-05 
KCNN2 -
1.707053902 
0.043377258 
DPYSL4 -
1.710701553 
8.44023E-06 
BMP3 -
1.711521652 
0.033495137 
LNX1 -
1.711534267 
0.010975419 
ESRP1 -
1.714575875 
0.043750738 
MMP2 -
1.717831326 
2.02679E-12 
SOX4 -
1.720659977 
1.89129E-09 
KCNMB4 -
1.722101657 
1.48268E-05 
GLI1 -
1.722653907 
0.002628812 
NRXN3 -
1.723792538 
6.29253E-05 
SLC29A4 -
1.725642473 
0.000593291 
ISM1 -
1.731069475 
0.00010277 
SYNE1 -
1.732383285 
7.41093E-09 
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CCDC170 -
1.732680173 
8.73345E-05 
PCSK1N -
1.732995374 
0.006620563 
MSC -
1.733359878 
0.003591872 
SIPA1L2 -
1.736737869 
0.000111656 
BMF -
1.736775691 
0.000105355 
C8orf34 -
1.741338599 
0.006955252 
ST6GAL1 -1.74270831 1.85949E-06 
RP11-
344E13.3 
-
1.745093794 
0.001743546 
KIAA1755 -
1.745286778 
0.001335599 
MAP2K6 -1.75008688 0.000425727 
PCDHB15 -
1.753361409 
0.021688801 
PLCXD2 -
1.754012476 
0.022708116 
RP11-
999E24.3 
-
1.757371818 
0.000816311 
NIPAL4 -
1.760066575 
0.008832518 
SLA -
1.764507261 
0.001504071 
ABCA10 -
1.767574885 
0.004609152 
RP11-395N3.2 -
1.768553061 
0.001077919 
PALLD -
1.768929957 
1.96057E-05 
ALOX5AP -
1.770102664 
0.013892233 
SERTAD4 -
1.775632289 
0.000182362 
LUZP2 -
1.786071731 
0.008339494 
ANGPT1 -
1.789041681 
4.02869E-06 
FGFR2 -
1.800175494 
0.030031761 
AC112721.2 -
1.806036677 
0.024909504 
PKNOX2 -
1.808554295 
8.45414E-05 
RP11-
383H13.1 
-
1.809784162 
0.000376712 
  
303 
 
ZNF556 -
1.813232902 
0.00038131 
SBK1 -
1.814995582 
0.004920988 
SLC38A4 -
1.818133548 
1.03868E-05 
ADAM12 -
1.821092874 
4.5738E-05 
COL1A1 -
1.821888216 
1.37122E-09 
CDKN2B -
1.828118795 
1.9991E-05 
SNCAIP -
1.837460177 
5.07311E-06 
DNAJC12 -
1.838496715 
0.003442091 
RP11-64C1.1 -
1.841637234 
0.024424023 
DIRAS3 -
1.844292306 
1.34221E-05 
ARHGEF37 -
1.852600692 
6.0002E-07 
ASXL3 -
1.854011793 
0.023213668 
CTB-92J24.3 -1.85508656 7.06923E-06 
IGF1 -
1.856528567 
0.011722464 
SLIT3 -
1.859527234 
0.005852752 
TP53I3 -
1.860572775 
1.86186E-08 
GRIK2 -
1.861757438 
2.01288E-11 
PCDHB16 -
1.862425516 
0.000649431 
S1PR1 -
1.866720885 
0.001300327 
GDPD4 -
1.875445416 
0.020856394 
PCDHB14 -
1.878082461 
0.005817001 
OLFM2 -
1.879542171 
0.002660167 
C3orf80 -
1.881880926 
0.000651633 
CDK6 -
1.882687652 
1.01967E-09 
PCDHB5 -
1.883891519 
0.005634212 
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MIAT -
1.888796323 
0.002790803 
GFRA1 -1.89538925 0.002353612 
PCDHB13 -
1.896723764 
0.00586709 
37226 -
1.896946291 
0.013725437 
PCDHB7 -
1.897147537 
0.002497579 
GSG1 -
1.900783444 
0.001437689 
RASGRF2 -
1.906070575 
2.35792E-05 
SCN7A -
1.908018363 
0.002010818 
GRIA4 -
1.910300625 
0.000136306 
TMEFF1 -
1.913425936 
0.011613234 
SKIL -
1.915778883 
2.42406E-11 
RP11-
521J24.1 
-
1.923299875 
0.016411465 
CXXC4 -
1.928185525 
0.009127827 
SGCG -
1.929804786 
0.015760477 
FAM133A -
1.932333981 
0.015742101 
CDH3 -
1.935500276 
0.007854584 
CASC15 -
1.936042809 
2.60866E-05 
BMP6 -
1.941438062 
0.01501158 
BGN -
1.942471854 
7.7583E-05 
ZBED6CL -
1.942767625 
5.58625E-06 
RP11-
396O20.2 
-
1.948523049 
0.013190197 
GPC2 -
1.957790243 
2.99335E-05 
TCF21 -
1.957847136 
0.006330892 
HR -
1.959784299 
0.000732708 
MLLT11 -
1.960333104 
1.56379E-06 
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ADAMTS6 -
1.965858384 
5.34313E-08 
PDE1A -
1.983061604 
0.000647074 
RP11-33A14.1 -
1.985375604 
0.00927709 
ZCCHC18 -
1.985654204 
7.63135E-06 
LPCAT2 -
1.986084239 
5.2384E-07 
SYTL2 -
1.989465333 
1.06372E-05 
INHBA -
1.991681265 
4.48737E-06 
TSPAN33 -
1.998348802 
1.99148E-05 
VCAN -
2.000872024 
2.7168E-07 
ZSWIM5 -
2.002110149 
2.76986E-07 
PALM2 -
2.008745712 
4.19407E-05 
AC093850.2 -
2.019469294 
0.009528213 
TNC -
2.019688856 
0.009906615 
FN1 -
2.030019716 
2.34691E-08 
PCDH9 -
2.038941333 
1.64866E-05 
ABCA4 -
2.044160168 
0.000543869 
PID1 -2.04577043 1.46269E-08 
HSD17B2 -
2.046792065 
0.000141109 
PRSS12 -
2.047138713 
8.83331E-09 
POU2F2 -
2.047781744 
6.64233E-10 
KCNIP4 -
2.051655215 
0.006373718 
DNM3OS -
2.056635784 
6.64692E-12 
PGM2L1 -
2.058903908 
3.68887E-12 
ZNF853 -
2.059176282 
0.00116375 
MIR214 -
2.077086281 
2.10176E-07 
ELFN2 -2.07761603 0.000254485 
  
306 
 
NRG4 -
2.077785815 
0.006637224 
ACTC1 -
2.077868744 
0.005623645 
CILP -
2.083974109 
0.001646899 
CBX2 -2.08534355 1.41801E-07 
NRP2 -2.08881767 9.54412E-12 
PCDHB10 -
2.089264836 
0.000495968 
FAT4 -
2.090498953 
4.62532E-09 
KCNAB1 -2.09215729 0.006030614 
LINC00607 -
2.092652766 
0.00214605 
LINC00704 -
2.098788964 
0.00566621 
TPRG1 -
2.104058143 
0.0010915 
CHN1 -
2.110348483 
6.33932E-18 
PCDH10 -
2.110894338 
6.96592E-18 
RP11-
259N19.1 
-
2.114475572 
7.06923E-06 
RP3-512B11.3 -
2.114966522 
0.001292137 
PIEZO2 -
2.116217993 
0.000225883 
COMP -2.11700877 0.00595781 
PCYT1B -
2.118240967 
0.000149493 
AL163953.3 -
2.122136092 
4.00854E-06 
WNT11 -
2.125401916 
0.005349686 
KMO -
2.132484737 
0.002679196 
ATP10A -
2.132586423 
0.003408966 
ADCY2 -
2.133326866 
0.000189456 
MDFI -
2.137221049 
0.005121291 
IGDCC4 -
2.137547393 
2.92181E-06 
RP1-212P9.2 -
2.138702321 
0.00486077 
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RARRES2 -
2.140130773 
4.57586E-07 
PADI2 -
2.144327327 
0.004504975 
F2RL2 -
2.147575246 
2.06025E-05 
CTTNBP2 -
2.158318266 
1.54362E-09 
NEGR1 -
2.159862065 
4.02974E-11 
AFF3 -
2.190235275 
1.26447E-08 
CDH2 -
2.193611787 
1.03483E-19 
VANGL2 -
2.206635944 
0.000784123 
NOX4 -
2.220046417 
1.24764E-05 
MXRA5P1 -
2.249008056 
0.000256989 
ISLR2 -
2.249123842 
8.64341E-05 
KCNA3 -
2.249408613 
0.001697363 
LINC00900 -
2.264860417 
0.000935529 
HPGD -
2.270325101 
7.94326E-06 
METTL21C -
2.270517404 
0.002361551 
CAPN6 -2.28554698 2.5647E-08 
C7orf57 -
2.285945053 
0.001953313 
AC090954.5 -
2.294486951 
0.002037008 
LRRC4 -
2.296541943 
0.000157283 
RP11-664D7.4 -
2.301500146 
0.001990311 
SPOCK1 -
2.302065838 
6.80844E-14 
NTM -
2.302989034 
7.62015E-05 
NEDD9 -
2.307341468 
9.18381E-10 
CTD-
2319I12.1 
-
2.318731887 
0.00109352 
EMB -2.3198147 0.00114359 
PCDHB11 -2.33218444 0.000559367 
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RP11-
356J5.12 
-
2.348906194 
2.80777E-07 
ITIH3 -
2.353078942 
2.54561E-14 
LPAR4 -
2.358580512 
3.34022E-06 
ENTPD1 -
2.362963218 
3.59017E-07 
EYA2 -
2.386555528 
0.00116375 
AC007362.1 -
2.392631785 
6.50233E-10 
RP11-247C2.2 -
2.402232247 
5.79095E-05 
MIR181A2HG -
2.404314535 
4.05952E-05 
LYPD1 -
2.405967201 
1.45035E-08 
ZFHX2 -
2.417346378 
1.56379E-06 
IGF2 -2.43232945 4.95358E-06 
NELL2 -
2.437755324 
0.00033082 
ATRNL1 -
2.439154069 
2.99645E-10 
PLN -
2.441706135 
1.2446E-05 
ICOSLG -
2.451293011 
3.20588E-05 
CHRDL2 -
2.456564271 
0.000687626 
NREP -
2.457605771 
1.47961E-13 
TC2N -2.47261367 3.98997E-07 
CALB2 -
2.482153596 
7.63135E-06 
NAP1L3 -
2.489862215 
3.21884E-10 
TYRP1 -
2.492135907 
0.000571964 
HAS2 -
2.502709898 
3.98997E-07 
C1QTNF7 -
2.514075758 
1.58884E-09 
LRIG1 -
2.516046911 
1.37558E-06 
EPHA3 -
2.526027008 
0.000339918 
ZNF711 -
2.532562333 
2.24528E-07 
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SAMD11 -
2.569954012 
1.71666E-05 
SPON2 -
2.570959665 
7.73188E-11 
COL11A1 -
2.582648258 
1.42922E-14 
ABCB1 -2.59211482 2.24791E-06 
TFAP2A -
2.610557762 
4.67241E-15 
ZPLD1 -
2.620526229 
0.000177111 
OMD -
2.625436366 
1.19181E-05 
IGFBP5 -
2.631341953 
3.49489E-06 
LRRC17 -
2.635369491 
7.17366E-07 
DSP -
2.643963469 
4.65973E-17 
F2RL1 -
2.657762185 
1.98857E-09 
KANK4 -
2.658604239 
0.000100564 
RP11-
817J15.3 
-
2.681678672 
0.000152405 
LRP1B -
2.687776713 
2.53746E-09 
LRRTM3 -
2.692726315 
0.00014002 
FAM150B -
2.696500954 
0.000119098 
FRMPD4 -
2.699785495 
5.43443E-07 
FAM196B -
2.708649168 
5.96792E-12 
TSPAN2 -
2.719526283 
1.75464E-05 
PLXDC1 -
2.721731043 
3.90681E-06 
C7 -
2.725249371 
1.04659E-05 
KCNS1 -
2.758504959 
1.14968E-06 
MFAP5 -2.76710485 1.07393E-05 
RPRM -
2.771648594 
2.41624E-05 
COL6A6 -
2.788141942 
2.52776E-06 
KIF26B -
2.791833575 
6.36016E-19 
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DGKI -
2.828958785 
3.67936E-10 
SEMA3D -2.83683745 5.4236E-11 
PDE1C -
2.855529834 
3.08091E-05 
CACNA2D3 -
2.885658644 
5.3376E-08 
PLXDC2 -
2.888677529 
1.16369E-15 
TSPAN11 -2.90836048 4.48737E-06 
SCXA -
2.932908207 
3.45263E-09 
ST6GAL2 -
2.943521012 
1.59405E-26 
B3GALT1 -
2.945703352 
7.18904E-13 
FIBIN -
2.953214283 
7.29682E-07 
RP11-284N8.3 -
2.962164216 
8.10658E-06 
GPR68 -
2.962568733 
3.20797E-06 
ROBO2 -
2.982732036 
5.16738E-18 
PRR5L -
2.993391908 
1.7856E-13 
APCDD1L -
3.000400747 
5.50638E-09 
SLC14A1 -
3.001994959 
7.06923E-06 
GRIA3 -
3.016047443 
6.18385E-15 
NRK -3.02929229 1.85949E-06 
FGF10 -
3.065540603 
1.48849E-06 
EFHD1 -
3.068058255 
3.46431E-14 
CCDC88C -
3.078824502 
1.06751E-06 
LDLRAD4 -
3.082221409 
1.9009E-07 
MXRA5 -
3.083071792 
3.1317E-16 
SULT1C4 -3.08329137 1.45394E-06 
MEX3A -
3.098310067 
1.88422E-10 
AL121578.2 -
3.103729147 
2.81945E-07 
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PKD1L1 -
3.111127904 
1.16495E-11 
CHRM2 -
3.135166063 
3.01436E-12 
RP11-
567M16.1 
-
3.161690977 
6.51053E-10 
FIGF -
3.179697294 
1.27095E-08 
CTGF -
3.182807582 
2.60982E-27 
COCH -
3.254932222 
2.59236E-09 
PKIA -
3.255853823 
8.46252E-11 
COL8A1 -
3.295080925 
2.46596E-11 
RP11-
355I22.7 
-
3.296662383 
5.44243E-09 
DLX5 -
3.299609446 
1.45035E-08 
SGCD -
3.313037252 
6.52922E-13 
SIK1 -
3.315847491 
9.70607E-25 
RFTN2 -3.3711162 4.41541E-24 
CXCR4 -
3.376829738 
1.52624E-09 
DIO2 -
3.400051234 
9.37958E-41 
TEK -
3.403354152 
2.55349E-35 
OSGIN2 -
3.426117412 
6.52168E-35 
CORIN -
3.433010421 
2.29708E-13 
HEPH -
3.433775639 
1.88631E-18 
MKX -
3.442720859 
1.00524E-25 
SYT16 -
3.458110791 
1.88977E-09 
MMP7 -
3.476306817 
8.0129E-12 
PREX2 -
3.479914644 
5.60209E-11 
SERPINE2 -
3.487519343 
8.71652E-22 
TMEM215 -
3.495134405 
6.90297E-08 
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CSMD3 -
3.512134402 
2.64262E-09 
EGR2 -
3.522310021 
6.58807E-11 
EDNRB -
3.522936121 
1.89129E-09 
HUNK -
3.528167826 
4.16842E-21 
WNT5A -
3.540337265 
4.99808E-30 
TNFSF18 -
3.548948163 
6.41625E-14 
NPBWR1 -
3.554439652 
3.17381E-08 
ALPL -
3.554476968 
2.26167E-09 
WNT2 -
3.602851955 
4.33008E-14 
CCND2 -
3.616496445 
4.4211E-10 
SYTL5 -
3.636929333 
3.74035E-31 
ESR1 -
3.664376545 
7.03795E-29 
TENM4 -3.67136597 7.45585E-28 
EPHA7 -
3.690076245 
8.93497E-11 
NCAM1 -
3.724242248 
5.16738E-18 
KCNMB2 -
3.736265991 
1.43528E-22 
NKD2 -
3.743045934 
4.14815E-10 
HMCN1 -
3.745331708 
2.24101E-19 
DIRC3 -
3.881284809 
7.73959E-19 
CLSTN2 -
3.933863047 
2.42606E-26 
PTHLH -
3.935931394 
8.31702E-15 
COL25A1 -
3.980171784 
4.59105E-18 
TNFSF15 -
4.036151947 
4.20505E-25 
CST4 -4.04063998 2.17525E-11 
MEOX1 -
4.131813768 
1.05628E-12 
RASSF2 -
4.227649306 
2.83959E-32 
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CHRNA1 -
4.244059875 
1.50826E-16 
ELN -
4.266666039 
7.82622E-15 
COL10A1 -
4.317286369 
7.16832E-19 
KCNC1 -
4.338936901 
7.79828E-15 
CST2 -
4.382294904 
2.86349E-14 
C11orf87 -
4.435728175 
3.13546E-19 
KCNH1 -4.48977746 2.03115E-18 
PLCH1 -
4.508772564 
2.57512E-44 
VASH2 -
4.563993386 
3.13504E-40 
MMP10 -
4.578072389 
1.19757E-17 
HTRA1 -
4.673379334 
3.54806E-30 
HTR1D -
5.583471612 
2.37595E-28 
CADM1 -
5.817100237 
1.92958E-46 
LINC00643 -
6.236143291 
7.07665E-37 
PMEPA1 -
6.743359183 
1.67117E-57 
CST1 -
6.771958173 
2.80323E-64 
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Appendix 7. A83-01 Up-regulated GO categories 
 
 
Go Term Term P 
GO:0005886 plasma membrane 9.26E-10 
GO:0019838 growth factor binding 3.83E-05 
GO:0004896 cytokine receptor 
activity 
0.000271 
GO:0030522 intracellular receptor 
signaling pathway 
0.000454 
GO:0043034 costamere 0.000458 
GO:0004016 adenylate cyclase 
activity 
0.000476 
GO:0004016 adenylate cyclase 
activity 
0.000476 
GO:0004016 adenylate cyclase 
activity 
0.000476 
GO:0001558 regulation of cell 
growth 
0.000776 
GO:0003707 steroid hormone 
receptor activity 
0.00089 
GO:0017080 sodium channel 
regulator activity 
0.000913 
GO:0017080 sodium channel 
regulator activity 
0.000913 
GO:0043401 steroid hormone 
mediated signaling 
pathway 
0.001199 
GO:0004879 RNA polymerase II 
transcription factor 
activity, ligand-
activated sequence-
specific DNA binding 
0.001734 
GO:0030054 cell junction 0.002582 
GO:0007169 transmembrane 
receptor protein 
tyrosine kinase 
signaling pathway 
0.003122 
GO:0004924 oncostatin-M receptor 
activity 
0.003867 
GO:0002003 angiotensin 
maturation 
0.00686 
GO:0004897 ciliary neurotrophic 
factor receptor activity 
0.007547 
GO:0038165 oncostatin-M-
mediated signaling 
pathway 
0.007968 
GO:0043565 sequence-specific 
DNA binding 
0.00842 
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GO:0016021 integral component of 
membrane 
0.00853 
GO:0006069 ethanol oxidation 0.008895 
GO:0009190 cyclic nucleotide 
biosynthetic process 
0.008895 
GO:0009190 cyclic nucleotide 
biosynthetic process 
0.008895 
GO:0005201 extracellular matrix 
structural constituent 
0.010719 
GO:0006367 transcription initiation 
from RNA polymerase 
II promoter 
0.01183 
GO:0070120 ciliary neurotrophic 
factor-mediated 
signaling pathway 
0.012953 
GO:0001657 ureteric bud 
development 
0.013026 
GO:0008076 voltage-gated 
potassium channel 
complex 
0.014011 
GO:0010951 negative regulation of 
endopeptidase activity 
0.015361 
GO:0014069 postsynaptic density 0.016133 
GO:0005587 collagen type IV trimer 0.017675 
GO:0001665 alpha-N-
acetylgalactosaminide 
alpha-2,6-
sialyltransferase 
activity 
0.017974 
GO:0008191 metalloendopeptidase 
inhibitor activity 
0.018828 
GO:0003081 regulation of systemic 
arterial blood pressure 
by renin-angiotensin 
0.018951 
GO:0071376 cellular response to 
corticotropin-releasing 
hormone stimulus 
0.018951 
GO:0006869 lipid transport 0.023361 
GO:0004908 interleukin-1 receptor 
activity 
0.024563 
GO:0019221 cytokine-mediated 
signaling pathway 
0.025252 
GO:0032755 positive regulation of 
interleukin-6 
production 
0.025647 
GO:0005112 Notch binding 0.026002 
GO:0001574 ganglioside 
biosynthetic process 
0.027945 
GO:0005044 scavenger receptor 
activity 
0.029617 
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GO:0032760 positive regulation of 
tumor necrosis factor 
production 
0.030316 
GO:0050700 CARD domain binding 0.031971 
GO:0010765 positive regulation of 
sodium ion transport 
0.032286 
GO:0045747 positive regulation of 
Notch signaling 
pathway 
0.033592 
GO:0014068 positive regulation of 
phosphatidylinositol 3-
kinase signaling 
0.034247 
GO:0097503 sialylation 0.036956 
GO:0007189 adenylate cyclase-
activating G-protein 
coupled receptor 
signaling pathway 
0.038265 
GO:0008074 guanylate cyclase 
complex, soluble 
0.039487 
GO:0004383 guanylate cyclase 
activity 
0.04013 
GO:0001822 kidney development 0.041942 
GO:0051894 positive regulation of 
focal adhesion 
assembly 
0.041952 
GO:0003208 cardiac ventricle 
morphogenesis 
0.042225 
GO:0061314 Notch signaling 
involved in heart 
development 
0.042225 
GO:0034097 response to cytokine 0.044208 
GO:0005581 collagen trimer 0.048347 
GO:0001223 transcription 
coactivator binding 
0.048976 
GO:0004716 receptor signaling 
protein tyrosine 
kinase activity 
0.048976 
 
 
 
Appendix 8. A83-01 Down-regulated GO categories 
 
GO Term Term P 
GO:0005578 proteinaceous 
extracellular matrix 
4.31E-22 
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GO:0030574 collagen catabolic 
process 
1.73E-13 
GO:0007156 homophilic cell 
adhesion via plasma 
membrane adhesion 
molecules 
1.17E-10 
GO:0005509 calcium ion binding 4E-10 
GO:0005201 extracellular matrix 
structural constituent 
4.17E-09 
GO:0005886 plasma membrane 4.74E-09 
GO:0005788 endoplasmic 
reticulum lumen 
2.27E-08 
GO:0016339 calcium-dependent 
cell-cell adhesion via 
plasma membrane 
cell adhesion 
molecules 
2.08E-07 
GO:0030199 collagen fibril 
organization 
4.59E-06 
GO:0005581 collagen trimer 9.99E-06 
GO:0050919 negative chemotaxis 1.34E-05 
GO:0050919 negative chemotaxis 1.34E-05 
GO:0007416 synapse assembly 3.4E-05 
GO:0001755 neural crest cell 
migration 
0.000115 
GO:0001837 epithelial to 
mesenchymal 
transition 
0.000117 
GO:0048843 negative regulation of 
axon extension 
involved in axon 
guidance 
0.000187 
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GO:0045499 chemorepellent 
activity 
0.00022 
GO:0022617 extracellular matrix 
disassembly 
0.000229 
GO:0004222 metalloendopeptidase 
activity 
0.000395 
GO:0048846 axon extension 
involved in axon 
guidance 
0.000513 
GO:0030215 semaphorin receptor 
binding 
0.000835 
GO:0060070 canonical Wnt 
signaling pathway 
0.001909 
GO:0021612 facial nerve structural 
organization 
0.002762 
GO:0070493 thrombin receptor 
signaling pathway 
0.002762 
GO:0045165 cell fate commitment 0.004291 
GO:0045211 postsynaptic 
membrane 
0.004509 
GO:0071526 semaphorin-plexin 
signaling pathway 
0.004678 
GO:0048407 platelet-derived 
growth factor binding 
0.005008 
GO:0005088 Ras guanyl-
nucleotide exchange 
factor activity 
0.005171 
GO:0050918 positive chemotaxis 0.006055 
GO:0003873 6-phosphofructo-2-
kinase activity 
0.006393 
GO:0006813 potassium ion 
transport 
0.006409 
  
319 
 
GO:0036486 ventral trunk neural 
crest cell migration 
0.006527 
GO:0097490 sympathetic neuron 
projection extension 
0.006527 
GO:0097491 sympathetic neuron 
projection guidance 
0.006527 
GO:1902285 semaphorin-plexin 
signaling pathway 
involved in neuron 
projection guidance 
0.006527 
GO:0005109 frizzled binding 0.006547 
GO:0071805 potassium ion 
transmembrane 
transport 
0.007899 
GO:0008076 voltage-gated 
potassium channel 
complex 
0.008582 
GO:0071300 cellular response to 
retinoic acid 
0.009208 
GO:0015459 potassium channel 
regulator activity 
0.010249 
GO:0004331 fructose-2,6-
bisphosphate 2-
phosphatase activity 
0.01042 
GO:0015057 thrombin receptor 
activity 
0.01042 
GO:0006003 fructose 2,6-
bisphosphate 
metabolic process 
0.010635 
GO:1901166 neural crest cell 
migration involved in 
autonomic nervous 
system development 
0.010635 
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GO:0016021 integral component of 
membrane 
0.011279 
GO:0005161 platelet-derived 
growth factor receptor 
binding 
0.012505 
GO:0005161 platelet-derived 
growth factor receptor 
binding 
0.012505 
GO:0038191 neuropilin binding 0.012505 
GO:0007215 glutamate receptor 
signaling pathway 
0.012868 
GO:0045725 positive regulation of 
glycogen biosynthetic 
process 
0.012868 
GO:0050930 induction of positive 
chemotaxis 
0.012868 
GO:0040007 growth 0.013837 
GO:0051482 positive regulation of 
cytosolic calcium ion 
concentration 
involved in 
phospholipase C-
activating G-protein 
coupled signaling 
pathway 
0.013837 
GO:0030182 neuron differentiation 0.014985 
GO:0048341 paraxial mesoderm 
formation 
0.015598 
GO:0005158 insulin receptor 
binding 
0.018974 
GO:0005520 insulin-like growth 
factor binding 
0.020827 
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GO:0005004 GPI-linked ephrin 
receptor activity 
0.02093 
GO:0008373 sialyltransferase 
activity 
0.024131 
GO:0016055 Wnt signaling 
pathway 
0.025146 
GO:0048015 phosphatidylinositol-
mediated signaling 
0.027072 
GO:0097503 sialylation 0.028468 
GO:0007160 cell-matrix adhesion 0.032473 
GO:0070700 BMP receptor binding 0.034329 
GO:0021675 nerve development 0.035006 
GO:0061549 sympathetic ganglion 
development 
0.035006 
GO:0001568 blood vessel 
development 
0.038366 
GO:0005796 Golgi lumen 0.039666 
GO:0046835 carbohydrate 
phosphorylation 
0.041067 
GO:0006000 fructose metabolic 
process 
0.042795 
GO:0035235 ionotropic glutamate 
receptor signaling 
pathway 
0.045793 
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